Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2026-06-20
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| score | |
|---|---|
| AARS2 | -7.2459291 |
| AASS | -0.2262333 |
| ABAT | -0.7818429 |
| ABCB10 | 0.1846879 |
| ABCB6 | 0.2339680 |
| ABCB7 | -0.3214584 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 7608 |
| num_genes_in_profile | 982 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 925 |
| num_profile_genes_not_in_sets | 57 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 7608 |
| num_genesets_excluded | 6998 |
| num_genesets_included | 610 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| MITOCHONDRIAL GENE EXPRESSION | 156 | 2.94e-05 | -0.210 | 0.0326 |
| MITOCHONDRIAL TRANSLATION | 128 | 7.89e-05 | -0.215 | 0.0437 |
| TRANSLATION | 148 | 1.37e-04 | -0.196 | 0.0506 |
| ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 319 | 4.35e-04 | -0.138 | 0.1200 |
| PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 12 | 1.40e-03 | -0.535 | 0.2900 |
| ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 64 | 1.57e-03 | -0.236 | 0.2900 |
| PROTEIN TARGETING TO MITOCHONDRION | 54 | 2.38e-03 | -0.245 | 0.3770 |
| NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 65 | 3.52e-03 | 0.216 | 0.4630 |
| PROTEIN TARGETING | 60 | 3.76e-03 | -0.223 | 0.4630 |
| PROTEIN LOCALIZATION TO ORGANELLE | 72 | 4.90e-03 | -0.199 | 0.5160 |
| PROTEIN TRANSMEMBRANE TRANSPORT | 24 | 5.33e-03 | -0.332 | 0.5160 |
| ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 54 | 6.84e-03 | 0.218 | 0.5160 |
| NEGATIVE REGULATION OF CATABOLIC PROCESS | 13 | 7.32e-03 | 0.432 | 0.5160 |
| PROTEIN TRANSPORT | 69 | 7.68e-03 | -0.192 | 0.5160 |
| RESPONSE TO HYDROGEN PEROXIDE | 15 | 7.79e-03 | 0.400 | 0.5160 |
| REGULATION OF APOPTOTIC SIGNALING PATHWAY | 38 | 7.86e-03 | 0.254 | 0.5160 |
| PROTEIN LOCALIZATION TO MITOCHONDRION | 64 | 7.93e-03 | -0.198 | 0.5160 |
| PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 21 | 8.89e-03 | -0.333 | 0.5240 |
| NITROGEN COMPOUND TRANSPORT | 109 | 9.01e-03 | -0.153 | 0.5240 |
| 2FE 2S CLUSTER ASSEMBLY | 8 | 9.71e-03 | -0.530 | 0.5250 |
| REGULATION OF PROGRAMMED CELL DEATH | 88 | 9.96e-03 | 0.166 | 0.5250 |
| RESPONSE TO REACTIVE OXYGEN SPECIES | 24 | 1.17e-02 | 0.301 | 0.5610 |
| DETOXIFICATION | 24 | 1.17e-02 | 0.301 | 0.5610 |
| RESPONSE TO TOXIC SUBSTANCE | 36 | 1.24e-02 | 0.245 | 0.5720 |
| CELLULAR KETONE METABOLIC PROCESS | 38 | 1.64e-02 | 0.229 | 0.7010 |
| REGULATION OF CELLULAR CATABOLIC PROCESS | 29 | 1.79e-02 | 0.258 | 0.7010 |
| MITOCHONDRIAL TRANSCRIPTION | 13 | 1.92e-02 | -0.377 | 0.7010 |
| RESPONSE TO INORGANIC SUBSTANCE | 38 | 1.92e-02 | 0.224 | 0.7010 |
| CELLULAR RESPONSE TO TOXIC SUBSTANCE | 25 | 1.96e-02 | 0.273 | 0.7010 |
| APOPTOTIC SIGNALING PATHWAY | 60 | 2.26e-02 | 0.175 | 0.7010 |
| RESPONSE TO OXIDATIVE STRESS | 60 | 2.27e-02 | 0.175 | 0.7010 |
| MITOCHONDRIAL FISSION | 20 | 2.34e-02 | 0.296 | 0.7010 |
| CELLULAR OXIDANT DETOXIFICATION | 20 | 2.36e-02 | 0.295 | 0.7010 |
| INTRACELLULAR PROTEIN TRANSPORT | 43 | 2.43e-02 | -0.203 | 0.7010 |
| REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 28 | 2.50e-02 | 0.248 | 0.7010 |
| SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 10 | 2.62e-02 | 0.408 | 0.7010 |
| ISOPRENOID METABOLIC PROCESS | 13 | 2.66e-02 | 0.357 | 0.7010 |
| ESTABLISHMENT OF PROTEIN LOCALIZATION | 98 | 2.68e-02 | -0.136 | 0.7010 |
| RESPONSE TO HYPEROXIA | 6 | 2.75e-02 | 0.521 | 0.7010 |
| RESPONSE TO INCREASED OXYGEN LEVELS | 6 | 2.75e-02 | 0.521 | 0.7010 |
| MICROTUBULE BASED MOVEMENT | 10 | 2.82e-02 | 0.403 | 0.7010 |
| CELL DIVISION | 10 | 2.83e-02 | 0.402 | 0.7010 |
| ISOCITRATE METABOLIC PROCESS | 5 | 3.12e-02 | 0.558 | 0.7010 |
| PHOSPHOLIPID BIOSYNTHETIC PROCESS | 19 | 3.12e-02 | 0.288 | 0.7010 |
| REGULATION OF IMMUNE EFFECTOR PROCESS | 8 | 3.16e-02 | -0.441 | 0.7010 |
| REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 3.19e-02 | 0.440 | 0.7010 |
| NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 9 | 3.20e-02 | 0.415 | 0.7010 |
| PROCESS UTILIZING AUTOPHAGIC MECHANISM | 41 | 3.23e-02 | 0.197 | 0.7010 |
| POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 12 | 3.30e-02 | 0.358 | 0.7010 |
| NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 11 | 3.34e-02 | 0.372 | 0.7010 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| MITOCHONDRIAL GENE EXPRESSION | 156 | 2.94e-05 | -0.210000 | 0.0326 |
| MITOCHONDRIAL TRANSLATION | 128 | 7.89e-05 | -0.215000 | 0.0437 |
| TRANSLATION | 148 | 1.37e-04 | -0.196000 | 0.0506 |
| ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 319 | 4.35e-04 | -0.138000 | 0.1200 |
| PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 12 | 1.40e-03 | -0.535000 | 0.2900 |
| ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 64 | 1.57e-03 | -0.236000 | 0.2900 |
| PROTEIN TARGETING TO MITOCHONDRION | 54 | 2.38e-03 | -0.245000 | 0.3770 |
| NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 65 | 3.52e-03 | 0.216000 | 0.4630 |
| PROTEIN TARGETING | 60 | 3.76e-03 | -0.223000 | 0.4630 |
| PROTEIN LOCALIZATION TO ORGANELLE | 72 | 4.90e-03 | -0.199000 | 0.5160 |
| PROTEIN TRANSMEMBRANE TRANSPORT | 24 | 5.33e-03 | -0.332000 | 0.5160 |
| ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 54 | 6.84e-03 | 0.218000 | 0.5160 |
| NEGATIVE REGULATION OF CATABOLIC PROCESS | 13 | 7.32e-03 | 0.432000 | 0.5160 |
| PROTEIN TRANSPORT | 69 | 7.68e-03 | -0.192000 | 0.5160 |
| RESPONSE TO HYDROGEN PEROXIDE | 15 | 7.79e-03 | 0.400000 | 0.5160 |
| REGULATION OF APOPTOTIC SIGNALING PATHWAY | 38 | 7.86e-03 | 0.254000 | 0.5160 |
| PROTEIN LOCALIZATION TO MITOCHONDRION | 64 | 7.93e-03 | -0.198000 | 0.5160 |
| PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 21 | 8.89e-03 | -0.333000 | 0.5240 |
| NITROGEN COMPOUND TRANSPORT | 109 | 9.01e-03 | -0.153000 | 0.5240 |
| 2FE 2S CLUSTER ASSEMBLY | 8 | 9.71e-03 | -0.530000 | 0.5250 |
| REGULATION OF PROGRAMMED CELL DEATH | 88 | 9.96e-03 | 0.166000 | 0.5250 |
| RESPONSE TO REACTIVE OXYGEN SPECIES | 24 | 1.17e-02 | 0.301000 | 0.5610 |
| DETOXIFICATION | 24 | 1.17e-02 | 0.301000 | 0.5610 |
| RESPONSE TO TOXIC SUBSTANCE | 36 | 1.24e-02 | 0.245000 | 0.5720 |
| CELLULAR KETONE METABOLIC PROCESS | 38 | 1.64e-02 | 0.229000 | 0.7010 |
| REGULATION OF CELLULAR CATABOLIC PROCESS | 29 | 1.79e-02 | 0.258000 | 0.7010 |
| MITOCHONDRIAL TRANSCRIPTION | 13 | 1.92e-02 | -0.377000 | 0.7010 |
| RESPONSE TO INORGANIC SUBSTANCE | 38 | 1.92e-02 | 0.224000 | 0.7010 |
| CELLULAR RESPONSE TO TOXIC SUBSTANCE | 25 | 1.96e-02 | 0.273000 | 0.7010 |
| APOPTOTIC SIGNALING PATHWAY | 60 | 2.26e-02 | 0.175000 | 0.7010 |
| RESPONSE TO OXIDATIVE STRESS | 60 | 2.27e-02 | 0.175000 | 0.7010 |
| MITOCHONDRIAL FISSION | 20 | 2.34e-02 | 0.296000 | 0.7010 |
| CELLULAR OXIDANT DETOXIFICATION | 20 | 2.36e-02 | 0.295000 | 0.7010 |
| INTRACELLULAR PROTEIN TRANSPORT | 43 | 2.43e-02 | -0.203000 | 0.7010 |
| REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 28 | 2.50e-02 | 0.248000 | 0.7010 |
| SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 10 | 2.62e-02 | 0.408000 | 0.7010 |
| ISOPRENOID METABOLIC PROCESS | 13 | 2.66e-02 | 0.357000 | 0.7010 |
| ESTABLISHMENT OF PROTEIN LOCALIZATION | 98 | 2.68e-02 | -0.136000 | 0.7010 |
| RESPONSE TO HYPEROXIA | 6 | 2.75e-02 | 0.521000 | 0.7010 |
| RESPONSE TO INCREASED OXYGEN LEVELS | 6 | 2.75e-02 | 0.521000 | 0.7010 |
| MICROTUBULE BASED MOVEMENT | 10 | 2.82e-02 | 0.403000 | 0.7010 |
| CELL DIVISION | 10 | 2.83e-02 | 0.402000 | 0.7010 |
| ISOCITRATE METABOLIC PROCESS | 5 | 3.12e-02 | 0.558000 | 0.7010 |
| PHOSPHOLIPID BIOSYNTHETIC PROCESS | 19 | 3.12e-02 | 0.288000 | 0.7010 |
| REGULATION OF IMMUNE EFFECTOR PROCESS | 8 | 3.16e-02 | -0.441000 | 0.7010 |
| REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 3.19e-02 | 0.440000 | 0.7010 |
| NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 9 | 3.20e-02 | 0.415000 | 0.7010 |
| PROCESS UTILIZING AUTOPHAGIC MECHANISM | 41 | 3.23e-02 | 0.197000 | 0.7010 |
| POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 12 | 3.30e-02 | 0.358000 | 0.7010 |
| NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 11 | 3.34e-02 | 0.372000 | 0.7010 |
| ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 27 | 3.47e-02 | -0.238000 | 0.7010 |
| REGULATION OF NEURON APOPTOTIC PROCESS | 15 | 3.50e-02 | 0.317000 | 0.7010 |
| APOPTOTIC PROCESS | 117 | 3.55e-02 | 0.120000 | 0.7010 |
| PROTEIN FOLDING | 17 | 3.71e-02 | -0.295000 | 0.7010 |
| PEROXISOME ORGANIZATION | 7 | 3.77e-02 | 0.455000 | 0.7010 |
| ORGANELLE FISSION | 27 | 3.79e-02 | 0.234000 | 0.7010 |
| ENERGY COUPLED PROTON TRANSMEMBRANE TRANSPORT AGAINST ELECTROCHEMICAL GRADIENT | 5 | 3.81e-02 | 0.537000 | 0.7010 |
| REGULATION OF AUTOPHAGY | 24 | 3.86e-02 | 0.247000 | 0.7010 |
| GLUTATHIONE METABOLIC PROCESS | 10 | 4.01e-02 | 0.377000 | 0.7010 |
| LACTATE METABOLIC PROCESS | 6 | 4.16e-02 | 0.482000 | 0.7010 |
| HYDROGEN PEROXIDE METABOLIC PROCESS | 11 | 4.20e-02 | 0.356000 | 0.7010 |
| TERPENOID METABOLIC PROCESS | 8 | 4.29e-02 | 0.415000 | 0.7010 |
| REGULATION OF MITOCHONDRIAL FISSION | 12 | 4.39e-02 | 0.338000 | 0.7010 |
| CELLULAR HOMEOSTASIS | 66 | 4.43e-02 | 0.148000 | 0.7010 |
| NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 5 | 4.44e-02 | -0.521000 | 0.7010 |
| REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 5 | 4.54e-02 | 0.518000 | 0.7010 |
| NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 31 | 4.64e-02 | 0.210000 | 0.7010 |
| POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 7 | 4.70e-02 | 0.435000 | 0.7010 |
| SHORT CHAIN FATTY ACID METABOLIC PROCESS | 10 | 4.76e-02 | -0.364000 | 0.7010 |
| ENDOMEMBRANE SYSTEM ORGANIZATION | 9 | 4.92e-02 | 0.380000 | 0.7010 |
| POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 11 | 4.97e-02 | 0.344000 | 0.7010 |
| ALCOHOL METABOLIC PROCESS | 38 | 5.04e-02 | 0.187000 | 0.7010 |
| POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 5 | 5.13e-02 | 0.505000 | 0.7010 |
| POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 5.13e-02 | 0.505000 | 0.7010 |
| PROTEIN TARGETING TO MEMBRANE | 5 | 5.13e-02 | 0.505000 | 0.7010 |
| REGULATION OF PROTEIN TARGETING TO MEMBRANE | 5 | 5.13e-02 | 0.505000 | 0.7010 |
| MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 5.17e-02 | -0.504000 | 0.7010 |
| PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 5.23e-02 | -0.267000 | 0.7010 |
| CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 6 | 5.30e-02 | 0.458000 | 0.7010 |
| 4FE 4S CLUSTER ASSEMBLY | 5 | 5.40e-02 | -0.499000 | 0.7010 |
| REGULATION OF MEMBRANE PERMEABILITY | 26 | 5.45e-02 | 0.221000 | 0.7010 |
| REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 26 | 5.45e-02 | 0.221000 | 0.7010 |
| AMIDE TRANSPORT | 20 | 5.50e-02 | -0.250000 | 0.7010 |
| SUBSTANTIA NIGRA DEVELOPMENT | 5 | 5.58e-02 | -0.495000 | 0.7010 |
| REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 49 | 5.59e-02 | 0.162000 | 0.7010 |
| NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 5.64e-02 | 0.451000 | 0.7010 |
| AMEBOIDAL TYPE CELL MIGRATION | 5 | 5.64e-02 | -0.494000 | 0.7010 |
| REGULATION OF PROTEIN TARGETING | 11 | 5.71e-02 | 0.333000 | 0.7010 |
| RESPONSE TO OXYGEN RADICAL | 5 | 5.73e-02 | 0.492000 | 0.7010 |
| MICROTUBULE BASED PROCESS | 14 | 5.78e-02 | 0.295000 | 0.7010 |
| SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 5.80e-02 | -0.448000 | 0.7010 |
| REGULATION OF CATABOLIC PROCESS | 52 | 5.83e-02 | 0.156000 | 0.7010 |
| RESPONSE TO OXYGEN CONTAINING COMPOUND | 86 | 5.89e-02 | 0.123000 | 0.7010 |
| REGULATION OF CELL DIVISION | 5 | 5.98e-02 | 0.487000 | 0.7040 |
| PHOSPHOLIPID TRANSPORT | 6 | 6.13e-02 | 0.443000 | 0.7080 |
| APOPTOTIC MITOCHONDRIAL CHANGES | 42 | 6.28e-02 | 0.170000 | 0.7080 |
| STEROID METABOLIC PROCESS | 26 | 6.35e-02 | 0.213000 | 0.7080 |
| INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 11 | 6.38e-02 | 0.325000 | 0.7080 |
| ADIPOSE TISSUE DEVELOPMENT | 5 | 6.40e-02 | 0.480000 | 0.7080 |
| CONNECTIVE TISSUE DEVELOPMENT | 5 | 6.40e-02 | 0.480000 | 0.7080 |
| IMPORT INTO THE MITOCHONDRION | 44 | 6.78e-02 | -0.163000 | 0.7420 |
| RESPONSE TO XENOBIOTIC STIMULUS | 28 | 6.92e-02 | 0.201000 | 0.7430 |
| NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 11 | 6.95e-02 | -0.318000 | 0.7430 |
| SULFUR COMPOUND TRANSPORT | 8 | 6.99e-02 | -0.372000 | 0.7430 |
| INTRINSIC APOPTOTIC SIGNALING PATHWAY | 38 | 7.19e-02 | 0.172000 | 0.7510 |
| CELLULAR ALDEHYDE METABOLIC PROCESS | 16 | 7.22e-02 | 0.262000 | 0.7510 |
| ACTIVATION OF INNATE IMMUNE RESPONSE | 10 | 7.29e-02 | -0.329000 | 0.7510 |
| CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 16 | 7.33e-02 | 0.261000 | 0.7510 |
| MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 7.42e-02 | -0.462000 | 0.7520 |
| NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 7.58e-02 | 0.389000 | 0.7580 |
| POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 14 | 7.61e-02 | 0.276000 | 0.7580 |
| ORGANIC CATION TRANSPORT | 11 | 7.69e-02 | -0.310000 | 0.7600 |
| REGULATION OF MEMBRANE POTENTIAL | 32 | 8.13e-02 | 0.181000 | 0.7740 |
| CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 8 | 8.17e-02 | 0.357000 | 0.7740 |
| INORGANIC ION HOMEOSTASIS | 39 | 8.19e-02 | 0.164000 | 0.7740 |
| POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 23 | 8.26e-02 | 0.212000 | 0.7740 |
| REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 8.27e-02 | 0.336000 | 0.7740 |
| RESPONSE TO ETHANOL | 14 | 8.31e-02 | 0.269000 | 0.7740 |
| DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 27 | 8.32e-02 | 0.195000 | 0.7740 |
| NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 5 | 8.47e-02 | -0.446000 | 0.7770 |
| NEGATIVE REGULATION OF SECRETION | 5 | 8.70e-02 | -0.443000 | 0.7770 |
| REGULATION OF TRANS SYNAPTIC SIGNALING | 6 | 8.72e-02 | 0.405000 | 0.7770 |
| RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 26 | 8.73e-02 | 0.196000 | 0.7770 |
| NEUROTRANSMITTER TRANSPORT | 5 | 8.75e-02 | 0.443000 | 0.7770 |
| POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 11 | 8.83e-02 | 0.299000 | 0.7770 |
| EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 8.85e-02 | 0.241000 | 0.7770 |
| MICROTUBULE BASED TRANSPORT | 7 | 9.21e-02 | 0.369000 | 0.7970 |
| HOMEOSTATIC PROCESS | 118 | 9.38e-02 | 0.095000 | 0.7970 |
| MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 11 | 9.53e-02 | 0.292000 | 0.7970 |
| IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 12 | 9.78e-02 | -0.278000 | 0.7970 |
| MITOCHONDRION ORGANIZATION | 251 | 9.82e-02 | 0.069900 | 0.7970 |
| POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 11 | 9.94e-02 | -0.289000 | 0.7970 |
| PHOSPHOLIPID METABOLIC PROCESS | 26 | 1.01e-01 | 0.188000 | 0.7970 |
| RESPONSE TO METAL ION | 26 | 1.01e-01 | 0.188000 | 0.7970 |
| MONOATOMIC ION HOMEOSTASIS | 45 | 1.02e-01 | 0.144000 | 0.7970 |
| POSITIVE REGULATION OF AUTOPHAGY | 10 | 1.04e-01 | 0.298000 | 0.7970 |
| REGULATION OF MITOCHONDRION ORGANIZATION | 58 | 1.05e-01 | 0.127000 | 0.7970 |
| REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 1.06e-01 | 0.182000 | 0.7970 |
| CELL REDOX HOMEOSTASIS | 16 | 1.06e-01 | 0.235000 | 0.7970 |
| AMINE CATABOLIC PROCESS | 5 | 1.07e-01 | 0.417000 | 0.7970 |
| DNA DAMAGE RESPONSE | 41 | 1.07e-01 | 0.148000 | 0.7970 |
| RESPONSE TO NUTRIENT | 15 | 1.09e-01 | 0.241000 | 0.7970 |
| POSITIVE REGULATION OF CELL ADHESION | 8 | 1.10e-01 | -0.328000 | 0.7970 |
| DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 10 | 1.10e-01 | 0.293000 | 0.7970 |
| MODIFIED AMINO ACID TRANSPORT | 6 | 1.10e-01 | -0.378000 | 0.7970 |
| REGULATION OF HORMONE SECRETION | 14 | 1.10e-01 | -0.248000 | 0.7970 |
| REGULATION OF AUTOPHAGY OF MITOCHONDRION | 13 | 1.11e-01 | 0.257000 | 0.7970 |
| SUCCINYL COA METABOLIC PROCESS | 8 | 1.12e-01 | -0.326000 | 0.7970 |
| STEM CELL DIFFERENTIATION | 6 | 1.12e-01 | 0.376000 | 0.7970 |
| POSITIVE REGULATION OF PROTEIN LOCALIZATION | 20 | 1.13e-01 | 0.207000 | 0.7970 |
| ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 60 | 1.13e-01 | 0.122000 | 0.7970 |
| IMMUNE SYSTEM DEVELOPMENT | 6 | 1.13e-01 | 0.375000 | 0.7970 |
| REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 1.14e-01 | 0.374000 | 0.7970 |
| RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 6 | 1.14e-01 | 0.374000 | 0.7970 |
| ORGANELLE LOCALIZATION | 16 | 1.14e-01 | 0.230000 | 0.7970 |
| IMMUNE EFFECTOR PROCESS | 12 | 1.15e-01 | -0.265000 | 0.7970 |
| GAMETE GENERATION | 19 | 1.15e-01 | 0.211000 | 0.7970 |
| MITOCHONDRION LOCALIZATION | 10 | 1.16e-01 | 0.289000 | 0.7970 |
| RIBOSOME DISASSEMBLY | 8 | 1.18e-01 | -0.320000 | 0.7970 |
| POSITIVE REGULATION OF DEFENSE RESPONSE | 14 | 1.19e-01 | -0.243000 | 0.7970 |
| PROTEIN MATURATION | 49 | 1.19e-01 | -0.132000 | 0.7970 |
| TISSUE HOMEOSTASIS | 5 | 1.19e-01 | 0.404000 | 0.7970 |
| ACTIVATION OF IMMUNE RESPONSE | 13 | 1.19e-01 | -0.251000 | 0.7970 |
| MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 9 | 1.21e-01 | 0.300000 | 0.7970 |
| RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 15 | 1.23e-01 | 0.232000 | 0.7970 |
| POSITIVE REGULATION OF IMMUNE RESPONSE | 18 | 1.23e-01 | -0.212000 | 0.7970 |
| BASE EXCISION REPAIR | 7 | 1.24e-01 | 0.337000 | 0.7970 |
| OSTEOBLAST DIFFERENTIATION | 10 | 1.24e-01 | 0.283000 | 0.7970 |
| MAINTENANCE OF PROTEIN LOCATION | 6 | 1.25e-01 | -0.363000 | 0.7970 |
| MAINTENANCE OF PROTEIN LOCATION IN CELL | 6 | 1.25e-01 | -0.363000 | 0.7970 |
| INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 40 | 1.26e-01 | -0.143000 | 0.7970 |
| MACROAUTOPHAGY | 27 | 1.29e-01 | 0.171000 | 0.7970 |
| MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS | 23 | 1.29e-01 | 0.185000 | 0.7970 |
| ELECTRON TRANSPORT CHAIN | 94 | 1.30e-01 | 0.094900 | 0.7970 |
| POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 19 | 1.30e-01 | 0.203000 | 0.7970 |
| FAT CELL DIFFERENTIATION | 6 | 1.32e-01 | 0.357000 | 0.7970 |
| SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 9 | 1.32e-01 | 0.292000 | 0.7970 |
| REGULATION OF PHOSPHORYLATION | 15 | 1.32e-01 | 0.226000 | 0.7970 |
| CELLULAR RESPONSE TO STARVATION | 5 | 1.33e-01 | 0.389000 | 0.7970 |
| NEUROGENESIS | 27 | 1.34e-01 | 0.169000 | 0.7970 |
| POSITIVE REGULATION OF MACROAUTOPHAGY | 7 | 1.34e-01 | 0.328000 | 0.7970 |
| DNA RECOMBINATION | 10 | 1.36e-01 | 0.274000 | 0.7970 |
| ORGANELLE FUSION | 30 | 1.36e-01 | 0.160000 | 0.7970 |
| MALE SEX DIFFERENTIATION | 7 | 1.38e-01 | 0.325000 | 0.7970 |
| NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 5 | 1.40e-01 | -0.383000 | 0.7970 |
| CYTOKINE MEDIATED SIGNALING PATHWAY | 6 | 1.42e-01 | 0.348000 | 0.7970 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 9 | 1.42e-01 | 0.284000 | 0.7970 |
| MACROMOLECULE CATABOLIC PROCESS | 54 | 1.42e-01 | 0.119000 | 0.7970 |
| TRANSLATIONAL ELONGATION | 10 | 1.42e-01 | -0.269000 | 0.7970 |
| STEROL METABOLIC PROCESS | 13 | 1.43e-01 | 0.236000 | 0.7970 |
| SENSORY ORGAN DEVELOPMENT | 11 | 1.45e-01 | 0.255000 | 0.7970 |
| REGULATION OF EPITHELIAL CELL PROLIFERATION | 9 | 1.46e-01 | -0.281000 | 0.7970 |
| NEGATIVE REGULATION OF MOLECULAR FUNCTION | 13 | 1.47e-01 | -0.234000 | 0.7970 |
| PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 5 | 1.47e-01 | -0.375000 | 0.7970 |
| SECONDARY METABOLIC PROCESS | 5 | 1.49e-01 | 0.374000 | 0.7970 |
| BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 52 | 1.49e-01 | 0.119000 | 0.7970 |
| SEXUAL REPRODUCTION | 22 | 1.50e-01 | 0.180000 | 0.7970 |
| EPIDERMIS DEVELOPMENT | 6 | 1.51e-01 | 0.340000 | 0.7970 |
| GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 13 | 1.52e-01 | 0.231000 | 0.7970 |
| MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 44 | 1.52e-01 | 0.128000 | 0.7970 |
| PEPTIDE TRANSPORT | 15 | 1.52e-01 | -0.215000 | 0.7970 |
| PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 1.56e-01 | 0.336000 | 0.7970 |
| HORMONE TRANSPORT | 15 | 1.57e-01 | -0.213000 | 0.7970 |
| NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 5 | 1.57e-01 | 0.366000 | 0.7970 |
| MULTICELLULAR ORGANISM GROWTH | 9 | 1.59e-01 | 0.272000 | 0.7970 |
| REGULATION OF ORGANELLE ORGANIZATION | 62 | 1.60e-01 | 0.107000 | 0.7970 |
| RESPONSE TO CADMIUM ION | 5 | 1.60e-01 | 0.364000 | 0.7970 |
| NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 1.60e-01 | 0.332000 | 0.7970 |
| PIGMENT BIOSYNTHETIC PROCESS | 16 | 1.62e-01 | -0.204000 | 0.7970 |
| B CELL DIFFERENTIATION | 5 | 1.63e-01 | 0.362000 | 0.7970 |
| MITOCHONDRIAL TRANSPORT | 118 | 1.63e-01 | -0.079100 | 0.7970 |
| PLACENTA DEVELOPMENT | 5 | 1.64e-01 | 0.360000 | 0.7970 |
| POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 36 | 1.65e-01 | 0.136000 | 0.7970 |
| REGULATION OF MACROAUTOPHAGY | 16 | 1.65e-01 | 0.202000 | 0.7970 |
| POSITIVE REGULATION OF SIGNALING | 37 | 1.65e-01 | 0.135000 | 0.7970 |
| INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 12 | 1.66e-01 | 0.233000 | 0.7970 |
| VESICLE ORGANIZATION | 5 | 1.67e-01 | 0.358000 | 0.7970 |
| OLEFINIC COMPOUND METABOLIC PROCESS | 12 | 1.69e-01 | 0.231000 | 0.7970 |
| POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 16 | 1.71e-01 | -0.200000 | 0.7970 |
| CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 8 | 1.72e-01 | -0.280000 | 0.7970 |
| MITOCHONDRIAL PROTEIN PROCESSING | 10 | 1.72e-01 | -0.251000 | 0.7970 |
| RESPONSE TO BACTERIUM | 22 | 1.73e-01 | 0.170000 | 0.7970 |
| CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 6 | 1.74e-01 | 0.321000 | 0.7970 |
| TRICARBOXYLIC ACID METABOLIC PROCESS | 8 | 1.75e-01 | 0.278000 | 0.7970 |
| LOCALIZATION WITHIN MEMBRANE | 41 | 1.75e-01 | -0.125000 | 0.7970 |
| REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.75e-01 | 0.351000 | 0.7970 |
| UBIQUINONE METABOLIC PROCESS | 15 | 1.76e-01 | 0.203000 | 0.7970 |
| MITOCHONDRIAL FUSION | 28 | 1.76e-01 | 0.150000 | 0.7970 |
| ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 7 | 1.77e-01 | 0.296000 | 0.7970 |
| RNA 3 END PROCESSING | 8 | 1.78e-01 | 0.276000 | 0.7970 |
| REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 20 | 1.78e-01 | 0.176000 | 0.7970 |
| MONONUCLEAR CELL DIFFERENTIATION | 13 | 1.79e-01 | 0.217000 | 0.7970 |
| NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 15 | 1.81e-01 | -0.201000 | 0.7970 |
| AMINO ACID CATABOLIC PROCESS | 44 | 1.81e-01 | -0.119000 | 0.7970 |
| CARDIOLIPIN BIOSYNTHETIC PROCESS | 5 | 1.84e-01 | 0.344000 | 0.7970 |
| RESPONSE TO IONIZING RADIATION | 8 | 1.84e-01 | 0.272000 | 0.7970 |
| B CELL ACTIVATION | 10 | 1.84e-01 | 0.244000 | 0.7970 |
| REGULATION OF INSULIN SECRETION | 13 | 1.84e-01 | -0.214000 | 0.7970 |
| REGULATION OF PEPTIDE TRANSPORT | 13 | 1.84e-01 | -0.214000 | 0.7970 |
| POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 22 | 1.85e-01 | 0.165000 | 0.7970 |
| SENSORY PERCEPTION OF LIGHT STIMULUS | 5 | 1.86e-01 | -0.343000 | 0.7970 |
| ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 79 | 1.86e-01 | 0.089700 | 0.7970 |
| REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 41 | 1.86e-01 | 0.122000 | 0.7970 |
| REPRODUCTIVE SYSTEM DEVELOPMENT | 12 | 1.87e-01 | 0.221000 | 0.7970 |
| SEX DIFFERENTIATION | 12 | 1.87e-01 | 0.221000 | 0.7970 |
| MITOCHONDRIAL RNA 3 END PROCESSING | 7 | 1.87e-01 | 0.289000 | 0.7970 |
| POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 5 | 1.88e-01 | -0.341000 | 0.7970 |
| MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 29 | 1.88e-01 | 0.143000 | 0.7970 |
| LIPID BIOSYNTHETIC PROCESS | 66 | 1.89e-01 | 0.096700 | 0.7970 |
| CELL MORPHOGENESIS | 7 | 1.90e-01 | 0.287000 | 0.7970 |
| REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 5 | 1.90e-01 | 0.340000 | 0.7970 |
| RESPONSE TO ISCHEMIA | 5 | 1.90e-01 | 0.340000 | 0.7970 |
| POSITIVE REGULATION OF CATABOLIC PROCESS | 23 | 1.91e-01 | 0.159000 | 0.7970 |
| QUINONE METABOLIC PROCESS | 16 | 1.91e-01 | 0.190000 | 0.7970 |
| REGULATION OF DEVELOPMENTAL GROWTH | 8 | 1.91e-01 | 0.268000 | 0.7970 |
| CHEMICAL HOMEOSTASIS | 65 | 1.93e-01 | 0.096500 | 0.7970 |
| DEPHOSPHORYLATION | 7 | 1.94e-01 | -0.285000 | 0.7970 |
| CELLULAR RESPONSE TO NUTRIENT LEVELS | 9 | 1.94e-01 | 0.252000 | 0.7970 |
| RENAL SYSTEM DEVELOPMENT | 10 | 1.94e-01 | 0.238000 | 0.7970 |
| POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 30 | 1.94e-01 | 0.139000 | 0.7970 |
| CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 7 | 1.94e-01 | 0.284000 | 0.7970 |
| XENOBIOTIC METABOLIC PROCESS | 7 | 1.94e-01 | 0.284000 | 0.7970 |
| REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 23 | 1.95e-01 | 0.158000 | 0.7970 |
| MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 1.95e-01 | 0.307000 | 0.7970 |
| REGULATION OF GLUCOSE METABOLIC PROCESS | 11 | 1.95e-01 | 0.227000 | 0.7970 |
| REGULATION OF ELECTRON TRANSFER ACTIVITY | 5 | 1.96e-01 | -0.335000 | 0.7970 |
| POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 5 | 1.96e-01 | -0.335000 | 0.7970 |
| REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 27 | 1.97e-01 | -0.146000 | 0.7970 |
| CELLULAR LIPID METABOLIC PROCESS | 117 | 1.98e-01 | 0.073300 | 0.7970 |
| RESPONSE TO GAMMA RADIATION | 6 | 1.98e-01 | 0.305000 | 0.7970 |
| REGULATION OF OXIDOREDUCTASE ACTIVITY | 12 | 1.98e-01 | -0.216000 | 0.7970 |
| MALE GAMETE GENERATION | 17 | 1.98e-01 | 0.182000 | 0.7970 |
| NEURON APOPTOTIC PROCESS | 20 | 1.99e-01 | 0.168000 | 0.7970 |
| POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 19 | 2.00e-01 | 0.171000 | 0.7970 |
| POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 19 | 2.00e-01 | 0.171000 | 0.7970 |
| ISOPRENOID BIOSYNTHETIC PROCESS | 6 | 2.03e-01 | 0.301000 | 0.7970 |
| NEURAL NUCLEUS DEVELOPMENT | 6 | 2.05e-01 | -0.300000 | 0.7970 |
| PROTEIN DEPHOSPHORYLATION | 6 | 2.05e-01 | -0.300000 | 0.7970 |
| REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 5 | 2.05e-01 | 0.328000 | 0.7970 |
| ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 38 | 2.06e-01 | -0.121000 | 0.7970 |
| PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 9 | 2.06e-01 | 0.245000 | 0.7970 |
| MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 5 | 2.08e-01 | 0.326000 | 0.7970 |
| PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 18 | 2.09e-01 | -0.173000 | 0.7970 |
| TETRAPYRROLE BIOSYNTHETIC PROCESS | 18 | 2.09e-01 | -0.173000 | 0.7970 |
| REGULATION OF PROTEIN TRANSPORT | 19 | 2.09e-01 | -0.168000 | 0.7970 |
| RESPONSE TO CALCIUM ION | 8 | 2.10e-01 | 0.257000 | 0.7970 |
| AUTOPHAGY OF MITOCHONDRION | 24 | 2.11e-01 | 0.149000 | 0.7970 |
| CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 6 | 2.12e-01 | -0.295000 | 0.7970 |
| STEROL BIOSYNTHETIC PROCESS | 7 | 2.13e-01 | 0.273000 | 0.7970 |
| RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 6 | 2.13e-01 | -0.294000 | 0.7970 |
| CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 12 | 2.14e-01 | 0.209000 | 0.7970 |
| SMALL MOLECULE METABOLIC PROCESS | 349 | 2.14e-01 | 0.047900 | 0.7970 |
| RNA CATABOLIC PROCESS | 22 | 2.15e-01 | 0.154000 | 0.7970 |
| PROTEIN DNA COMPLEX ORGANIZATION | 10 | 2.15e-01 | 0.228000 | 0.7970 |
| NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 53 | 2.16e-01 | 0.101000 | 0.7970 |
| NADH DEHYDROGENASE COMPLEX ASSEMBLY | 55 | 2.18e-01 | 0.098900 | 0.7970 |
| VIRAL LIFE CYCLE | 6 | 2.18e-01 | 0.292000 | 0.7970 |
| VIRAL PROCESS | 6 | 2.18e-01 | 0.292000 | 0.7970 |
| REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 7 | 2.18e-01 | 0.270000 | 0.7970 |
| MACROMOLECULE DEACYLATION | 5 | 2.19e-01 | -0.319000 | 0.7970 |
| PEPTIDYL SERINE MODIFICATION | 7 | 2.19e-01 | 0.269000 | 0.7970 |
| EXECUTION PHASE OF APOPTOSIS | 11 | 2.19e-01 | 0.215000 | 0.7970 |
| PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 6 | 2.20e-01 | 0.290000 | 0.7970 |
| POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 24 | 2.21e-01 | -0.146000 | 0.7970 |
| FATTY ACID BIOSYNTHETIC PROCESS | 22 | 2.22e-01 | 0.152000 | 0.7970 |
| PHOSPHORYLATION | 30 | 2.22e-01 | 0.131000 | 0.7970 |
| CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 9 | 2.23e-01 | -0.236000 | 0.7970 |
| POSITIVE REGULATION OF GROWTH | 6 | 2.23e-01 | 0.288000 | 0.7970 |
| POSITIVE REGULATION OF CELL CELL ADHESION | 5 | 2.25e-01 | -0.314000 | 0.7970 |
| POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 5 | 2.25e-01 | -0.314000 | 0.7970 |
| CYTOKINESIS | 6 | 2.25e-01 | 0.287000 | 0.7970 |
| TRICARBOXYLIC ACID CYCLE | 24 | 2.29e-01 | -0.144000 | 0.7970 |
| POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 6 | 2.29e-01 | 0.285000 | 0.7970 |
| NADP METABOLIC PROCESS | 10 | 2.31e-01 | 0.220000 | 0.7970 |
| CALCIUM ION TRANSMEMBRANE TRANSPORT | 22 | 2.33e-01 | 0.149000 | 0.7970 |
| REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 6 | 2.34e-01 | 0.281000 | 0.7970 |
| ESTABLISHMENT OF ORGANELLE LOCALIZATION | 11 | 2.34e-01 | 0.208000 | 0.7970 |
| NEGATIVE REGULATION OF CELL DIFFERENTIATION | 8 | 2.35e-01 | 0.244000 | 0.7970 |
| DICARBOXYLIC ACID TRANSPORT | 8 | 2.35e-01 | -0.244000 | 0.7970 |
| FOREBRAIN DEVELOPMENT | 6 | 2.38e-01 | 0.279000 | 0.7970 |
| REGULATION OF CELL DIFFERENTIATION | 28 | 2.38e-01 | 0.131000 | 0.7970 |
| HYDROGEN PEROXIDE CATABOLIC PROCESS | 7 | 2.39e-01 | 0.258000 | 0.7970 |
| FEMALE SEX DIFFERENTIATION | 7 | 2.39e-01 | 0.258000 | 0.7970 |
| REGULATION OF INNATE IMMUNE RESPONSE | 14 | 2.40e-01 | -0.183000 | 0.7970 |
| DNA REPAIR | 21 | 2.41e-01 | 0.149000 | 0.7970 |
| MITOCHONDRIAL DNA REPLICATION | 10 | 2.41e-01 | -0.215000 | 0.7970 |
| PROTEIN STABILIZATION | 6 | 2.43e-01 | -0.276000 | 0.7970 |
| POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 6 | 2.44e-01 | 0.276000 | 0.7970 |
| MYOTUBE DIFFERENTIATION | 5 | 2.45e-01 | 0.301000 | 0.7970 |
| SYNAPSE ORGANIZATION | 5 | 2.46e-01 | -0.301000 | 0.7970 |
| REGULATION OF PEPTIDASE ACTIVITY | 26 | 2.47e-01 | 0.133000 | 0.7970 |
| DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 2.48e-01 | -0.274000 | 0.7970 |
| FATTY ACID DERIVATIVE METABOLIC PROCESS | 18 | 2.48e-01 | 0.159000 | 0.7970 |
| REGULATION OF MULTICELLULAR ORGANISM GROWTH | 6 | 2.48e-01 | 0.273000 | 0.7970 |
| REGULATION OF LEUKOCYTE DIFFERENTIATION | 7 | 2.48e-01 | 0.253000 | 0.7970 |
| FIBROBLAST PROLIFERATION | 5 | 2.48e-01 | 0.299000 | 0.7970 |
| ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED | 5 | 2.49e-01 | 0.299000 | 0.7970 |
| ORGANELLE TRANSPORT ALONG MICROTUBULE | 5 | 2.49e-01 | 0.299000 | 0.7970 |
| RESPONSE TO NICOTINE | 7 | 2.49e-01 | 0.252000 | 0.7970 |
| DEVELOPMENTAL GROWTH | 14 | 2.50e-01 | 0.179000 | 0.7970 |
| DITERPENOID METABOLIC PROCESS | 5 | 2.51e-01 | 0.297000 | 0.7970 |
| INSULIN SECRETION | 14 | 2.51e-01 | -0.179000 | 0.7970 |
| STRIATED MUSCLE CELL DIFFERENTIATION | 8 | 2.51e-01 | 0.235000 | 0.7970 |
| NAD METABOLIC PROCESS | 7 | 2.53e-01 | -0.250000 | 0.7970 |
| SMALL MOLECULE BIOSYNTHETIC PROCESS | 94 | 2.55e-01 | 0.071400 | 0.7970 |
| GLIOGENESIS | 6 | 2.55e-01 | 0.269000 | 0.7970 |
| RNA SPLICING | 6 | 2.55e-01 | -0.269000 | 0.7970 |
| NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 7 | 2.56e-01 | -0.249000 | 0.7970 |
| CALCIUM ION HOMEOSTASIS | 23 | 2.56e-01 | 0.139000 | 0.7970 |
| RESPONSE TO UV | 8 | 2.56e-01 | 0.233000 | 0.7970 |
| FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 6 | 2.57e-01 | 0.268000 | 0.7970 |
| DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 6 | 2.58e-01 | 0.268000 | 0.7970 |
| REPRODUCTIVE PROCESS | 33 | 2.59e-01 | 0.116000 | 0.7970 |
| KETONE CATABOLIC PROCESS | 6 | 2.60e-01 | 0.266000 | 0.7970 |
| REGULATION OF CELL DEVELOPMENT | 13 | 2.61e-01 | 0.181000 | 0.7970 |
| LEUKOCYTE DIFFERENTIATION | 16 | 2.62e-01 | 0.164000 | 0.7970 |
| STEROID BIOSYNTHETIC PROCESS | 18 | 2.62e-01 | 0.154000 | 0.7970 |
| PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 2.62e-01 | -0.246000 | 0.7970 |
| REGULATION OF IMMUNE RESPONSE | 23 | 2.65e-01 | -0.136000 | 0.7970 |
| REGULATION OF BODY FLUID LEVELS | 7 | 2.65e-01 | 0.244000 | 0.7970 |
| MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 77 | 2.67e-01 | -0.076200 | 0.7970 |
| REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 32 | 2.67e-01 | 0.115000 | 0.7970 |
| REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 5 | 2.68e-01 | 0.287000 | 0.7970 |
| REGULATION OF GLUCONEOGENESIS | 5 | 2.68e-01 | 0.287000 | 0.7970 |
| CELLULAR RESPONSE TO EXTERNAL STIMULUS | 5 | 2.68e-01 | 0.287000 | 0.7970 |
| RESPONSE TO MECHANICAL STIMULUS | 5 | 2.68e-01 | 0.287000 | 0.7970 |
| POSITIVE REGULATION OF CELL GROWTH | 5 | 2.68e-01 | 0.287000 | 0.7970 |
| KETONE BIOSYNTHETIC PROCESS | 15 | 2.69e-01 | 0.166000 | 0.7970 |
| CALCIUM MEDIATED SIGNALING | 5 | 2.69e-01 | 0.286000 | 0.7970 |
| DNA TEMPLATED DNA REPLICATION | 13 | 2.69e-01 | -0.178000 | 0.7970 |
| MIDBRAIN DEVELOPMENT | 6 | 2.70e-01 | -0.261000 | 0.7970 |
| RESPONSE TO GROWTH FACTOR | 7 | 2.71e-01 | 0.241000 | 0.7970 |
| SKIN DEVELOPMENT | 5 | 2.71e-01 | 0.285000 | 0.7970 |
| CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 35 | 2.72e-01 | 0.109000 | 0.7970 |
| ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 11 | 2.73e-01 | 0.192000 | 0.7970 |
| REGULATION OF MUSCLE CELL DIFFERENTIATION | 5 | 2.73e-01 | 0.284000 | 0.7970 |
| CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 6 | 2.73e-01 | -0.259000 | 0.7970 |
| POSITIVE REGULATION OF HORMONE SECRETION | 8 | 2.75e-01 | -0.224000 | 0.7970 |
| POSITIVE REGULATION OF INSULIN SECRETION | 8 | 2.75e-01 | -0.224000 | 0.7970 |
| POSITIVE REGULATION OF PEPTIDE SECRETION | 8 | 2.75e-01 | -0.224000 | 0.7970 |
| PRIMARY ALCOHOL METABOLIC PROCESS | 10 | 2.75e-01 | 0.200000 | 0.7970 |
| REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 2.75e-01 | 0.200000 | 0.7970 |
| REGULATION OF PROTEIN MODIFICATION PROCESS | 19 | 2.78e-01 | 0.145000 | 0.8000 |
| REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 5 | 2.78e-01 | 0.281000 | 0.8000 |
| DNA CONFORMATION CHANGE | 9 | 2.79e-01 | 0.210000 | 0.8000 |
| PROTEASOMAL PROTEIN CATABOLIC PROCESS | 6 | 2.80e-01 | 0.255000 | 0.8000 |
| REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 2.81e-01 | -0.126000 | 0.8000 |
| MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 2.82e-01 | 0.279000 | 0.8000 |
| LEUKOCYTE APOPTOTIC PROCESS | 9 | 2.83e-01 | 0.208000 | 0.8000 |
| RESPONSE TO ORGANOPHOSPHORUS | 8 | 2.83e-01 | 0.220000 | 0.8000 |
| PIGMENT METABOLIC PROCESS | 17 | 2.83e-01 | -0.152000 | 0.8000 |
| RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 5 | 2.84e-01 | -0.278000 | 0.8000 |
| REGULATION OF HEMOPOIESIS | 10 | 2.86e-01 | 0.196000 | 0.8010 |
| NUCLEAR EXPORT | 6 | 2.86e-01 | 0.252000 | 0.8010 |
| MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 5 | 2.87e-01 | 0.276000 | 0.8010 |
| AMINO ACID BETAINE BIOSYNTHETIC PROCESS | 5 | 2.87e-01 | 0.276000 | 0.8010 |
| MONOCARBOXYLIC ACID TRANSPORT | 13 | 2.88e-01 | 0.172000 | 0.8010 |
| MONOATOMIC ANION TRANSPORT | 6 | 2.88e-01 | -0.251000 | 0.8010 |
| REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 13 | 2.92e-01 | 0.170000 | 0.8080 |
| REGULATION OF GROWTH | 19 | 2.92e-01 | 0.141000 | 0.8080 |
| RESPONSE TO ORGANIC CYCLIC COMPOUND | 47 | 2.93e-01 | 0.090900 | 0.8080 |
| MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 16 | 2.95e-01 | 0.152000 | 0.8120 |
| PROTEIN CATABOLIC PROCESS | 28 | 2.97e-01 | 0.116000 | 0.8120 |
| GROWTH | 25 | 2.98e-01 | 0.122000 | 0.8120 |
| AMINE METABOLIC PROCESS | 11 | 2.98e-01 | 0.182000 | 0.8120 |
| NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 25 | 2.98e-01 | 0.122000 | 0.8120 |
| L AMINO ACID CATABOLIC PROCESS | 23 | 2.99e-01 | -0.127000 | 0.8120 |
| RESPONSE TO LIPID | 43 | 3.00e-01 | 0.093400 | 0.8120 |
| CHROMATIN REMODELING | 9 | 3.01e-01 | 0.200000 | 0.8120 |
| ORGANOPHOSPHATE ESTER TRANSPORT | 21 | 3.02e-01 | 0.132000 | 0.8120 |
| SENSORY PERCEPTION | 18 | 3.03e-01 | -0.142000 | 0.8120 |
| AMP METABOLIC PROCESS | 5 | 3.03e-01 | -0.267000 | 0.8120 |
| REGULATION OF LYMPHOCYTE DIFFERENTIATION | 5 | 3.03e-01 | 0.267000 | 0.8120 |
| POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 21 | 3.07e-01 | 0.130000 | 0.8190 |
| INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 8 | 3.08e-01 | 0.209000 | 0.8190 |
| NECROPTOTIC PROCESS | 8 | 3.08e-01 | 0.209000 | 0.8190 |
| FATTY ACYL COA METABOLIC PROCESS | 13 | 3.09e-01 | 0.164000 | 0.8190 |
| SERINE FAMILY AMINO ACID METABOLIC PROCESS | 6 | 3.10e-01 | -0.240000 | 0.8190 |
| PURINE NUCLEOTIDE TRANSPORT | 11 | 3.11e-01 | 0.177000 | 0.8200 |
| REGULATION OF LIPID LOCALIZATION | 8 | 3.12e-01 | 0.207000 | 0.8200 |
| REGULATION OF LIPID TRANSPORT | 8 | 3.12e-01 | 0.207000 | 0.8200 |
| RESPONSE TO ACID CHEMICAL | 8 | 3.14e-01 | 0.207000 | 0.8230 |
| MUSCLE CELL DIFFERENTIATION | 11 | 3.15e-01 | 0.176000 | 0.8250 |
| POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 39 | 3.16e-01 | 0.094700 | 0.8250 |
| NEURON DEVELOPMENT | 18 | 3.22e-01 | 0.136000 | 0.8340 |
| LEUKOCYTE HOMEOSTASIS | 8 | 3.22e-01 | 0.203000 | 0.8340 |
| LYMPHOCYTE HOMEOSTASIS | 8 | 3.22e-01 | 0.203000 | 0.8340 |
| ORGANELLE ASSEMBLY | 23 | 3.24e-01 | 0.120000 | 0.8340 |
| REGULATION OF RESPONSE TO BIOTIC STIMULUS | 16 | 3.24e-01 | -0.144000 | 0.8340 |
| OSSIFICATION | 13 | 3.25e-01 | 0.159000 | 0.8340 |
| REGULATION OF FATTY ACID METABOLIC PROCESS | 8 | 3.25e-01 | 0.202000 | 0.8340 |
| CELL ADHESION | 15 | 3.26e-01 | -0.148000 | 0.8340 |
| INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 9 | 3.29e-01 | -0.189000 | 0.8380 |
| MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 88 | 3.29e-01 | 0.063000 | 0.8380 |
| NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 17 | 3.30e-01 | -0.138000 | 0.8380 |
| NEGATIVE REGULATION OF SIGNALING | 52 | 3.31e-01 | 0.080100 | 0.8400 |
| REGULATION OF PROTEIN SECRETION | 15 | 3.34e-01 | -0.145000 | 0.8440 |
| AMINO ACID BETAINE METABOLIC PROCESS | 10 | 3.37e-01 | 0.177000 | 0.8460 |
| GENERATION OF NEURONS | 24 | 3.37e-01 | 0.115000 | 0.8460 |
| POSITIVE REGULATION OF LIPID LOCALIZATION | 5 | 3.38e-01 | 0.248000 | 0.8460 |
| POSITIVE REGULATION OF LIPID TRANSPORT | 5 | 3.38e-01 | 0.248000 | 0.8460 |
| NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 10 | 3.38e-01 | 0.176000 | 0.8460 |
| RESPONSE TO ALCOHOL | 22 | 3.40e-01 | 0.119000 | 0.8460 |
| NEURAL TUBE DEVELOPMENT | 6 | 3.40e-01 | 0.226000 | 0.8460 |
| GLUTAMINE METABOLIC PROCESS | 5 | 3.43e-01 | -0.246000 | 0.8510 |
| HORMONE METABOLIC PROCESS | 11 | 3.43e-01 | 0.166000 | 0.8510 |
| EPITHELIAL CELL DEVELOPMENT | 5 | 3.47e-01 | 0.244000 | 0.8520 |
| INFLAMMATORY RESPONSE | 15 | 3.48e-01 | 0.141000 | 0.8520 |
| GLYCEROLIPID BIOSYNTHETIC PROCESS | 15 | 3.48e-01 | 0.141000 | 0.8520 |
| TUBE DEVELOPMENT | 25 | 3.49e-01 | 0.110000 | 0.8520 |
| REGULATION OF INTRACELLULAR TRANSPORT | 6 | 3.49e-01 | 0.222000 | 0.8520 |
| CELL FATE COMMITMENT | 5 | 3.50e-01 | 0.242000 | 0.8520 |
| MYELOID LEUKOCYTE DIFFERENTIATION | 5 | 3.50e-01 | 0.242000 | 0.8520 |
| DEFENSE RESPONSE TO VIRUS | 17 | 3.53e-01 | 0.131000 | 0.8520 |
| REGULATION OF CELLULAR COMPONENT BIOGENESIS | 14 | 3.53e-01 | -0.144000 | 0.8520 |
| VALINE METABOLIC PROCESS | 5 | 3.53e-01 | -0.241000 | 0.8520 |
| PROTEIN LOCALIZATION TO NUCLEUS | 5 | 3.54e-01 | -0.240000 | 0.8520 |
| RESPONSE TO GLUCAGON | 5 | 3.55e-01 | 0.240000 | 0.8520 |
| POSITIVE REGULATION OF HYDROLASE ACTIVITY | 24 | 3.56e-01 | 0.110000 | 0.8520 |
| WATER SOLUBLE VITAMIN METABOLIC PROCESS | 17 | 3.56e-01 | -0.131000 | 0.8520 |
| ORGANIC ACID CATABOLIC PROCESS | 87 | 3.57e-01 | -0.059800 | 0.8520 |
| RESPONSE TO ABIOTIC STIMULUS | 62 | 3.58e-01 | 0.069800 | 0.8520 |
| CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 3.59e-01 | -0.217000 | 0.8520 |
| MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 47 | 3.60e-01 | 0.079100 | 0.8520 |
| NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 12 | 3.61e-01 | 0.153000 | 0.8520 |
| POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 8 | 3.62e-01 | -0.187000 | 0.8520 |
| NUCLEAR TRANSPORT | 9 | 3.63e-01 | 0.176000 | 0.8520 |
| RESPONSE TO OXYGEN LEVELS | 35 | 3.64e-01 | 0.090400 | 0.8520 |
| LIPID METABOLIC PROCESS | 150 | 3.65e-01 | 0.046500 | 0.8520 |
| MITOPHAGY | 17 | 3.65e-01 | 0.128000 | 0.8520 |
| NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 14 | 3.65e-01 | -0.141000 | 0.8520 |
| REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 18 | 3.67e-01 | 0.124000 | 0.8520 |
| BILE ACID METABOLIC PROCESS | 7 | 3.67e-01 | 0.198000 | 0.8520 |
| REGULATION OF MITOPHAGY | 10 | 3.68e-01 | 0.165000 | 0.8520 |
| REGULATION OF TRANSLATIONAL FIDELITY | 8 | 3.70e-01 | -0.184000 | 0.8520 |
| PROTEIN CONTAINING COMPLEX ASSEMBLY | 156 | 3.70e-01 | 0.045200 | 0.8520 |
| EPITHELIAL TUBE FORMATION | 5 | 3.71e-01 | 0.232000 | 0.8520 |
| IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 5 | 3.71e-01 | -0.232000 | 0.8520 |
| NEURAL TUBE FORMATION | 5 | 3.71e-01 | 0.232000 | 0.8520 |
| TUBE FORMATION | 5 | 3.71e-01 | 0.232000 | 0.8520 |
| CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 55 | 3.73e-01 | 0.071500 | 0.8520 |
| MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 3.75e-01 | 0.129000 | 0.8520 |
| MUSCLE STRUCTURE DEVELOPMENT | 14 | 3.76e-01 | 0.138000 | 0.8520 |
| PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 17 | 3.77e-01 | -0.125000 | 0.8520 |
| SULFUR COMPOUND METABOLIC PROCESS | 59 | 3.78e-01 | 0.068500 | 0.8520 |
| RESPONSE TO NUTRIENT LEVELS | 31 | 3.78e-01 | 0.093000 | 0.8520 |
| REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 20 | 3.78e-01 | 0.115000 | 0.8520 |
| GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 20 | 3.79e-01 | 0.115000 | 0.8520 |
| NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 9 | 3.79e-01 | -0.170000 | 0.8520 |
| CELLULAR RESPONSE TO BIOTIC STIMULUS | 6 | 3.80e-01 | 0.208000 | 0.8520 |
| CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 6 | 3.80e-01 | 0.208000 | 0.8520 |
| ADAPTIVE IMMUNE RESPONSE | 5 | 3.81e-01 | -0.227000 | 0.8520 |
| RESPONSE TO ALKALOID | 7 | 3.82e-01 | 0.192000 | 0.8520 |
| POSITIVE REGULATION OF MOLECULAR FUNCTION | 43 | 3.82e-01 | 0.078700 | 0.8520 |
| VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 6 | 3.83e-01 | 0.206000 | 0.8520 |
| REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 5 | 3.84e-01 | -0.226000 | 0.8520 |
| REGULATION OF RESPONSE TO OXIDATIVE STRESS | 5 | 3.84e-01 | -0.226000 | 0.8520 |
| RESPONSE TO TEMPERATURE STIMULUS | 12 | 3.84e-01 | 0.146000 | 0.8520 |
| REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 3.85e-01 | 0.225000 | 0.8520 |
| NUCLEOSIDE METABOLIC PROCESS | 5 | 3.86e-01 | -0.225000 | 0.8520 |
| REGULATION OF CELL ADHESION | 13 | 3.86e-01 | -0.140000 | 0.8520 |
| REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 7 | 3.87e-01 | 0.190000 | 0.8520 |
| ERK1 AND ERK2 CASCADE | 5 | 3.90e-01 | -0.223000 | 0.8560 |
| RESPONSE TO VITAMIN | 8 | 3.90e-01 | 0.176000 | 0.8560 |
| PROTEIN POLYMERIZATION | 5 | 3.92e-01 | -0.222000 | 0.8570 |
| ADP TRANSPORT | 7 | 3.93e-01 | 0.187000 | 0.8570 |
| ATP TRANSPORT | 7 | 3.93e-01 | 0.187000 | 0.8570 |
| POSITIVE REGULATION OF RNA METABOLIC PROCESS | 22 | 3.98e-01 | -0.105000 | 0.8640 |
| REGULATION OF MITOTIC CELL CYCLE | 7 | 4.00e-01 | -0.184000 | 0.8640 |
| DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 6 | 4.00e-01 | 0.199000 | 0.8640 |
| MITOCHONDRIAL TRNA PROCESSING | 14 | 4.00e-01 | 0.131000 | 0.8640 |
| REGULATION OF DEFENSE RESPONSE | 21 | 4.01e-01 | -0.107000 | 0.8640 |
| POLYOL BIOSYNTHETIC PROCESS | 7 | 4.02e-01 | -0.184000 | 0.8640 |
| ADAPTIVE THERMOGENESIS | 17 | 4.03e-01 | 0.118000 | 0.8640 |
| CYTOSKELETON ORGANIZATION | 8 | 4.03e-01 | 0.171000 | 0.8640 |
| ALDEHYDE CATABOLIC PROCESS | 5 | 4.05e-01 | 0.216000 | 0.8640 |
| REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 4.05e-01 | -0.183000 | 0.8640 |
| REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 12 | 4.05e-01 | 0.140000 | 0.8640 |
| NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 18 | 4.06e-01 | 0.114000 | 0.8640 |
| NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 11 | 4.06e-01 | 0.146000 | 0.8640 |
| REGULATION OF ATP DEPENDENT ACTIVITY | 5 | 4.08e-01 | -0.214000 | 0.8660 |
| PROTEIN COMPLEX OLIGOMERIZATION | 26 | 4.09e-01 | 0.094900 | 0.8660 |
| EPITHELIAL CELL DIFFERENTIATION | 15 | 4.10e-01 | 0.124000 | 0.8660 |
| ORGANIC ACID BIOSYNTHETIC PROCESS | 48 | 4.11e-01 | 0.070400 | 0.8660 |
| CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 5 | 4.11e-01 | 0.213000 | 0.8660 |
| UNSATURATED FATTY ACID METABOLIC PROCESS | 9 | 4.12e-01 | 0.159000 | 0.8670 |
| CELL SUBSTRATE ADHESION | 5 | 4.15e-01 | -0.211000 | 0.8710 |
| SKELETAL MUSCLE ORGAN DEVELOPMENT | 6 | 4.16e-01 | 0.193000 | 0.8710 |
| HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 4.18e-01 | 0.210000 | 0.8740 |
| POSITIVE REGULATION OF CELL ACTIVATION | 8 | 4.21e-01 | -0.165000 | 0.8770 |
| NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 18 | 4.21e-01 | 0.111000 | 0.8770 |
| MEMBRANE ORGANIZATION | 88 | 4.22e-01 | 0.051800 | 0.8770 |
| AMINO ACID METABOLIC PROCESS | 89 | 4.23e-01 | -0.051500 | 0.8770 |
| SEQUESTERING OF CALCIUM ION | 5 | 4.26e-01 | 0.206000 | 0.8770 |
| RRNA METABOLIC PROCESS | 15 | 4.27e-01 | 0.120000 | 0.8770 |
| RRNA PROCESSING | 15 | 4.27e-01 | 0.120000 | 0.8770 |
| CARBOHYDRATE HOMEOSTASIS | 12 | 4.28e-01 | 0.133000 | 0.8770 |
| SENSORY ORGAN MORPHOGENESIS | 6 | 4.29e-01 | 0.187000 | 0.8770 |
| REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 26 | 4.29e-01 | 0.090800 | 0.8770 |
| CELL PROJECTION MORPHOGENESIS | 5 | 4.29e-01 | 0.205000 | 0.8770 |
| SPERMATID DIFFERENTIATION | 9 | 4.30e-01 | 0.153000 | 0.8770 |
| REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 4.30e-01 | 0.187000 | 0.8770 |
| SENSORY SYSTEM DEVELOPMENT | 9 | 4.33e-01 | 0.152000 | 0.8790 |
| MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 15 | 4.33e-01 | 0.118000 | 0.8790 |
| INTRACELLULAR TRANSPORT | 62 | 4.34e-01 | -0.059300 | 0.8790 |
| SENSORY PERCEPTION OF MECHANICAL STIMULUS | 9 | 4.35e-01 | -0.151000 | 0.8790 |
| REGULATION OF PROTEIN CATABOLIC PROCESS | 6 | 4.36e-01 | 0.184000 | 0.8790 |
| PROTEIN EXPORT FROM NUCLEUS | 5 | 4.37e-01 | 0.202000 | 0.8790 |
| CELLULAR CATABOLIC PROCESS | 152 | 4.37e-01 | 0.039600 | 0.8790 |
| RESPONSE TO NITROGEN COMPOUND | 44 | 4.37e-01 | 0.069200 | 0.8790 |
| MUSCLE ORGAN DEVELOPMENT | 7 | 4.39e-01 | 0.170000 | 0.8790 |
| PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 8 | 4.39e-01 | 0.159000 | 0.8790 |
| PROTEIN TETRAMERIZATION | 13 | 4.41e-01 | 0.124000 | 0.8790 |
| RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 5 | 4.42e-01 | -0.199000 | 0.8790 |
| HEART PROCESS | 6 | 4.43e-01 | 0.182000 | 0.8790 |
| MEIOTIC CELL CYCLE | 5 | 4.43e-01 | 0.199000 | 0.8790 |
| RECOMBINATIONAL REPAIR | 5 | 4.44e-01 | 0.198000 | 0.8790 |
| MITOCHONDRIAL GENOME MAINTENANCE | 18 | 4.44e-01 | -0.105000 | 0.8790 |
| RESPONSE TO CARBOHYDRATE | 13 | 4.44e-01 | 0.123000 | 0.8790 |
| NEUTRAL AMINO ACID TRANSPORT | 6 | 4.46e-01 | 0.180000 | 0.8800 |
| EXOCYTOSIS | 5 | 4.46e-01 | 0.197000 | 0.8800 |
| MUSCLE CELL APOPTOTIC PROCESS | 5 | 4.48e-01 | 0.197000 | 0.8810 |
| LOCOMOTORY BEHAVIOR | 9 | 4.52e-01 | 0.146000 | 0.8840 |
| CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 5 | 4.53e-01 | -0.195000 | 0.8840 |
| FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 10 | 4.53e-01 | 0.138000 | 0.8840 |
| REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 24 | 4.54e-01 | 0.089400 | 0.8840 |
| REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 24 | 4.54e-01 | 0.089400 | 0.8840 |
| NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 28 | 4.54e-01 | 0.083000 | 0.8840 |
| REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 8 | 4.56e-01 | -0.153000 | 0.8860 |
| EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 10 | 4.56e-01 | 0.137000 | 0.8860 |
| PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS | 7 | 4.58e-01 | -0.163000 | 0.8870 |
| CELL JUNCTION ASSEMBLY | 5 | 4.59e-01 | 0.192000 | 0.8870 |
| RESPONSE TO VIRUS | 18 | 4.62e-01 | 0.101000 | 0.8870 |
| MITOCHONDRIAL RIBOSOME ASSEMBLY | 12 | 4.62e-01 | 0.124000 | 0.8870 |
| ESTABLISHMENT OF RNA LOCALIZATION | 6 | 4.63e-01 | 0.174000 | 0.8870 |
| PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS | 6 | 4.63e-01 | -0.174000 | 0.8870 |
| RNA LOCALIZATION | 6 | 4.63e-01 | 0.174000 | 0.8870 |
| FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 10 | 4.64e-01 | 0.135000 | 0.8880 |
| TETRAPYRROLE METABOLIC PROCESS | 22 | 4.67e-01 | -0.090700 | 0.8910 |
| REGULATION OF IMMUNE SYSTEM PROCESS | 38 | 4.67e-01 | -0.069500 | 0.8910 |
| CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 12 | 4.68e-01 | 0.122000 | 0.8910 |
| NEGATIVE REGULATION OF PHOSPHORYLATION | 7 | 4.70e-01 | 0.158000 | 0.8930 |
| RESPONSE TO CAMP | 7 | 4.72e-01 | 0.158000 | 0.8930 |
| RESPONSE TO PURINE CONTAINING COMPOUND | 7 | 4.72e-01 | 0.158000 | 0.8930 |
| LYMPHOCYTE DIFFERENTIATION | 11 | 4.72e-01 | 0.126000 | 0.8930 |
| EPITHELIUM DEVELOPMENT | 28 | 4.74e-01 | 0.079400 | 0.8930 |
| REGULATION OF TRANSLATION | 33 | 4.75e-01 | -0.073100 | 0.8930 |
| PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 17 | 4.77e-01 | -0.101000 | 0.8930 |
| MITOCHONDRIAL DNA METABOLIC PROCESS | 14 | 4.77e-01 | -0.111000 | 0.8930 |
| EPITHELIAL TUBE MORPHOGENESIS | 7 | 4.77e-01 | 0.156000 | 0.8930 |
| REGULATION OF PHOSPHORUS METABOLIC PROCESS | 30 | 4.78e-01 | 0.076100 | 0.8930 |
| CALCIUM ION TRANSPORT | 26 | 4.78e-01 | 0.081400 | 0.8930 |
| NEGATIVE REGULATION OF AUTOPHAGY | 6 | 4.82e-01 | 0.166000 | 0.8930 |
| NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 6 | 4.82e-01 | 0.166000 | 0.8930 |
| LYMPHOCYTE APOPTOTIC PROCESS | 7 | 4.84e-01 | 0.153000 | 0.8930 |
| T CELL APOPTOTIC PROCESS | 7 | 4.84e-01 | 0.153000 | 0.8930 |
| INNATE IMMUNE RESPONSE | 23 | 4.84e-01 | -0.085300 | 0.8930 |
| TUBE MORPHOGENESIS | 19 | 4.84e-01 | 0.093600 | 0.8930 |
| EPITHELIAL CELL APOPTOTIC PROCESS | 6 | 4.85e-01 | 0.165000 | 0.8930 |
| INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 4.87e-01 | 0.135000 | 0.8930 |
| RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 4.87e-01 | 0.135000 | 0.8930 |
| INTRACELLULAR IRON ION HOMEOSTASIS | 9 | 4.87e-01 | 0.135000 | 0.8930 |
| PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 17 | 4.87e-01 | 0.098300 | 0.8930 |
| CELLULAR RESPONSE TO OXYGEN LEVELS | 16 | 4.89e-01 | -0.101000 | 0.8950 |
| PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 4.95e-01 | 0.162000 | 0.9030 |
| PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 22 | 4.96e-01 | -0.084900 | 0.9030 |
| SULFUR COMPOUND CATABOLIC PROCESS | 11 | 4.96e-01 | 0.119000 | 0.9030 |
| SYNAPTIC SIGNALING | 14 | 4.96e-01 | 0.106000 | 0.9030 |
| RESPONSE TO ESTRADIOL | 8 | 4.99e-01 | 0.139000 | 0.9040 |
| POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 19 | 5.00e-01 | 0.090300 | 0.9040 |
| HOMEOSTASIS OF NUMBER OF CELLS | 26 | 5.01e-01 | 0.077400 | 0.9040 |
| HINDBRAIN DEVELOPMENT | 10 | 5.01e-01 | 0.124000 | 0.9040 |
| METENCEPHALON DEVELOPMENT | 10 | 5.01e-01 | 0.124000 | 0.9040 |
| REGULATION OF LIPID BIOSYNTHETIC PROCESS | 7 | 5.03e-01 | -0.147000 | 0.9040 |
| CARBOHYDRATE CATABOLIC PROCESS | 8 | 5.03e-01 | -0.137000 | 0.9040 |
| SUCCINATE METABOLIC PROCESS | 5 | 5.03e-01 | -0.173000 | 0.9040 |
| PROTEIN CONTAINING COMPLEX DISASSEMBLY | 7 | 5.06e-01 | -0.146000 | 0.9070 |
| POSITIVE REGULATION OF PROTEOLYSIS | 26 | 5.08e-01 | 0.076100 | 0.9070 |
| DEFENSE RESPONSE | 48 | 5.08e-01 | 0.056700 | 0.9070 |
| T CELL HOMEOSTASIS | 7 | 5.10e-01 | 0.145000 | 0.9090 |
| NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 5.12e-01 | -0.144000 | 0.9110 |
| CHROMOSOME ORGANIZATION | 14 | 5.12e-01 | 0.102000 | 0.9110 |
| REGULATION OF TRANSPORT | 67 | 5.15e-01 | 0.047600 | 0.9130 |
| NEGATIVE REGULATION OF CELL GROWTH | 8 | 5.15e-01 | 0.133000 | 0.9130 |
| REGULATION OF CELLULAR LOCALIZATION | 37 | 5.17e-01 | 0.062800 | 0.9130 |
| POSITIVE REGULATION OF PROTEIN SECRETION | 10 | 5.17e-01 | -0.119000 | 0.9130 |
| LONG CHAIN FATTY ACID METABOLIC PROCESS | 16 | 5.17e-01 | 0.094300 | 0.9130 |
| VITAMIN METABOLIC PROCESS | 20 | 5.19e-01 | -0.084200 | 0.9130 |
| REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 5 | 5.20e-01 | 0.167000 | 0.9130 |
| BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 23 | 5.21e-01 | -0.078300 | 0.9130 |
| ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 18 | 5.21e-01 | 0.088200 | 0.9130 |
| FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 7 | 5.22e-01 | -0.141000 | 0.9130 |
| POSITIVE REGULATION OF CATALYTIC ACTIVITY | 39 | 5.24e-01 | 0.060100 | 0.9160 |
| RESPONSE TO STEROID HORMONE | 14 | 5.27e-01 | -0.098400 | 0.9190 |
| REGULATION OF TRANSFERASE ACTIVITY | 8 | 5.28e-01 | 0.130000 | 0.9190 |
| PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 13 | 5.29e-01 | 0.102000 | 0.9190 |
| PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 6 | 5.32e-01 | -0.148000 | 0.9210 |
| PYRUVATE METABOLIC PROCESS | 22 | 5.34e-01 | -0.077500 | 0.9210 |
| NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 11 | 5.34e-01 | 0.109000 | 0.9210 |
| ALPHA AMINO ACID METABOLIC PROCESS | 53 | 5.35e-01 | -0.050700 | 0.9210 |
| RRNA METHYLATION | 11 | 5.35e-01 | 0.109000 | 0.9210 |
| RRNA MODIFICATION | 11 | 5.35e-01 | 0.109000 | 0.9210 |
| HEME B METABOLIC PROCESS | 5 | 5.36e-01 | -0.160000 | 0.9220 |
| LIPID OXIDATION | 38 | 5.42e-01 | 0.058400 | 0.9290 |
| POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 5 | 5.44e-01 | 0.157000 | 0.9290 |
| POSITIVE REGULATION OF PHOSPHORYLATION | 5 | 5.44e-01 | 0.157000 | 0.9290 |
| SUCCINYL COA CATABOLIC PROCESS | 5 | 5.44e-01 | -0.157000 | 0.9290 |
| INTRACELLULAR LIPID TRANSPORT | 7 | 5.44e-01 | 0.133000 | 0.9290 |
| REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 24 | 5.46e-01 | -0.072100 | 0.9300 |
| IRON ION TRANSPORT | 8 | 5.49e-01 | -0.123000 | 0.9300 |
| NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 5.49e-01 | 0.084700 | 0.9300 |
| MITOTIC CELL CYCLE | 10 | 5.50e-01 | -0.110000 | 0.9300 |
| MITOTIC CELL CYCLE PROCESS | 10 | 5.50e-01 | -0.110000 | 0.9300 |
| LEUKOCYTE MEDIATED IMMUNITY | 6 | 5.50e-01 | -0.141000 | 0.9300 |
| REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 28 | 5.51e-01 | -0.066100 | 0.9300 |
| MYELOID CELL DIFFERENTIATION | 19 | 5.52e-01 | 0.079700 | 0.9300 |
| NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 12 | 5.53e-01 | -0.099700 | 0.9310 |
| RESPONSE TO STARVATION | 10 | 5.55e-01 | 0.108000 | 0.9330 |
| GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 7 | 5.56e-01 | -0.129000 | 0.9330 |
| PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 7 | 5.61e-01 | 0.128000 | 0.9360 |
| POSITIVE REGULATION OF DNA METABOLIC PROCESS | 7 | 5.61e-01 | -0.127000 | 0.9360 |
| POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 53 | 5.61e-01 | 0.047400 | 0.9360 |
| POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 42 | 5.63e-01 | -0.052700 | 0.9360 |
| PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 10 | 5.63e-01 | -0.106000 | 0.9360 |
| CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 6 | 5.64e-01 | 0.137000 | 0.9360 |
| ALPHA BETA T CELL ACTIVATION | 5 | 5.65e-01 | -0.149000 | 0.9360 |
| PEPTIDE METABOLIC PROCESS | 6 | 5.67e-01 | -0.136000 | 0.9360 |
| CELLULAR RESPONSE TO STRESS | 107 | 5.71e-01 | 0.033600 | 0.9360 |
| LYMPHOCYTE ACTIVATION | 20 | 5.71e-01 | 0.074000 | 0.9360 |
| MULTI MULTICELLULAR ORGANISM PROCESS | 5 | 5.71e-01 | 0.147000 | 0.9360 |
| REGULATION OF T CELL PROLIFERATION | 5 | 5.71e-01 | -0.147000 | 0.9360 |
| ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 6 | 5.71e-01 | 0.134000 | 0.9360 |
| DICARBOXYLIC ACID METABOLIC PROCESS | 39 | 5.72e-01 | -0.053400 | 0.9360 |
| SIGNAL RELEASE | 20 | 5.72e-01 | -0.073800 | 0.9360 |
| MEMBRANE DEPOLARIZATION | 7 | 5.74e-01 | 0.123000 | 0.9360 |
| AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 5 | 5.75e-01 | -0.145000 | 0.9360 |
| ENSHEATHMENT OF NEURONS | 5 | 5.75e-01 | 0.145000 | 0.9360 |
| ISOLEUCINE METABOLIC PROCESS | 5 | 5.75e-01 | 0.145000 | 0.9360 |
| CELL CELL SIGNALING | 26 | 5.76e-01 | -0.064300 | 0.9360 |
| CELLULAR RESPONSE TO LIPID | 27 | 5.76e-01 | -0.063100 | 0.9360 |
| POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 32 | 5.77e-01 | 0.057900 | 0.9360 |
| REGULATION OF DNA METABOLIC PROCESS | 11 | 5.77e-01 | -0.097700 | 0.9360 |
| NUCLEIC ACID CATABOLIC PROCESS | 65 | 5.79e-01 | 0.041200 | 0.9370 |
| RESPONSE TO WOUNDING | 14 | 5.81e-01 | 0.085900 | 0.9390 |
| FATTY ACID METABOLIC PROCESS | 81 | 5.82e-01 | 0.036900 | 0.9390 |
| HEMOPOIESIS | 34 | 5.83e-01 | 0.055300 | 0.9390 |
| MITOCHONDRIAL RNA METABOLIC PROCESS | 47 | 5.84e-01 | -0.047300 | 0.9390 |
| T CELL PROLIFERATION | 7 | 5.84e-01 | -0.120000 | 0.9390 |
| RESPONSE TO KETONE | 14 | 5.87e-01 | -0.084600 | 0.9400 |
| POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 5 | 5.87e-01 | 0.141000 | 0.9400 |
| TAXIS | 5 | 5.87e-01 | -0.141000 | 0.9400 |
| SMALL MOLECULE CATABOLIC PROCESS | 99 | 5.91e-01 | -0.032900 | 0.9430 |
| DOUBLE STRAND BREAK REPAIR | 8 | 5.95e-01 | 0.109000 | 0.9430 |
| BILE ACID BIOSYNTHETIC PROCESS | 5 | 5.95e-01 | 0.138000 | 0.9430 |
| PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 5.95e-01 | 0.126000 | 0.9430 |
| RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 8 | 5.96e-01 | -0.109000 | 0.9430 |
| POLYOL METABOLIC PROCESS | 10 | 5.97e-01 | -0.097100 | 0.9430 |
| OVARIAN FOLLICLE DEVELOPMENT | 5 | 5.98e-01 | 0.137000 | 0.9430 |
| FATTY ACID BETA OXIDATION | 37 | 5.99e-01 | 0.050900 | 0.9430 |
| PROTEIN AUTOPROCESSING | 5 | 5.99e-01 | -0.136000 | 0.9430 |
| INTRACELLULAR SIGNALING CASSETTE | 32 | 6.00e-01 | 0.054500 | 0.9430 |
| COENZYME A METABOLIC PROCESS | 10 | 6.00e-01 | 0.096300 | 0.9430 |
| PALLIUM DEVELOPMENT | 5 | 6.01e-01 | 0.136000 | 0.9430 |
| TELENCEPHALON DEVELOPMENT | 5 | 6.01e-01 | 0.136000 | 0.9430 |
| MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 6 | 6.02e-01 | -0.123000 | 0.9440 |
| MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 6 | 6.02e-01 | 0.123000 | 0.9440 |
| NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 29 | 6.07e-01 | 0.056000 | 0.9500 |
| EPITHELIAL CELL PROLIFERATION | 12 | 6.09e-01 | -0.085900 | 0.9510 |
| CELL GROWTH | 13 | 6.12e-01 | 0.081800 | 0.9530 |
| REGULATION OF CELL GROWTH | 13 | 6.12e-01 | 0.081800 | 0.9530 |
| ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 138 | 6.14e-01 | 0.026800 | 0.9550 |
| CELLULAR RESPONSE TO KETONE | 9 | 6.15e-01 | -0.097400 | 0.9550 |
| EYE MORPHOGENESIS | 5 | 6.16e-01 | 0.130000 | 0.9560 |
| FOLIC ACID METABOLIC PROCESS | 5 | 6.18e-01 | -0.129000 | 0.9580 |
| CELLULAR RESPIRATION | 169 | 6.23e-01 | 0.024100 | 0.9620 |
| CELL PROJECTION ORGANIZATION | 16 | 6.23e-01 | 0.071700 | 0.9620 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 41 | 6.24e-01 | 0.045200 | 0.9620 |
| RESPONSE TO RADIATION | 14 | 6.26e-01 | 0.075900 | 0.9640 |
| REGULATION OF CELL CELL ADHESION | 8 | 6.27e-01 | -0.099800 | 0.9640 |
| NEGATIVE REGULATION OF CELL CYCLE | 10 | 6.29e-01 | 0.088900 | 0.9640 |
| NEGATIVE REGULATION OF GROWTH | 10 | 6.29e-01 | 0.088900 | 0.9640 |
| LEARNING | 5 | 6.31e-01 | -0.125000 | 0.9660 |
| REGULATION OF MYELOID CELL DIFFERENTIATION | 5 | 6.34e-01 | 0.123000 | 0.9680 |
| CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 6 | 6.35e-01 | 0.112000 | 0.9680 |
| MITOCHONDRIAL RESPIRASOME ASSEMBLY | 5 | 6.37e-01 | 0.122000 | 0.9680 |
| NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 7 | 6.40e-01 | -0.102000 | 0.9680 |
| NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 6 | 6.41e-01 | 0.110000 | 0.9680 |
| TETRAHYDROFOLATE METABOLIC PROCESS | 5 | 6.42e-01 | 0.121000 | 0.9680 |
| GENERATION OF PRECURSOR METABOLITES AND ENERGY | 192 | 6.42e-01 | 0.021600 | 0.9680 |
| MONOATOMIC ION TRANSPORT | 105 | 6.42e-01 | -0.027700 | 0.9680 |
| EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 20 | 6.46e-01 | 0.060000 | 0.9680 |
| POSITIVE REGULATION OF CELL DEVELOPMENT | 6 | 6.49e-01 | 0.108000 | 0.9680 |
| AROMATIC AMINO ACID METABOLIC PROCESS | 6 | 6.51e-01 | 0.107000 | 0.9680 |
| IRON ION TRANSMEMBRANE TRANSPORT | 5 | 6.53e-01 | -0.116000 | 0.9680 |
| CALCIUM IMPORT INTO THE MITOCHONDRION | 13 | 6.55e-01 | 0.072200 | 0.9680 |
| WOUND HEALING | 5 | 6.55e-01 | 0.116000 | 0.9680 |
| ANATOMICAL STRUCTURE MATURATION | 8 | 6.56e-01 | 0.091400 | 0.9680 |
| DEVELOPMENTAL MATURATION | 8 | 6.56e-01 | 0.091400 | 0.9680 |
| TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 8 | 6.56e-01 | 0.091400 | 0.9680 |
| AMIDE BIOSYNTHETIC PROCESS | 29 | 6.58e-01 | -0.048300 | 0.9680 |
| REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 5 | 6.59e-01 | 0.114000 | 0.9680 |
| REGULATION OF RESPONSE TO OSMOTIC STRESS | 5 | 6.59e-01 | 0.114000 | 0.9680 |
| DNA REPLICATION | 16 | 6.59e-01 | -0.064300 | 0.9680 |
| PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 6 | 6.61e-01 | 0.104000 | 0.9680 |
| MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 7 | 6.62e-01 | -0.096000 | 0.9680 |
| PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 7 | 6.62e-01 | -0.096000 | 0.9680 |
| PEPTIDYL AMINO ACID MODIFICATION | 27 | 6.63e-01 | 0.049200 | 0.9680 |
| VASCULAR PROCESS IN CIRCULATORY SYSTEM | 5 | 6.63e-01 | 0.113000 | 0.9680 |
| ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 172 | 6.64e-01 | 0.021100 | 0.9680 |
| REGULATION OF CALCIUM ION TRANSPORT | 11 | 6.65e-01 | -0.075900 | 0.9680 |
| PROTON TRANSMEMBRANE TRANSPORT | 55 | 6.65e-01 | 0.034700 | 0.9680 |
| NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 5 | 6.66e-01 | 0.112000 | 0.9680 |
| NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 5 | 6.66e-01 | 0.112000 | 0.9680 |
| NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 5 | 6.66e-01 | 0.112000 | 0.9680 |
| MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 85 | 6.66e-01 | 0.028300 | 0.9680 |
| PROLINE METABOLIC PROCESS | 5 | 6.67e-01 | 0.112000 | 0.9680 |
| CELL CYCLE PHASE TRANSITION | 6 | 6.70e-01 | -0.101000 | 0.9680 |
| REGULATION OF CELL CYCLE PHASE TRANSITION | 6 | 6.70e-01 | -0.101000 | 0.9680 |
| ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 9 | 6.71e-01 | -0.082100 | 0.9680 |
| REGULATION OF KINASE ACTIVITY | 6 | 6.72e-01 | 0.100000 | 0.9680 |
| CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 6 | 6.74e-01 | 0.099700 | 0.9680 |
| DOPAMINE METABOLIC PROCESS | 6 | 6.74e-01 | 0.099700 | 0.9680 |
| PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE | 6 | 6.75e-01 | -0.099400 | 0.9680 |
| MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 13 | 6.76e-01 | 0.067600 | 0.9680 |
| BIOGENIC AMINE METABOLIC PROCESS | 7 | 6.76e-01 | 0.091600 | 0.9680 |
| POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 11 | 6.77e-01 | -0.073100 | 0.9680 |
| CELLULAR RESPONSE TO OXIDATIVE STRESS | 34 | 6.77e-01 | 0.042000 | 0.9680 |
| GLYCOSYL COMPOUND METABOLIC PROCESS | 9 | 6.77e-01 | -0.080500 | 0.9680 |
| PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE | 10 | 6.79e-01 | 0.076100 | 0.9680 |
| REGULATION OF SECRETION | 22 | 6.79e-01 | -0.051600 | 0.9680 |
| POSITIVE REGULATION OF PROTEIN TRANSPORT | 11 | 6.81e-01 | -0.072000 | 0.9680 |
| CELL CYCLE PROCESS | 21 | 6.82e-01 | 0.052300 | 0.9680 |
| RESPONSE TO ACTIVITY | 7 | 6.82e-01 | 0.089800 | 0.9680 |
| INORGANIC ANION TRANSPORT | 6 | 6.83e-01 | -0.096700 | 0.9680 |
| MITOCHONDRIAL RNA PROCESSING | 22 | 6.84e-01 | 0.050800 | 0.9680 |
| MITOCHONDRIAL DEPOLARIZATION | 6 | 6.84e-01 | 0.096300 | 0.9680 |
| PROTEIN RNA COMPLEX ORGANIZATION | 8 | 6.84e-01 | -0.083400 | 0.9680 |
| ALCOHOL BIOSYNTHETIC PROCESS | 15 | 6.85e-01 | 0.061000 | 0.9680 |
| HEPATICOBILIARY SYSTEM DEVELOPMENT | 13 | 6.86e-01 | -0.065300 | 0.9680 |
| REGULATION OF MRNA METABOLIC PROCESS | 15 | 6.86e-01 | -0.060700 | 0.9680 |
| BEHAVIOR | 20 | 6.87e-01 | 0.052600 | 0.9680 |
| GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 8 | 6.87e-01 | -0.082600 | 0.9680 |
| AMIDE METABOLIC PROCESS | 70 | 6.89e-01 | 0.028700 | 0.9680 |
| C4 DICARBOXYLATE TRANSPORT | 6 | 6.89e-01 | -0.094600 | 0.9680 |
| REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 11 | 6.90e-01 | 0.069900 | 0.9680 |
| NEGATIVE REGULATION OF TRANSPORT | 14 | 6.90e-01 | -0.062000 | 0.9680 |
| GLYCEROLIPID METABOLIC PROCESS | 28 | 6.91e-01 | 0.044100 | 0.9680 |
| RNA PROCESSING | 61 | 6.91e-01 | -0.030400 | 0.9680 |
| AMINO ACID BIOSYNTHETIC PROCESS | 17 | 6.91e-01 | -0.056100 | 0.9680 |
| REGULATION OF PROTEOLYSIS | 31 | 6.92e-01 | 0.041800 | 0.9680 |
| CELL MOTILITY | 19 | 6.93e-01 | -0.053000 | 0.9680 |
| GLUCOSE METABOLIC PROCESS | 25 | 6.94e-01 | -0.046000 | 0.9700 |
| REGULATION OF STEROID METABOLIC PROCESS | 5 | 6.98e-01 | -0.101000 | 0.9740 |
| REGULATION OF HYDROLASE ACTIVITY | 31 | 7.00e-01 | 0.040700 | 0.9750 |
| LIPID MODIFICATION | 39 | 7.02e-01 | 0.036200 | 0.9750 |
| MRNA PROCESSING | 18 | 7.02e-01 | -0.052600 | 0.9750 |
| NERVOUS SYSTEM PROCESS | 30 | 7.04e-01 | -0.040800 | 0.9750 |
| RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 7.04e-01 | -0.098500 | 0.9750 |
| CELL CYCLE | 31 | 7.05e-01 | 0.039900 | 0.9750 |
| GOLGI VESICLE TRANSPORT | 6 | 7.06e-01 | 0.089300 | 0.9750 |
| REGULATION OF SYSTEM PROCESS | 12 | 7.07e-01 | -0.063100 | 0.9750 |
| REGULATION OF PROTEIN STABILITY | 11 | 7.08e-01 | 0.065600 | 0.9750 |
| RIBOSOME ASSEMBLY | 15 | 7.09e-01 | 0.056200 | 0.9750 |
| GLUTAMATE METABOLIC PROCESS | 12 | 7.10e-01 | -0.062500 | 0.9750 |
| ATP METABOLIC PROCESS | 84 | 7.10e-01 | -0.024600 | 0.9750 |
| BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 7.13e-01 | -0.048000 | 0.9780 |
| CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 64 | 7.16e-01 | 0.027200 | 0.9810 |
| SECRETION | 30 | 7.18e-01 | -0.038800 | 0.9820 |
| REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 7 | 7.19e-01 | 0.079000 | 0.9830 |
| REGULATION OF ANATOMICAL STRUCTURE SIZE | 7 | 7.21e-01 | 0.078400 | 0.9830 |
| HEAD DEVELOPMENT | 25 | 7.21e-01 | -0.041800 | 0.9830 |
| ORGANOPHOSPHATE METABOLIC PROCESS | 196 | 7.21e-01 | 0.016500 | 0.9830 |
| MUSCLE TISSUE DEVELOPMENT | 10 | 7.24e-01 | 0.064800 | 0.9850 |
| CELL JUNCTION ORGANIZATION | 9 | 7.26e-01 | -0.067900 | 0.9850 |
| REGULATION OF CELL CYCLE | 21 | 7.26e-01 | 0.044700 | 0.9850 |
| NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 9 | 7.31e-01 | 0.066600 | 0.9900 |
| POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 6 | 7.31e-01 | -0.081300 | 0.9900 |
| REGULATION OF LYMPHOCYTE ACTIVATION | 12 | 7.34e-01 | 0.057000 | 0.9900 |
| REGULATION OF MUSCLE SYSTEM PROCESS | 5 | 7.36e-01 | 0.087400 | 0.9900 |
| REGULATION OF VESICLE MEDIATED TRANSPORT | 8 | 7.36e-01 | -0.069200 | 0.9900 |
| DNA METABOLIC PROCESS | 42 | 7.37e-01 | 0.030600 | 0.9900 |
| LONG CHAIN FATTY ACID TRANSPORT | 7 | 7.37e-01 | -0.073700 | 0.9900 |
| ZYMOGEN ACTIVATION | 5 | 7.37e-01 | 0.087000 | 0.9900 |
| AMINO ACID TRANSPORT | 14 | 7.39e-01 | -0.051800 | 0.9900 |
| BLOOD VESSEL MORPHOGENESIS | 12 | 7.39e-01 | 0.055800 | 0.9900 |
| RNA 5 END PROCESSING | 5 | 7.39e-01 | -0.086200 | 0.9900 |
| TRNA MODIFICATION | 23 | 7.43e-01 | 0.039900 | 0.9940 |
| ERYTHROCYTE HOMEOSTASIS | 13 | 7.45e-01 | -0.052500 | 0.9950 |
| FATTY ACID TRANSPORT | 11 | 7.47e-01 | 0.056600 | 0.9950 |
| REGULATION OF LOCOMOTION | 9 | 7.47e-01 | -0.062500 | 0.9950 |
| CELLULAR RESPONSE TO HORMONE STIMULUS | 18 | 7.48e-01 | -0.044300 | 0.9950 |
| COGNITION | 8 | 7.49e-01 | 0.065700 | 0.9950 |
| REGULATION OF CELL POPULATION PROLIFERATION | 36 | 7.49e-01 | 0.031400 | 0.9950 |
| SULFUR COMPOUND BIOSYNTHETIC PROCESS | 24 | 7.51e-01 | 0.037800 | 0.9950 |
| NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS | 12 | 7.53e-01 | 0.052700 | 0.9950 |
| L AMINO ACID METABOLIC PROCESS | 42 | 7.54e-01 | -0.028600 | 0.9950 |
| CELLULAR COMPONENT DISASSEMBLY | 41 | 7.55e-01 | 0.028700 | 0.9950 |
| RESPONSE TO HEAT | 5 | 7.56e-01 | 0.080500 | 0.9950 |
| PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 7 | 7.57e-01 | -0.067800 | 0.9950 |
| REGENERATION | 10 | 7.58e-01 | -0.056600 | 0.9950 |
| NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 21 | 7.59e-01 | 0.039100 | 0.9950 |
| MAINTENANCE OF LOCATION | 15 | 7.60e-01 | -0.046000 | 0.9950 |
| NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 19 | 7.60e-01 | 0.040900 | 0.9950 |
| RENAL SYSTEM PROCESS | 5 | 7.60e-01 | 0.079200 | 0.9950 |
| REGULATION OF MRNA CATABOLIC PROCESS | 11 | 7.60e-01 | -0.053500 | 0.9950 |
| ORGANIC HYDROXY COMPOUND TRANSPORT | 9 | 7.61e-01 | -0.058800 | 0.9950 |
| NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS | 6 | 7.62e-01 | -0.071700 | 0.9950 |
| POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 9 | 7.64e-01 | 0.058100 | 0.9960 |
| AXON DEVELOPMENT | 6 | 7.66e-01 | 0.070400 | 0.9960 |
| ORGANELLE DISASSEMBLY | 32 | 7.67e-01 | 0.030800 | 0.9960 |
| REGULATION OF LIPID METABOLIC PROCESS | 19 | 7.67e-01 | -0.039600 | 0.9960 |
| MITOTIC NUCLEAR DIVISION | 5 | 7.68e-01 | -0.076400 | 0.9960 |
| RESPONSE TO ENDOGENOUS STIMULUS | 45 | 7.69e-01 | 0.025900 | 0.9960 |
| POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 5 | 7.71e-01 | 0.075500 | 0.9960 |
| LEUKOCYTE CELL CELL ADHESION | 9 | 7.73e-01 | -0.055800 | 0.9960 |
| NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 94 | 7.74e-01 | -0.018000 | 0.9960 |
| CARBOHYDRATE DERIVATIVE TRANSPORT | 12 | 7.75e-01 | 0.047900 | 0.9960 |
| AMINO ACID ACTIVATION | 22 | 7.76e-01 | 0.035500 | 0.9960 |
| CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 22 | 7.76e-01 | -0.035500 | 0.9960 |
| PROTEIN PROCESSING | 22 | 7.76e-01 | -0.035400 | 0.9960 |
| NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 12 | 7.77e-01 | -0.047600 | 0.9960 |
| GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 17 | 7.80e-01 | -0.039600 | 0.9960 |
| NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 8 | 7.80e-01 | -0.057200 | 0.9960 |
| FATTY ACID DERIVATIVE CATABOLIC PROCESS | 6 | 7.84e-01 | 0.064900 | 0.9960 |
| NEGATIVE REGULATION OF CELL CYCLE PROCESS | 6 | 7.84e-01 | 0.064900 | 0.9960 |
| FERTILIZATION | 6 | 7.84e-01 | 0.064900 | 0.9960 |
| NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.84e-01 | -0.064900 | 0.9960 |
| ORGANIC ACID TRANSMEMBRANE TRANSPORT | 23 | 7.85e-01 | -0.033200 | 0.9960 |
| LOCOMOTION | 12 | 7.85e-01 | -0.045700 | 0.9960 |
| MUSCLE CELL DEVELOPMENT | 5 | 7.86e-01 | 0.070200 | 0.9960 |
| L AMINO ACID BIOSYNTHETIC PROCESS | 14 | 7.87e-01 | -0.042100 | 0.9960 |
| NEGATIVE REGULATION OF DEFENSE RESPONSE | 8 | 7.91e-01 | -0.054400 | 0.9960 |
| CELLULAR RESPONSE TO OSMOTIC STRESS | 7 | 7.94e-01 | 0.057300 | 0.9960 |
| LEUKOCYTE PROLIFERATION | 10 | 7.94e-01 | -0.047900 | 0.9960 |
| MONOCARBOXYLIC ACID METABOLIC PROCESS | 116 | 7.96e-01 | 0.014800 | 0.9960 |
| REGULATION OF HORMONE LEVELS | 26 | 7.96e-01 | -0.029700 | 0.9960 |
| TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 11 | 7.96e-01 | 0.045200 | 0.9960 |
| T CELL DIFFERENTIATION | 8 | 7.97e-01 | 0.052900 | 0.9960 |
| CELLULAR RESPONSE TO ABIOTIC STIMULUS | 14 | 7.99e-01 | 0.039700 | 0.9960 |
| FEMALE GAMETE GENERATION | 5 | 7.99e-01 | 0.066100 | 0.9960 |
| MUSCLE CONTRACTION | 5 | 8.00e-01 | 0.065700 | 0.9960 |
| RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 31 | 8.00e-01 | 0.026700 | 0.9960 |
| RIBOSOME BIOGENESIS | 31 | 8.00e-01 | 0.026700 | 0.9960 |
| REGULATION OF ATP METABOLIC PROCESS | 10 | 8.01e-01 | -0.046300 | 0.9960 |
| RHYTHMIC PROCESS | 5 | 8.01e-01 | 0.065300 | 0.9960 |
| CARDIOLIPIN METABOLIC PROCESS | 9 | 8.01e-01 | -0.048800 | 0.9960 |
| FATTY ACYL COA BIOSYNTHETIC PROCESS | 7 | 8.02e-01 | 0.054900 | 0.9960 |
| MEMBRANE LIPID METABOLIC PROCESS | 6 | 8.04e-01 | -0.058700 | 0.9960 |
| SPHINGOLIPID METABOLIC PROCESS | 6 | 8.04e-01 | -0.058700 | 0.9960 |
| NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 10 | 8.04e-01 | -0.045600 | 0.9960 |
| KETONE BODY METABOLIC PROCESS | 5 | 8.06e-01 | 0.063700 | 0.9960 |
| ORGANIC ANION TRANSPORT | 43 | 8.07e-01 | -0.022000 | 0.9960 |
| PROGRAMMED NECROTIC CELL DEATH | 11 | 8.08e-01 | 0.042600 | 0.9960 |
| REGULATION OF CELL ACTIVATION | 16 | 8.09e-01 | -0.035200 | 0.9960 |
| ANTIVIRAL INNATE IMMUNE RESPONSE | 7 | 8.10e-01 | -0.052600 | 0.9960 |
| POSITIVE REGULATION OF SECRETION | 12 | 8.11e-01 | -0.040200 | 0.9960 |
| CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 10 | 8.13e-01 | 0.043400 | 0.9960 |
| REGULATION OF REPRODUCTIVE PROCESS | 5 | 8.13e-01 | -0.061200 | 0.9960 |
| METHYLATION | 31 | 8.14e-01 | 0.024800 | 0.9960 |
| TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 5 | 8.18e-01 | -0.059600 | 0.9960 |
| POSITIVE REGULATION OF GENE EXPRESSION | 34 | 8.19e-01 | 0.023100 | 0.9960 |
| HEART DEVELOPMENT | 10 | 8.19e-01 | 0.042000 | 0.9960 |
| REGULATION OF RESPONSE TO STRESS | 46 | 8.19e-01 | -0.019900 | 0.9960 |
| REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 6 | 8.20e-01 | 0.054000 | 0.9960 |
| ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 18 | 8.20e-01 | 0.031200 | 0.9960 |
| BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 6 | 8.25e-01 | -0.052300 | 0.9960 |
| ARACHIDONIC ACID METABOLIC PROCESS | 5 | 8.26e-01 | 0.057100 | 0.9960 |
| ESTABLISHMENT OF LOCALIZATION IN CELL | 81 | 8.26e-01 | -0.014800 | 0.9960 |
| ANIMAL ORGAN MORPHOGENESIS | 10 | 8.26e-01 | 0.040300 | 0.9960 |
| NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 24 | 8.27e-01 | 0.026200 | 0.9960 |
| PROTEIN HOMOOLIGOMERIZATION | 16 | 8.27e-01 | 0.031800 | 0.9960 |
| L LEUCINE METABOLIC PROCESS | 6 | 8.28e-01 | -0.051600 | 0.9960 |
| RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 7 | 8.29e-01 | 0.047300 | 0.9960 |
| REGULATION OF MOLECULAR FUNCTION | 56 | 8.30e-01 | 0.017100 | 0.9960 |
| DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 5 | 8.32e-01 | -0.055100 | 0.9960 |
| NEGATIVE REGULATION OF GENE EXPRESSION | 30 | 8.32e-01 | -0.022800 | 0.9960 |
| RESPONSE TO AXON INJURY | 7 | 8.32e-01 | 0.046400 | 0.9960 |
| SULFUR AMINO ACID METABOLIC PROCESS | 5 | 8.33e-01 | 0.054700 | 0.9960 |
| MAMMARY GLAND DEVELOPMENT | 6 | 8.33e-01 | 0.049900 | 0.9960 |
| NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 6 | 8.35e-01 | 0.049200 | 0.9960 |
| REGULATION OF CELLULAR RESPIRATION | 20 | 8.36e-01 | -0.027000 | 0.9960 |
| REGULATION OF CELL CYCLE PROCESS | 12 | 8.37e-01 | 0.034500 | 0.9960 |
| TISSUE MORPHOGENESIS | 10 | 8.39e-01 | 0.037200 | 0.9960 |
| MAINTENANCE OF LOCATION IN CELL | 12 | 8.40e-01 | -0.033800 | 0.9960 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 5 | 8.40e-01 | 0.052200 | 0.9960 |
| POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 8 | 8.40e-01 | 0.041300 | 0.9960 |
| RESPONSE TO LIGHT STIMULUS | 11 | 8.42e-01 | 0.034900 | 0.9960 |
| PURINE CONTAINING COMPOUND METABOLIC PROCESS | 154 | 8.43e-01 | -0.010100 | 0.9960 |
| TRNA METHYLATION | 10 | 8.46e-01 | -0.035600 | 0.9960 |
| REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 8 | 8.50e-01 | 0.038800 | 0.9960 |
| COENZYME A BIOSYNTHETIC PROCESS | 5 | 8.50e-01 | 0.048900 | 0.9960 |
| ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 7 | 8.52e-01 | 0.040900 | 0.9960 |
| RESPONSE TO PEPTIDE HORMONE | 17 | 8.53e-01 | 0.026300 | 0.9960 |
| MONOCARBOXYLIC ACID CATABOLIC PROCESS | 47 | 8.53e-01 | 0.016000 | 0.9960 |
| HEME A METABOLIC PROCESS | 6 | 8.57e-01 | -0.042700 | 0.9960 |
| OXIDATIVE PHOSPHORYLATION | 113 | 8.62e-01 | -0.010100 | 0.9960 |
| POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 5 | 8.63e-01 | 0.044800 | 0.9960 |
| POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 6 | 8.64e-01 | -0.040600 | 0.9960 |
| REGULATION OF PROTON TRANSPORT | 8 | 8.64e-01 | 0.035200 | 0.9960 |
| RNA MODIFICATION | 34 | 8.64e-01 | 0.017300 | 0.9960 |
| CENTRAL NERVOUS SYSTEM DEVELOPMENT | 31 | 8.64e-01 | 0.018000 | 0.9960 |
| CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 5 | 8.66e-01 | 0.043600 | 0.9960 |
| REGULATION OF DNA REPLICATION | 5 | 8.66e-01 | 0.043600 | 0.9960 |
| MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 93 | 8.67e-01 | 0.010600 | 0.9960 |
| CARNITINE METABOLIC PROCESS | 7 | 8.67e-01 | 0.036800 | 0.9960 |
| BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 7 | 8.68e-01 | 0.036500 | 0.9960 |
| ATP BIOSYNTHETIC PROCESS | 69 | 8.69e-01 | -0.011900 | 0.9960 |
| L LEUCINE CATABOLIC PROCESS | 5 | 8.69e-01 | -0.042800 | 0.9960 |
| ORGANOPHOSPHATE CATABOLIC PROCESS | 23 | 8.69e-01 | 0.020100 | 0.9960 |
| PEPTIDYL LYSINE MODIFICATION | 12 | 8.70e-01 | -0.027500 | 0.9960 |
| FATTY ACID CATABOLIC PROCESS | 45 | 8.71e-01 | 0.014300 | 0.9960 |
| REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 10 | 8.73e-01 | 0.029400 | 0.9960 |
| DIOL BIOSYNTHETIC PROCESS | 5 | 8.74e-01 | 0.041100 | 0.9960 |
| DIOL METABOLIC PROCESS | 5 | 8.74e-01 | 0.041100 | 0.9960 |
| PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 5 | 8.74e-01 | 0.041100 | 0.9960 |
| TRNA METABOLIC PROCESS | 52 | 8.74e-01 | 0.013000 | 0.9960 |
| REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 30 | 8.74e-01 | 0.016900 | 0.9960 |
| REGULATION OF TRANSMEMBRANE TRANSPORT | 21 | 8.76e-01 | 0.019900 | 0.9960 |
| POST EMBRYONIC DEVELOPMENT | 7 | 8.76e-01 | 0.034100 | 0.9960 |
| ADULT BEHAVIOR | 5 | 8.76e-01 | -0.040300 | 0.9960 |
| REGULATION OF CELLULAR RESPONSE TO STRESS | 26 | 8.78e-01 | 0.017600 | 0.9960 |
| REGULATION OF LEUKOCYTE PROLIFERATION | 7 | 8.84e-01 | 0.032100 | 0.9960 |
| CELL MATURATION | 7 | 8.84e-01 | 0.032100 | 0.9960 |
| POSITIVE REGULATION OF TRANSPORT | 33 | 8.84e-01 | 0.015000 | 0.9960 |
| PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 64 | 8.84e-01 | -0.010900 | 0.9960 |
| MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 6 | 8.84e-01 | 0.034500 | 0.9960 |
| PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE | 5 | 8.85e-01 | -0.037500 | 0.9960 |
| TRANSLATIONAL INITIATION | 5 | 8.85e-01 | 0.037500 | 0.9960 |
| NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 22 | 8.85e-01 | 0.018000 | 0.9960 |
| THIOESTER BIOSYNTHETIC PROCESS | 20 | 8.86e-01 | 0.018700 | 0.9960 |
| MITOCHONDRIAL MEMBRANE ORGANIZATION | 73 | 8.88e-01 | 0.009920 | 0.9960 |
| CELLULAR LIPID CATABOLIC PROCESS | 49 | 8.89e-01 | 0.011800 | 0.9960 |
| ANIMAL ORGAN REGENERATION | 6 | 8.90e-01 | 0.032800 | 0.9960 |
| AEROBIC RESPIRATION | 146 | 8.90e-01 | 0.007140 | 0.9960 |
| SUPRAMOLECULAR FIBER ORGANIZATION | 10 | 8.91e-01 | -0.025100 | 0.9960 |
| PSEUDOURIDINE SYNTHESIS | 5 | 8.93e-01 | -0.035000 | 0.9960 |
| RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 7 | 8.94e-01 | -0.029200 | 0.9960 |
| RESPONSE TO FATTY ACID | 7 | 8.97e-01 | 0.028300 | 0.9960 |
| POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 10 | 8.98e-01 | -0.023700 | 0.9960 |
| TRNA WOBBLE BASE MODIFICATION | 5 | 9.00e-01 | 0.032500 | 0.9960 |
| RESPONSE TO INSULIN | 10 | 9.00e-01 | -0.023000 | 0.9960 |
| POSITIVE REGULATION OF CYTOKINE PRODUCTION | 9 | 9.01e-01 | 0.024100 | 0.9960 |
| CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 160 | 9.02e-01 | 0.006140 | 0.9960 |
| NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 75 | 9.02e-01 | -0.008540 | 0.9960 |
| FATTY ACID TRANSMEMBRANE TRANSPORT | 6 | 9.05e-01 | 0.028300 | 0.9960 |
| REGULATION OF INFLAMMATORY RESPONSE | 7 | 9.05e-01 | -0.026200 | 0.9960 |
| ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 22 | 9.05e-01 | 0.014900 | 0.9960 |
| REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 14 | 9.08e-01 | -0.018000 | 0.9960 |
| ACETYL COA METABOLIC PROCESS | 18 | 9.08e-01 | 0.015900 | 0.9960 |
| TRNA PROCESSING | 32 | 9.08e-01 | -0.012000 | 0.9960 |
| POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 9.09e-01 | -0.016700 | 0.9960 |
| RESPONSE TO CORTICOSTEROID | 11 | 9.09e-01 | -0.019900 | 0.9960 |
| CIRCULATORY SYSTEM DEVELOPMENT | 24 | 9.10e-01 | -0.013600 | 0.9960 |
| CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 22 | 9.10e-01 | -0.014100 | 0.9960 |
| POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 5 | 9.10e-01 | 0.029300 | 0.9960 |
| PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 6 | 9.10e-01 | 0.026600 | 0.9960 |
| PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 11 | 9.11e-01 | 0.019600 | 0.9960 |
| CARBOHYDRATE METABOLIC PROCESS | 43 | 9.11e-01 | -0.010000 | 0.9960 |
| PROTEIN INSERTION INTO MEMBRANE | 7 | 9.13e-01 | -0.023900 | 0.9960 |
| MITOCHONDRIAL RNA MODIFICATION | 9 | 9.14e-01 | 0.020900 | 0.9960 |
| REGULATION OF TRANSPORTER ACTIVITY | 11 | 9.15e-01 | 0.018800 | 0.9960 |
| CARBOHYDRATE BIOSYNTHETIC PROCESS | 13 | 9.16e-01 | -0.017100 | 0.9960 |
| MONOSACCHARIDE BIOSYNTHETIC PROCESS | 13 | 9.16e-01 | -0.017100 | 0.9960 |
| CRISTAE FORMATION | 17 | 9.16e-01 | -0.014900 | 0.9960 |
| L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 7 | 9.16e-01 | 0.023000 | 0.9960 |
| RIBOSE PHOSPHATE METABOLIC PROCESS | 140 | 9.18e-01 | -0.005460 | 0.9960 |
| REGULATION OF AMINE METABOLIC PROCESS | 5 | 9.18e-01 | -0.026800 | 0.9960 |
| NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 22 | 9.18e-01 | 0.012800 | 0.9960 |
| DEFENSE RESPONSE TO OTHER ORGANISM | 31 | 9.19e-01 | 0.010700 | 0.9960 |
| PROTEOLYSIS | 63 | 9.20e-01 | -0.007600 | 0.9960 |
| GTP METABOLIC PROCESS | 7 | 9.20e-01 | -0.022100 | 0.9960 |
| ACETYL COA BIOSYNTHETIC PROCESS | 13 | 9.20e-01 | 0.016300 | 0.9960 |
| REGULATION OF MITOCHONDRIAL FUSION | 8 | 9.21e-01 | 0.020300 | 0.9960 |
| TRANSITION METAL ION TRANSPORT | 10 | 9.21e-01 | 0.018100 | 0.9960 |
| POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 6 | 9.22e-01 | 0.023200 | 0.9960 |
| CELL CELL ADHESION | 10 | 9.23e-01 | 0.017700 | 0.9960 |
| POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 7 | 9.25e-01 | 0.020700 | 0.9960 |
| REGULATION OF AMIDE METABOLIC PROCESS | 6 | 9.26e-01 | 0.021900 | 0.9960 |
| LIPID CATABOLIC PROCESS | 54 | 9.27e-01 | -0.007420 | 0.9960 |
| 2 OXOGLUTARATE METABOLIC PROCESS | 11 | 9.27e-01 | 0.016000 | 0.9960 |
| VESICLE MEDIATED TRANSPORT | 18 | 9.29e-01 | 0.012300 | 0.9960 |
| G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 5 | 9.29e-01 | -0.023100 | 0.9960 |
| RESPONSE TO HORMONE | 36 | 9.29e-01 | 0.008750 | 0.9960 |
| STEROL TRANSPORT | 5 | 9.30e-01 | 0.022700 | 0.9960 |
| MAPK CASCADE | 8 | 9.30e-01 | 0.018000 | 0.9960 |
| PROTEIN HOMOTETRAMERIZATION | 11 | 9.31e-01 | -0.015300 | 0.9960 |
| NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 43 | 9.31e-01 | -0.007750 | 0.9960 |
| MONOATOMIC CATION TRANSPORT | 94 | 9.32e-01 | 0.005370 | 0.9960 |
| AMINO ACID TRANSMEMBRANE TRANSPORT | 10 | 9.33e-01 | -0.015400 | 0.9960 |
| MONOSACCHARIDE METABOLIC PROCESS | 27 | 9.33e-01 | -0.009420 | 0.9960 |
| MORPHOGENESIS OF AN EPITHELIUM | 8 | 9.34e-01 | 0.016900 | 0.9960 |
| DNA BIOSYNTHETIC PROCESS | 6 | 9.34e-01 | -0.019500 | 0.9960 |
| GLAND DEVELOPMENT | 23 | 9.35e-01 | 0.010000 | 0.9960 |
| MRNA METABOLIC PROCESS | 28 | 9.36e-01 | 0.008910 | 0.9960 |
| CEREBELLAR CORTEX DEVELOPMENT | 5 | 9.36e-01 | -0.020700 | 0.9960 |
| CIRCULATORY SYSTEM PROCESS | 13 | 9.37e-01 | -0.012800 | 0.9960 |
| CELL ACTIVATION | 24 | 9.37e-01 | 0.009390 | 0.9960 |
| RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 23 | 9.37e-01 | -0.009570 | 0.9960 |
| EMBRYONIC MORPHOGENESIS | 10 | 9.38e-01 | 0.014400 | 0.9960 |
| IMPORT INTO CELL | 11 | 9.39e-01 | -0.013500 | 0.9960 |
| DICARBOXYLIC ACID CATABOLIC PROCESS | 5 | 9.40e-01 | -0.019400 | 0.9960 |
| NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 9 | 9.40e-01 | -0.014500 | 0.9960 |
| ORGANIC ACID TRANSPORT | 31 | 9.40e-01 | -0.007900 | 0.9960 |
| CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 7 | 9.41e-01 | -0.016300 | 0.9960 |
| INTRACELLULAR GLUCOSE HOMEOSTASIS | 7 | 9.41e-01 | -0.016300 | 0.9960 |
| ENDOCYTOSIS | 8 | 9.42e-01 | -0.015000 | 0.9960 |
| EXPORT FROM CELL | 27 | 9.44e-01 | -0.007990 | 0.9970 |
| MUSCLE SYSTEM PROCESS | 8 | 9.45e-01 | -0.014100 | 0.9970 |
| CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 111 | 9.49e-01 | 0.003750 | 0.9980 |
| REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 9 | 9.50e-01 | 0.012200 | 0.9980 |
| ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 98 | 9.50e-01 | 0.003880 | 0.9980 |
| POSITIVE REGULATION OF TRANSLATION | 18 | 9.50e-01 | 0.008590 | 0.9980 |
| CELLULAR RESPONSE TO INSULIN STIMULUS | 7 | 9.50e-01 | 0.013600 | 0.9980 |
| RNA METHYLATION | 19 | 9.51e-01 | 0.008200 | 0.9980 |
| SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 6 | 9.52e-01 | -0.014300 | 0.9980 |
| REGULATION OF CATALYTIC ACTIVITY | 49 | 9.55e-01 | 0.004750 | 0.9990 |
| POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 8 | 9.56e-01 | 0.011300 | 0.9990 |
| CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 9.57e-01 | 0.014100 | 0.9990 |
| REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 19 | 9.57e-01 | 0.007160 | 0.9990 |
| RESPONSE TO CYTOKINE | 29 | 9.58e-01 | -0.005750 | 0.9990 |
| RESPONSE TO TUMOR NECROSIS FACTOR | 5 | 9.59e-01 | -0.013300 | 0.9990 |
| REGULATION OF MONOATOMIC ION TRANSPORT | 22 | 9.61e-01 | -0.006060 | 0.9990 |
| ICOSANOID METABOLIC PROCESS | 6 | 9.64e-01 | 0.010600 | 0.9990 |
| OXALOACETATE METABOLIC PROCESS | 5 | 9.65e-01 | -0.011300 | 0.9990 |
| CERAMIDE METABOLIC PROCESS | 5 | 9.65e-01 | 0.011300 | 0.9990 |
| IN UTERO EMBRYONIC DEVELOPMENT | 13 | 9.66e-01 | 0.006910 | 0.9990 |
| CYTOCHROME COMPLEX ASSEMBLY | 31 | 9.67e-01 | -0.004310 | 0.9990 |
| POSITIVE REGULATION OF CELL DIFFERENTIATION | 13 | 9.67e-01 | -0.006590 | 0.9990 |
| L AMINO ACID TRANSPORT | 9 | 9.69e-01 | 0.007420 | 0.9990 |
| POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 32 | 9.71e-01 | -0.003820 | 0.9990 |
| RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 103 | 9.74e-01 | 0.001960 | 0.9990 |
| REGULATION OF OXIDATIVE PHOSPHORYLATION | 10 | 9.75e-01 | -0.005760 | 0.9990 |
| PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 10 | 9.75e-01 | -0.005760 | 0.9990 |
| VASCULATURE DEVELOPMENT | 17 | 9.76e-01 | 0.004330 | 0.9990 |
| ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 6 | 9.76e-01 | -0.007170 | 0.9990 |
| NEGATIVE REGULATION OF IMMUNE RESPONSE | 6 | 9.76e-01 | -0.007170 | 0.9990 |
| POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 9 | 9.77e-01 | 0.005600 | 0.9990 |
| NUCLEOTIDE TRANSPORT | 15 | 9.77e-01 | 0.004340 | 0.9990 |
| POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 8 | 9.79e-01 | -0.005390 | 0.9990 |
| PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 9 | 9.80e-01 | 0.004910 | 0.9990 |
| TEMPERATURE HOMEOSTASIS | 18 | 9.81e-01 | 0.003340 | 0.9990 |
| ACYL COA METABOLIC PROCESS | 38 | 9.82e-01 | -0.002170 | 0.9990 |
| CYTOKINE PRODUCTION | 18 | 9.83e-01 | 0.003000 | 0.9990 |
| CELLULAR RESPONSE TO NITROGEN COMPOUND | 24 | 9.84e-01 | -0.002440 | 0.9990 |
| MACROMOLECULE METHYLATION | 24 | 9.86e-01 | -0.002130 | 0.9990 |
| NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 112 | 9.86e-01 | 0.001030 | 0.9990 |
| LIPID LOCALIZATION | 31 | 9.87e-01 | -0.001730 | 0.9990 |
| NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 169 | 9.88e-01 | 0.000721 | 0.9990 |
| REGULATION OF AEROBIC RESPIRATION | 15 | 9.89e-01 | -0.002000 | 0.9990 |
| TRANSMEMBRANE TRANSPORT | 187 | 9.90e-01 | 0.000585 | 0.9990 |
| NEUTRAL LIPID METABOLIC PROCESS | 10 | 9.91e-01 | -0.002060 | 0.9990 |
| T CELL ACTIVATION | 16 | 9.91e-01 | -0.001550 | 0.9990 |
| DNA CATABOLIC PROCESS | 5 | 9.92e-01 | -0.002660 | 0.9990 |
| RESPONSE TO SALT STRESS | 5 | 9.92e-01 | -0.002660 | 0.9990 |
| TRIGLYCERIDE METABOLIC PROCESS | 8 | 9.92e-01 | 0.002050 | 0.9990 |
| CELLULAR RESPONSE TO ALCOHOL | 6 | 9.93e-01 | 0.002050 | 0.9990 |
| ONE CARBON METABOLIC PROCESS | 9 | 9.94e-01 | 0.001480 | 0.9990 |
| ORGANIC ACID METABOLIC PROCESS | 183 | 9.94e-01 | 0.000362 | 0.9990 |
| HEMOGLOBIN METABOLIC PROCESS | 5 | 9.94e-01 | 0.001840 | 0.9990 |
| LIPID HOMEOSTASIS | 11 | 9.95e-01 | 0.001030 | 0.9990 |
| RESPONSE TO OSMOTIC STRESS | 8 | 9.96e-01 | -0.001030 | 0.9990 |
| POSITIVE REGULATION OF LOCOMOTION | 8 | 9.96e-01 | 0.001030 | 0.9990 |
| EMBRYO DEVELOPMENT | 29 | 9.97e-01 | -0.000362 | 0.9990 |
| METALLO SULFUR CLUSTER ASSEMBLY | 17 | 9.98e-01 | -0.000305 | 0.9990 |
| MYELOID CELL HOMEOSTASIS | 16 | 9.99e-01 | -0.000259 | 0.9990 |
| REGULATION OF T CELL ACTIVATION | 11 | 9.99e-01 | 0.000281 | 0.9990 |
Detailed Gene set reports
MITOCHONDRIAL GENE EXPRESSION
| set | MITOCHONDRIAL GENE EXPRESSION |
| setSize | 156 |
| pANOVA | 2.94e-05 |
| s.dist | -0.21 |
| p.adjustANOVA | 0.0326 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TRMT5 | -513 |
| MRPS16 | -511 |
| MRPL10 | -509 |
| POLRMT | -507 |
| MRPS27 | -505 |
| COA3 | -504 |
| AARS2 | -501 |
| GFM2 | -498 |
| MTG1 | -493 |
| MRPL30 | -492 |
| MRPL32 | -490 |
| MRPL54 | -488 |
| MRPL41 | -479 |
| MRPS17 | -476 |
| MRPL42 | -474 |
| MRPS22 | -465 |
| MRPL18 | -463 |
| C1QBP | -445 |
| TACO1 | -442 |
| MTERF1 | -440 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TRMT5 | -513.0 |
| MRPS16 | -511.0 |
| MRPL10 | -509.0 |
| POLRMT | -507.0 |
| MRPS27 | -505.0 |
| COA3 | -504.0 |
| AARS2 | -501.0 |
| GFM2 | -498.0 |
| MTG1 | -493.0 |
| MRPL30 | -492.0 |
| MRPL32 | -490.0 |
| MRPL54 | -488.0 |
| MRPL41 | -479.0 |
| MRPS17 | -476.0 |
| MRPL42 | -474.0 |
| MRPS22 | -465.0 |
| MRPL18 | -463.0 |
| C1QBP | -445.0 |
| TACO1 | -442.0 |
| MTERF1 | -440.0 |
| MRPL44 | -438.0 |
| AURKAIP1 | -437.0 |
| MRPS24 | -435.0 |
| MRPL33 | -430.0 |
| MRPS6 | -426.0 |
| TUFM | -425.0 |
| MTRF1 | -423.0 |
| MALSU1 | -422.0 |
| MRPL52 | -420.0 |
| MRPL49 | -418.0 |
| MRPL23 | -415.0 |
| MRPL12 | -408.0 |
| MRPL19 | -404.0 |
| MRPL50 | -401.0 |
| MRPL11 | -399.0 |
| MRPL47 | -395.0 |
| TRUB2 | -394.0 |
| MRPL34 | -378.0 |
| MTIF3 | -371.0 |
| MRPL48 | -370.0 |
| GATC | -366.0 |
| MRPL16 | -364.0 |
| FASTK | -361.0 |
| TBRG4 | -348.0 |
| MRPL4 | -347.0 |
| MRPL40 | -344.0 |
| MRPL2 | -337.0 |
| MRPL28 | -331.0 |
| MRPL3 | -325.0 |
| MRPL14 | -320.0 |
| MRPL57 | -319.0 |
| MRPL9 | -318.0 |
| MRPL24 | -309.0 |
| MRPL46 | -308.0 |
| MRPS30 | -304.0 |
| MRPL27 | -302.0 |
| TFAM | -299.0 |
| FASTKD2 | -298.0 |
| MRPL58 | -291.0 |
| SHMT2 | -290.0 |
| CDK5RAP1 | -289.0 |
| MRPL21 | -283.0 |
| MRPL38 | -281.0 |
| TEFM | -271.0 |
| MRPS34 | -260.0 |
| MRPL51 | -257.0 |
| FASTKD5 | -254.0 |
| MRPL55 | -246.0 |
| MTRES1 | -234.0 |
| MRPL15 | -225.0 |
| MTG2 | -209.0 |
| GADD45GIP1 | -208.0 |
| PUS1 | -206.0 |
| MRPS12 | -205.0 |
| MRPS18A | -202.0 |
| TFB1M | -201.0 |
| MRPL22 | -199.0 |
| GATB | -197.0 |
| MRPL39 | -194.0 |
| TSFM | -191.0 |
| CHCHD10 | -180.0 |
| MRPL37 | -175.0 |
| MRPL53 | -167.0 |
| MRPL13 | -157.0 |
| SLC25A33 | -150.0 |
| YARS2 | -136.0 |
| MRPL1 | -133.0 |
| DAP3 | -126.0 |
| MTPAP | -123.0 |
| METTL8 | -122.0 |
| PRORP | -91.0 |
| MTERF3 | -65.0 |
| LARS2 | -64.0 |
| RPUSD3 | -63.0 |
| NSUN3 | -62.0 |
| EARS2 | -59.0 |
| MRPL17 | -57.0 |
| SARS2 | -26.0 |
| MTERF4 | -2.0 |
| MTO1 | 15.0 |
| PNPT1 | 16.0 |
| MRPS7 | 20.0 |
| TWNK | 33.0 |
| TRMT10C | 37.0 |
| TFB2M | 41.0 |
| MRPS14 | 62.0 |
| FASTKD1 | 67.0 |
| MRPS5 | 68.0 |
| ELAC2 | 69.5 |
| PTCD3 | 77.0 |
| MRPS33 | 78.0 |
| TARS2 | 89.0 |
| HSD17B10 | 97.0 |
| RCC1L | 98.0 |
| MTIF2 | 99.0 |
| MRPS15 | 104.0 |
| ALKBH1 | 122.0 |
| MTRF1L | 148.0 |
| GARS1 | 159.0 |
| QRSL1 | 190.0 |
| MRPS21 | 191.0 |
| DARS2 | 196.0 |
| MRPS23 | 199.0 |
| MRPS9 | 235.0 |
| MRPS31 | 236.0 |
| RMND1 | 242.0 |
| MPV17L2 | 245.0 |
| MRPS25 | 261.0 |
| MRPS35 | 268.0 |
| IARS2 | 269.0 |
| MRPS2 | 279.0 |
| RARS2 | 295.0 |
| GFM1 | 305.0 |
| MRPS18B | 317.0 |
| CHCHD1 | 323.0 |
| MRPS18C | 325.0 |
| NGRN | 327.0 |
| TRNT1 | 335.0 |
| UQCC2 | 343.0 |
| TRMT61B | 348.0 |
| NDUFA7 | 353.0 |
| MRPS10 | 365.0 |
| MRPL36 | 373.0 |
| MRPS26 | 380.0 |
| MRPS11 | 388.0 |
| FASTKD3 | 389.0 |
| SUPV3L1 | 390.0 |
| LRPPRC | 395.0 |
| MRPL45 | 424.0 |
| TRIT1 | 427.0 |
| MRPS28 | 429.0 |
| RPUSD4 | 434.0 |
| MRPL35 | 435.0 |
| WARS2 | 446.0 |
| MRPL20 | 452.0 |
| MRPL43 | 457.0 |
MITOCHONDRIAL TRANSLATION
| set | MITOCHONDRIAL TRANSLATION |
| setSize | 128 |
| pANOVA | 7.89e-05 |
| s.dist | -0.215 |
| p.adjustANOVA | 0.0437 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS16 | -511 |
| MRPL10 | -509 |
| MRPS27 | -505 |
| COA3 | -504 |
| AARS2 | -501 |
| GFM2 | -498 |
| MTG1 | -493 |
| MRPL30 | -492 |
| MRPL32 | -490 |
| MRPL54 | -488 |
| MRPL41 | -479 |
| MRPS17 | -476 |
| MRPL42 | -474 |
| MRPS22 | -465 |
| MRPL18 | -463 |
| C1QBP | -445 |
| TACO1 | -442 |
| MRPL44 | -438 |
| AURKAIP1 | -437 |
| MRPS24 | -435 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MRPS16 | -511 |
| MRPL10 | -509 |
| MRPS27 | -505 |
| COA3 | -504 |
| AARS2 | -501 |
| GFM2 | -498 |
| MTG1 | -493 |
| MRPL30 | -492 |
| MRPL32 | -490 |
| MRPL54 | -488 |
| MRPL41 | -479 |
| MRPS17 | -476 |
| MRPL42 | -474 |
| MRPS22 | -465 |
| MRPL18 | -463 |
| C1QBP | -445 |
| TACO1 | -442 |
| MRPL44 | -438 |
| AURKAIP1 | -437 |
| MRPS24 | -435 |
| MRPL33 | -430 |
| MRPS6 | -426 |
| TUFM | -425 |
| MTRF1 | -423 |
| MALSU1 | -422 |
| MRPL52 | -420 |
| MRPL49 | -418 |
| MRPL23 | -415 |
| MRPL12 | -408 |
| MRPL19 | -404 |
| MRPL50 | -401 |
| MRPL11 | -399 |
| MRPL47 | -395 |
| TRUB2 | -394 |
| MRPL34 | -378 |
| MTIF3 | -371 |
| MRPL48 | -370 |
| GATC | -366 |
| MRPL16 | -364 |
| MRPL4 | -347 |
| MRPL40 | -344 |
| MRPL2 | -337 |
| MRPL28 | -331 |
| MRPL3 | -325 |
| MRPL14 | -320 |
| MRPL57 | -319 |
| MRPL9 | -318 |
| MRPL24 | -309 |
| MRPL46 | -308 |
| MRPS30 | -304 |
| MRPL27 | -302 |
| FASTKD2 | -298 |
| MRPL58 | -291 |
| SHMT2 | -290 |
| CDK5RAP1 | -289 |
| MRPL21 | -283 |
| MRPL38 | -281 |
| MRPS34 | -260 |
| MRPL51 | -257 |
| MRPL55 | -246 |
| MRPL15 | -225 |
| MTG2 | -209 |
| GADD45GIP1 | -208 |
| MRPS12 | -205 |
| MRPS18A | -202 |
| MRPL22 | -199 |
| GATB | -197 |
| MRPL39 | -194 |
| TSFM | -191 |
| MRPL37 | -175 |
| MRPL53 | -167 |
| MRPL13 | -157 |
| YARS2 | -136 |
| MRPL1 | -133 |
| DAP3 | -126 |
| METTL8 | -122 |
| LARS2 | -64 |
| RPUSD3 | -63 |
| NSUN3 | -62 |
| EARS2 | -59 |
| MRPL17 | -57 |
| SARS2 | -26 |
| MRPS7 | 20 |
| TRMT10C | 37 |
| MRPS14 | 62 |
| MRPS5 | 68 |
| PTCD3 | 77 |
| MRPS33 | 78 |
| TARS2 | 89 |
| RCC1L | 98 |
| MTIF2 | 99 |
| MRPS15 | 104 |
| ALKBH1 | 122 |
| MTRF1L | 148 |
| GARS1 | 159 |
| QRSL1 | 190 |
| MRPS21 | 191 |
| DARS2 | 196 |
| MRPS23 | 199 |
| MRPS9 | 235 |
| MRPS31 | 236 |
| RMND1 | 242 |
| MPV17L2 | 245 |
| MRPS25 | 261 |
| MRPS35 | 268 |
| IARS2 | 269 |
| MRPS2 | 279 |
| RARS2 | 295 |
| GFM1 | 305 |
| MRPS18B | 317 |
| CHCHD1 | 323 |
| MRPS18C | 325 |
| NGRN | 327 |
| UQCC2 | 343 |
| NDUFA7 | 353 |
| MRPS10 | 365 |
| MRPL36 | 373 |
| MRPS26 | 380 |
| MRPS11 | 388 |
| FASTKD3 | 389 |
| LRPPRC | 395 |
| MRPL45 | 424 |
| MRPS28 | 429 |
| RPUSD4 | 434 |
| MRPL35 | 435 |
| WARS2 | 446 |
| MRPL20 | 452 |
| MRPL43 | 457 |
TRANSLATION
| set | TRANSLATION |
| setSize | 148 |
| pANOVA | 0.000137 |
| s.dist | -0.196 |
| p.adjustANOVA | 0.0506 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MRPS16 | -511 |
| MRPL10 | -509 |
| MRPS27 | -505 |
| COA3 | -504 |
| AARS2 | -501 |
| GFM2 | -498 |
| MTG1 | -493 |
| MRPL30 | -492 |
| MRPL32 | -490 |
| MRPL54 | -488 |
| MRPL41 | -479 |
| MRPS17 | -476 |
| MRPL42 | -474 |
| MRPS22 | -465 |
| MRPL18 | -463 |
| C1QBP | -445 |
| TACO1 | -442 |
| MRPL44 | -438 |
| AURKAIP1 | -437 |
| MRPS24 | -435 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MRPS16 | -511.0 |
| MRPL10 | -509.0 |
| MRPS27 | -505.0 |
| COA3 | -504.0 |
| AARS2 | -501.0 |
| GFM2 | -498.0 |
| MTG1 | -493.0 |
| MRPL30 | -492.0 |
| MRPL32 | -490.0 |
| MRPL54 | -488.0 |
| MRPL41 | -479.0 |
| MRPS17 | -476.0 |
| MRPL42 | -474.0 |
| MRPS22 | -465.0 |
| MRPL18 | -463.0 |
| C1QBP | -445.0 |
| TACO1 | -442.0 |
| MRPL44 | -438.0 |
| AURKAIP1 | -437.0 |
| MRPS24 | -435.0 |
| MRPL33 | -430.0 |
| MRPS6 | -426.0 |
| TUFM | -425.0 |
| MTRF1 | -423.0 |
| MALSU1 | -422.0 |
| MRPL52 | -420.0 |
| MRPL49 | -418.0 |
| MRPL23 | -415.0 |
| MRPL12 | -408.0 |
| MRPL19 | -404.0 |
| MRPL50 | -401.0 |
| MRPL11 | -399.0 |
| MRPL47 | -395.0 |
| TRUB2 | -394.0 |
| HARS2 | -390.0 |
| MRPL34 | -378.0 |
| MTIF3 | -371.0 |
| MRPL48 | -370.0 |
| GATC | -366.0 |
| MRPL16 | -364.0 |
| MRPL4 | -347.0 |
| MRPL40 | -344.0 |
| MRPL2 | -337.0 |
| MRPL28 | -331.0 |
| MRPL3 | -325.0 |
| MRPL14 | -320.0 |
| MRPL57 | -319.0 |
| MRPL9 | -318.0 |
| MRPL24 | -309.0 |
| MRPL46 | -308.0 |
| METTL17 | -307.0 |
| RIDA | -305.0 |
| MRPS30 | -304.0 |
| MRPL27 | -302.0 |
| FASTKD2 | -298.0 |
| MRPL58 | -291.0 |
| SHMT2 | -290.0 |
| CDK5RAP1 | -289.0 |
| MRPL21 | -283.0 |
| MTFMT | -282.0 |
| MRPL38 | -281.0 |
| VARS2 | -265.0 |
| MRPS34 | -260.0 |
| MRPL51 | -257.0 |
| MRRF | -247.0 |
| MRPL55 | -246.0 |
| MTRES1 | -234.0 |
| PTRH1 | -229.0 |
| MRPL15 | -225.0 |
| MTG2 | -209.0 |
| GADD45GIP1 | -208.0 |
| MRPS12 | -205.0 |
| MRPS18A | -202.0 |
| MRPL22 | -199.0 |
| GATB | -197.0 |
| MRPL39 | -194.0 |
| TSFM | -191.0 |
| MRPL37 | -175.0 |
| MRPL53 | -167.0 |
| MRPL13 | -157.0 |
| YARS2 | -136.0 |
| MRPL1 | -133.0 |
| DAP3 | -126.0 |
| METTL8 | -122.0 |
| KARS1 | -104.0 |
| TRAP1 | -100.0 |
| FARS2 | -66.0 |
| LARS2 | -64.0 |
| RPUSD3 | -63.0 |
| NSUN3 | -62.0 |
| EARS2 | -59.0 |
| MRPL17 | -57.0 |
| PARS2 | -38.0 |
| MARS2 | -29.0 |
| SARS2 | -26.0 |
| MRPS7 | 20.0 |
| TRMT10C | 37.0 |
| CARS2 | 52.0 |
| MRPS14 | 62.0 |
| MRPS5 | 68.0 |
| GUF1 | 69.5 |
| PTCD3 | 77.0 |
| MRPS33 | 78.0 |
| METTL5 | 87.0 |
| TARS2 | 89.0 |
| RCC1L | 98.0 |
| MTIF2 | 99.0 |
| MRPS15 | 104.0 |
| ALKBH1 | 122.0 |
| MTRF1L | 148.0 |
| GARS1 | 159.0 |
| QRSL1 | 190.0 |
| MRPS21 | 191.0 |
| DARS2 | 196.0 |
| MRPS23 | 199.0 |
| MRPS9 | 235.0 |
| MRPS31 | 236.0 |
| RMND1 | 242.0 |
| MPV17L2 | 245.0 |
| MRPS25 | 261.0 |
| MRPS35 | 268.0 |
| IARS2 | 269.0 |
| MRPS2 | 279.0 |
| RARS2 | 295.0 |
| GFM1 | 305.0 |
| MRPS18B | 317.0 |
| CHCHD1 | 323.0 |
| MRPS18C | 325.0 |
| NGRN | 327.0 |
| TRNT1 | 335.0 |
| UQCC2 | 343.0 |
| NDUFA7 | 353.0 |
| MRPS10 | 365.0 |
| MRPL36 | 373.0 |
| MRPS26 | 380.0 |
| MRPS11 | 388.0 |
| FASTKD3 | 389.0 |
| LRPPRC | 395.0 |
| NARS2 | 403.0 |
| FECH | 406.0 |
| MRPL45 | 424.0 |
| MRPS28 | 429.0 |
| RPUSD4 | 434.0 |
| MRPL35 | 435.0 |
| WARS2 | 446.0 |
| MRPL20 | 452.0 |
| MRPL43 | 457.0 |
| 460.0 |
ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS
| set | ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS |
| setSize | 319 |
| pANOVA | 0.000435 |
| s.dist | -0.138 |
| p.adjustANOVA | 0.12 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC25A39 | -514 |
| MRPS16 | -511 |
| MRPL10 | -509 |
| MRPS27 | -505 |
| COA3 | -504 |
| AARS2 | -501 |
| PNPO | -499 |
| GFM2 | -498 |
| NDUFB3 | -494 |
| MTG1 | -493 |
| MRPL30 | -492 |
| MRPL32 | -490 |
| MRPL54 | -488 |
| DGUOK | -487 |
| NDUFA2 | -486 |
| MRPL41 | -479 |
| MT-ND3 | -477 |
| MRPS17 | -476 |
| SDHC | -475 |
| MRPL42 | -474 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC25A39 | -514.0 |
| MRPS16 | -511.0 |
| MRPL10 | -509.0 |
| MRPS27 | -505.0 |
| COA3 | -504.0 |
| AARS2 | -501.0 |
| PNPO | -499.0 |
| GFM2 | -498.0 |
| NDUFB3 | -494.0 |
| MTG1 | -493.0 |
| MRPL30 | -492.0 |
| MRPL32 | -490.0 |
| MRPL54 | -488.0 |
| DGUOK | -487.0 |
| NDUFA2 | -486.0 |
| MRPL41 | -479.0 |
| MT-ND3 | -477.0 |
| MRPS17 | -476.0 |
| SDHC | -475.0 |
| MRPL42 | -474.0 |
| PYCR2 | -470.0 |
| NDUFB1 | -467.0 |
| MRPS22 | -465.0 |
| MRPL18 | -463.0 |
| ATP5ME | -462.0 |
| NDUFA9 | -456.0 |
| ATP5PB | -451.0 |
| NDUFB6 | -450.0 |
| DNAJC30 | -448.0 |
| C1QBP | -445.0 |
| TACO1 | -442.0 |
| SLC25A37 | -441.0 |
| MRPL44 | -438.0 |
| AURKAIP1 | -437.0 |
| MRPS24 | -435.0 |
| ACSF3 | -432.0 |
| ATP5IF1 | -431.0 |
| MRPL33 | -430.0 |
| MRPS6 | -426.0 |
| TUFM | -425.0 |
| NDUFA11 | -424.0 |
| MTRF1 | -423.0 |
| MALSU1 | -422.0 |
| MRPL52 | -420.0 |
| NDUFB9 | -419.0 |
| MRPL49 | -418.0 |
| MRPL23 | -415.0 |
| NUDT2 | -414.0 |
| ATP5PF | -410.0 |
| MRPL12 | -408.0 |
| GLUD1 | -407.0 |
| NDUFA5 | -406.0 |
| AGK | -405.0 |
| MRPL19 | -404.0 |
| MRPL50 | -401.0 |
| TMEM14C | -400.0 |
| MRPL11 | -399.0 |
| ATP5PD | -398.0 |
| MRPL47 | -395.0 |
| TRUB2 | -394.0 |
| HARS2 | -390.0 |
| ABAT | -384.0 |
| MRPL34 | -378.0 |
| MTIF3 | -371.0 |
| MRPL48 | -370.0 |
| NDUFA8 | -369.0 |
| ATP5PO | -368.0 |
| GATC | -366.0 |
| CPOX | -365.0 |
| MRPL16 | -364.0 |
| TSPO | -357.0 |
| FPGS | -355.0 |
| NDUFAB1 | -354.0 |
| SUCLA2 | -350.0 |
| MRPL4 | -347.0 |
| MRPL40 | -344.0 |
| PDHA1 | -343.0 |
| NDUFA13 | -342.0 |
| MRPL2 | -337.0 |
| ATP5F1B | -335.0 |
| MRPL28 | -331.0 |
| PPOX | -329.0 |
| MRPL3 | -325.0 |
| ATP5MG | -323.0 |
| ATP5MF | -322.0 |
| MRPL14 | -320.0 |
| MRPL57 | -319.0 |
| MRPL9 | -318.0 |
| ALAS1 | -317.0 |
| PDHB | -310.0 |
| MRPL24 | -309.0 |
| MRPL46 | -308.0 |
| METTL17 | -307.0 |
| RIDA | -305.0 |
| MRPS30 | -304.0 |
| NDUFS6 | -303.0 |
| MRPL27 | -302.0 |
| SLC25A15 | -300.0 |
| FASTKD2 | -298.0 |
| ATP5F1E | -293.0 |
| MRPL58 | -291.0 |
| SHMT2 | -290.0 |
| CDK5RAP1 | -289.0 |
| SLC25A19 | -285.0 |
| MRPL21 | -283.0 |
| MTFMT | -282.0 |
| MRPL38 | -281.0 |
| AK2 | -278.0 |
| ATP5F1A | -275.0 |
| VARS2 | -265.0 |
| SDHB | -264.0 |
| NDUFV1 | -262.0 |
| DMAC2L | -261.0 |
| MRPS34 | -260.0 |
| MRPL51 | -257.0 |
| NDUFA3 | -251.0 |
| MRRF | -247.0 |
| MRPL55 | -246.0 |
| CKMT1A | -245.0 |
| GLS2 | -242.0 |
| SIRT3 | -238.0 |
| MTRES1 | -234.0 |
| ATP5MC1 | -231.0 |
| PTRH1 | -229.0 |
| SDHD | -226.0 |
| MRPL15 | -225.0 |
| NDUFV2 | -220.0 |
| MTG2 | -209.0 |
| GADD45GIP1 | -208.0 |
| MRPS12 | -205.0 |
| MRPS18A | -202.0 |
| ATP5F1C | -200.0 |
| MRPL22 | -199.0 |
| GATB | -197.0 |
| MRPL39 | -194.0 |
| TSFM | -191.0 |
| AK4 | -190.0 |
| DLD | -185.0 |
| MRPL37 | -175.0 |
| PCBD2 | -174.0 |
| ABCB7 | -172.0 |
| ATP5F1D | -171.0 |
| ALDH2 | -170.0 |
| MRPL53 | -167.0 |
| NADK2 | -161.0 |
| MRPL13 | -157.0 |
| PDK1 | -155.0 |
| NFS1 | -152.0 |
| FXN | -151.0 |
| SPHK2 | -149.0 |
| CPS1 | -144.0 |
| STOML2 | -138.0 |
| YARS2 | -136.0 |
| MMUT | -135.0 |
| SDHA | -134.0 |
| MRPL1 | -133.0 |
| SLC25A1 | -129.0 |
| DAP3 | -126.0 |
| ACADM | -125.0 |
| DHODH | -124.0 |
| METTL8 | -122.0 |
| COASY | -112.0 |
| DLAT | -107.0 |
| DCAKD | -106.0 |
| NME3 | -105.0 |
| KARS1 | -104.0 |
| TRAP1 | -100.0 |
| GATM | -98.0 |
| ACSS1 | -96.0 |
| OAT | -92.0 |
| AASS | -84.0 |
| GLS | -81.0 |
| COX15 | -76.0 |
| NAGS | -74.0 |
| BCAT2 | -70.0 |
| FARS2 | -66.0 |
| LARS2 | -64.0 |
| RPUSD3 | -63.0 |
| NSUN3 | -62.0 |
| EARS2 | -59.0 |
| MRPL17 | -57.0 |
| ARG2 | -43.0 |
| TMLHE | -40.0 |
| PARS2 | -38.0 |
| MARS2 | -29.0 |
| SARS2 | -26.0 |
| ACAT1 | -25.0 |
| AK3 | -19.0 |
| PDHX | -16.0 |
| NME4 | -7.0 |
| GCDH | -3.0 |
| TK2 | 12.0 |
| PDK3 | 19.0 |
| MRPS7 | 20.0 |
| ACSL1 | 22.0 |
| DTYMK | 27.0 |
| RFK | 28.0 |
| SPR | 31.0 |
| QDPR | 36.0 |
| TRMT10C | 37.0 |
| ABCB10 | 39.0 |
| NAXD | 42.0 |
| CARS2 | 52.0 |
| HAGH | 55.0 |
| PANK2 | 57.0 |
| SLC25A38 | 61.0 |
| MRPS14 | 62.0 |
| FLAD1 | 64.0 |
| MRPS5 | 68.0 |
| GUF1 | 69.5 |
| PTCD3 | 77.0 |
| MRPS33 | 78.0 |
| MTHFD1L | 79.0 |
| METTL5 | 87.0 |
| TARS2 | 89.0 |
| MT-ND4 | 94.0 |
| ABCB6 | 96.0 |
| RCC1L | 98.0 |
| MTIF2 | 99.0 |
| MRPS15 | 104.0 |
| PARK7 | 115.0 |
| GOLPH3 | 121.0 |
| ALKBH1 | 122.0 |
| PAICS | 132.0 |
| CHPT1 | 134.0 |
| IBA57 | 144.0 |
| MTRF1L | 148.0 |
| ANTKMT | 154.0 |
| MOCS1 | 157.0 |
| CHDH | 158.0 |
| GARS1 | 159.0 |
| ACOT7 | 188.0 |
| QRSL1 | 190.0 |
| MRPS21 | 191.0 |
| DARS2 | 196.0 |
| DUT | 198.0 |
| MRPS23 | 199.0 |
| DHRS7B | 203.0 |
| NDUFS8 | 208.0 |
| ACLY | 211.0 |
| NDUFS4 | 217.0 |
| PDK2 | 220.0 |
| ACACA | 227.0 |
| NDUFS1 | 230.0 |
| MRPS9 | 235.0 |
| MRPS31 | 236.0 |
| NME6 | 238.0 |
| SPTLC2 | 239.0 |
| RMND1 | 242.0 |
| MPV17L2 | 245.0 |
| GUK1 | 253.0 |
| MT-ND5 | 260.0 |
| MRPS25 | 261.0 |
| ALDH9A1 | 264.0 |
| MRPS35 | 268.0 |
| IARS2 | 269.0 |
| SLC25A13 | 277.0 |
| MLYCD | 278.0 |
| MRPS2 | 279.0 |
| SDSL | 282.0 |
| NDUFA6 | 291.0 |
| RARS2 | 295.0 |
| ALDH7A1 | 299.0 |
| GFM1 | 305.0 |
| MPC2 | 306.0 |
| BCL2 | 307.0 |
| NDUFS7 | 310.0 |
| NDUFA12 | 315.0 |
| MRPS18B | 317.0 |
| MTHFS | 320.0 |
| CHCHD1 | 323.0 |
| MRPS18C | 325.0 |
| NGRN | 327.0 |
| TRNT1 | 335.0 |
| NDUFV3 | 337.0 |
| NDUFS5 | 342.0 |
| UQCC2 | 343.0 |
| DBI | 344.0 |
| NDUFA7 | 353.0 |
| NDUFS3 | 354.0 |
| MT-ND6 | 359.0 |
| HTD2 | 363.0 |
| MRPS10 | 365.0 |
| MRPL36 | 373.0 |
| COX11 | 374.0 |
| MT-ND2 | 375.0 |
| NDUFB8 | 376.0 |
| RSAD1 | 378.0 |
| MRPS26 | 380.0 |
| NDUFB7 | 384.0 |
| MRPS11 | 388.0 |
| FASTKD3 | 389.0 |
| LRPPRC | 395.0 |
| GOT2 | 399.0 |
| NARS2 | 403.0 |
| FECH | 406.0 |
| NDUFS2 | 407.0 |
| MT-ND1 | 412.0 |
| COX10 | 415.0 |
| PYCR1 | 423.0 |
| MRPL45 | 424.0 |
| MRPS28 | 429.0 |
| MT-ATP8 | 431.0 |
| MT-ATP6 | 432.0 |
| ALDH18A1 | 433.0 |
| RPUSD4 | 434.0 |
| MRPL35 | 435.0 |
| NDUFB5 | 436.0 |
| NDUFA10 | 439.0 |
| WARS2 | 446.0 |
| MRPL20 | 452.0 |
| NDUFC2 | 454.0 |
| NDUFB4 | 456.0 |
| MRPL43 | 457.0 |
| NDUFB10 | 458.0 |
| 460.0 | |
| ATPSCKMT | 464.0 |
| NDUFA1 | 465.0 |
| NDUFB11 | 467.0 |
PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE
| set | PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE |
| setSize | 12 |
| pANOVA | 0.0014 |
| s.dist | -0.535 |
| p.adjustANOVA | 0.29 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AGK | -405 |
| TIMM10 | -377 |
| TIMM9 | -372 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| TIMM13 | -327 |
| TIMM8A | -233 |
| TIMM29 | -148 |
| TIMM8B | -142 |
| TOMM70 | 10 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| AGK | -405 |
| TIMM10 | -377 |
| TIMM9 | -372 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| TIMM13 | -327 |
| TIMM8A | -233 |
| TIMM29 | -148 |
| TIMM8B | -142 |
| TOMM70 | 10 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE
| set | ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE |
| setSize | 64 |
| pANOVA | 0.00157 |
| s.dist | -0.236 |
| p.adjustANOVA | 0.29 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| TIMM13 | -327 |
| MIPEP | -316 |
| HSPD1 | -315 |
| BID | -295 |
| PARL | -263 |
| TIMM44 | -248 |
| COX18 | -236 |
| TIMM8A | -233 |
| BAX | -223 |
| PMPCA | -222 |
| DNLZ | -210 |
| PMPCB | -196 |
| IMMP2L | -189 |
| TMEM126A | -178 |
| TIMM29 | -148 |
| TIMM50 | -145 |
| TIMM8B | -142 |
| MAIP1 | -102 |
| PITRM1 | -88 |
| BCS1L | -61 |
| MTCH2 | -14 |
| MTERF4 | -2 |
| TOMM70 | 10 |
| MFN2 | 24 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| MTX1 | 84 |
| GOLPH3 | 121 |
| TOMM34 | 142 |
| BNIP3L | 165 |
| MAVS | 171 |
| MFF | 177 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| MTCH1 | 243 |
| TIMM17A | 263 |
| OXA1L | 368 |
| SAMM50 | 394 |
| FIS1 | 430 |
| TOMM7 | 462 |
| HTRA2 | 463 |
| GDAP1 | 466 |
PROTEIN TARGETING TO MITOCHONDRION
| set | PROTEIN TARGETING TO MITOCHONDRION |
| setSize | 54 |
| pANOVA | 0.00238 |
| s.dist | -0.245 |
| p.adjustANOVA | 0.377 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| TIMM13 | -327 |
| MIPEP | -316 |
| HSPD1 | -315 |
| BID | -295 |
| PARL | -263 |
| TIMM44 | -248 |
| TIMM8A | -233 |
| PMPCA | -222 |
| DNLZ | -210 |
| PMPCB | -196 |
| IMMP2L | -189 |
| TIMM29 | -148 |
| TIMM50 | -145 |
| TIMM8B | -142 |
| PITRM1 | -88 |
| MTCH2 | -14 |
| MTERF4 | -2 |
| TOMM70 | 10 |
| MFN2 | 24 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| MTX1 | 84 |
| TOMM34 | 142 |
| BNIP3L | 165 |
| MFF | 177 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| MTCH1 | 243 |
| TIMM17A | 263 |
| SAMM50 | 394 |
| FIS1 | 430 |
| TOMM7 | 462 |
| HTRA2 | 463 |
| GDAP1 | 466 |
NEGATIVE REGULATION OF PROGRAMMED CELL DEATH
| set | NEGATIVE REGULATION OF PROGRAMMED CELL DEATH |
| setSize | 65 |
| pANOVA | 0.00352 |
| s.dist | 0.216 |
| p.adjustANOVA | 0.463 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| HIGD1A | 451 |
| PRDX3 | 445 |
| PYCR1 | 423 |
| HSPA9 | 413 |
| PRELID1 | 408 |
| UNG | 400 |
| SUPV3L1 | 390 |
| YME1L1 | 366 |
| MPV17L | 357 |
| NDUFS3 | 354 |
| SLC25A5 | 345 |
| FTH1 | 340 |
| GHITM | 338 |
| BCL2 | 307 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| PPIF | 267 |
| CASP8 | 262 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463.0 |
| HIGD1A | 451.0 |
| PRDX3 | 445.0 |
| PYCR1 | 423.0 |
| HSPA9 | 413.0 |
| PRELID1 | 408.0 |
| UNG | 400.0 |
| SUPV3L1 | 390.0 |
| YME1L1 | 366.0 |
| MPV17L | 357.0 |
| NDUFS3 | 354.0 |
| SLC25A5 | 345.0 |
| FTH1 | 340.0 |
| GHITM | 338.0 |
| BCL2 | 307.0 |
| BAK1 | 274.0 |
| BCL2L2 | 272.0 |
| SLC25A4 | 270.0 |
| PPIF | 267.0 |
| CASP8 | 262.0 |
| VDAC1 | 250.0 |
| SOD2 | 247.0 |
| BOK | 214.0 |
| SOD1 | 207.0 |
| GPX4 | 206.0 |
| CAT | 200.0 |
| ARMC10 | 184.0 |
| HTATIP2 | 179.0 |
| BNIP3 | 169.0 |
| BNIP3L | 165.0 |
| SLC25A6 | 161.0 |
| MCL1 | 139.0 |
| NDUFAF4 | 137.0 |
| PRDX2 | 125.0 |
| ALKBH1 | 122.0 |
| GOLPH3 | 121.0 |
| GPAM | 120.0 |
| PARK7 | 115.0 |
| BCL2L1 | 114.0 |
| AIFM2 | 101.0 |
| FKBP8 | 71.5 |
| PTRH2 | 45.0 |
| MUTYH | 40.0 |
| GPX1 | 32.0 |
| NNT | -18.0 |
| ARG2 | -43.0 |
| TRAP1 | -100.0 |
| PRDX5 | -147.0 |
| FXN | -151.0 |
| SIRT5 | -168.0 |
| GFER | -217.0 |
| BAX | -223.0 |
| OXR1 | -259.0 |
| PARL | -263.0 |
| OPA1 | -269.0 |
| HIGD2A | -270.0 |
| BID | -295.0 |
| HSPD1 | -315.0 |
| NDUFA13 | -342.0 |
| ATAD3A | -345.0 |
| PHB2 | -389.0 |
| VDAC2 | -439.0 |
| ACAA2 | -458.0 |
| DNAJA3 | -484.0 |
| TRIAP1 | -503.0 |
PROTEIN TARGETING
| set | PROTEIN TARGETING |
| setSize | 60 |
| pANOVA | 0.00376 |
| s.dist | -0.223 |
| p.adjustANOVA | 0.463 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| TIMM13 | -327 |
| MIPEP | -316 |
| HSPD1 | -315 |
| SYNJ2BP | -301 |
| BID | -295 |
| PARL | -263 |
| TIMM44 | -248 |
| TIMM8A | -233 |
| PMPCA | -222 |
| DNLZ | -210 |
| PMPCB | -196 |
| IMMP2L | -189 |
| TIMM29 | -148 |
| TIMM50 | -145 |
| TIMM8B | -142 |
| PITRM1 | -88 |
| MTCH2 | -14 |
| MTERF4 | -2 |
| TOMM70 | 10 |
| MFN2 | 24 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| STOM | 49 |
| MTX1 | 84 |
| GOLPH3 | 121 |
| TOMM34 | 142 |
| BNIP3L | 165 |
| MFF | 177 |
| MIEF1 | 178 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| MTCH1 | 243 |
| TIMM17A | 263 |
| MIEF2 | 281 |
| SAMM50 | 394 |
| FIS1 | 430 |
| TOMM7 | 462 |
| HTRA2 | 463 |
| GDAP1 | 466 |
PROTEIN LOCALIZATION TO ORGANELLE
| set | PROTEIN LOCALIZATION TO ORGANELLE |
| setSize | 72 |
| pANOVA | 0.0049 |
| s.dist | -0.199 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| ARL2 | -421 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508.0 |
| VPS13D | -483.0 |
| PAM16 | -478.0 |
| DNAJC19 | -457.0 |
| GRPEL1 | -449.0 |
| ATP5IF1 | -431.0 |
| ARL2 | -421.0 |
| AIFM1 | -412.0 |
| AGK | -405.0 |
| MTX2 | -402.0 |
| CHCHD4 | -391.0 |
| PHB2 | -389.0 |
| TIMM10 | -377.0 |
| TOMM40L | -376.0 |
| TIMM9 | -372.0 |
| TOMM40 | -362.0 |
| ROMO1 | -360.0 |
| TIMM10B | -359.0 |
| TSPO | -357.0 |
| NDUFA13 | -342.0 |
| TIMM22 | -340.0 |
| GRPEL2 | -333.0 |
| TOMM22 | -328.0 |
| TIMM13 | -327.0 |
| MIPEP | -316.0 |
| HSPD1 | -315.0 |
| BID | -295.0 |
| PARL | -263.0 |
| TIMM44 | -248.0 |
| COX18 | -236.0 |
| TIMM8A | -233.0 |
| BAX | -223.0 |
| PMPCA | -222.0 |
| DNLZ | -210.0 |
| PMPCB | -196.0 |
| IMMP2L | -189.0 |
| CHCHD10 | -180.0 |
| TMEM126A | -178.0 |
| TIMM29 | -148.0 |
| TIMM50 | -145.0 |
| TIMM8B | -142.0 |
| MAIP1 | -102.0 |
| PITRM1 | -88.0 |
| BCS1L | -61.0 |
| MTCH2 | -14.0 |
| MTERF4 | -2.0 |
| TOMM70 | 10.0 |
| MFN2 | 24.0 |
| DNAJC15 | 34.0 |
| TOMM20 | 48.0 |
| FKBP8 | 71.5 |
| MTX1 | 84.0 |
| PARK7 | 115.0 |
| GOLPH3 | 121.0 |
| DNM1L | 126.0 |
| TOMM34 | 142.0 |
| MARCHF5 | 155.0 |
| BNIP3L | 165.0 |
| MAVS | 171.0 |
| PRKACA | 172.0 |
| MFF | 177.0 |
| TIMM17B | 181.0 |
| RAB5IF | 186.0 |
| TIMM23 | 192.0 |
| MTCH1 | 243.0 |
| TIMM17A | 263.0 |
| OXA1L | 368.0 |
| SAMM50 | 394.0 |
| FIS1 | 430.0 |
| TOMM7 | 462.0 |
| HTRA2 | 463.0 |
| GDAP1 | 466.0 |
PROTEIN TRANSMEMBRANE TRANSPORT
| set | PROTEIN TRANSMEMBRANE TRANSPORT |
| setSize | 24 |
| pANOVA | 0.00533 |
| s.dist | -0.332 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AIFM1 | -412 |
| CHCHD4 | -391 |
| TOMM40L | -376 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| HSPD1 | -315 |
| TIMM44 | -248 |
| DNLZ | -210 |
| TIMM50 | -145 |
| TOMM70 | 10 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| MCL1 | 139 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AIFM1 | -412 |
| CHCHD4 | -391 |
| TOMM40L | -376 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| HSPD1 | -315 |
| TIMM44 | -248 |
| DNLZ | -210 |
| TIMM50 | -145 |
| TOMM70 | 10 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| MCL1 | 139 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| TIMM17A | 263 |
| TOMM7 | 462 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS
| set | ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
| setSize | 54 |
| pANOVA | 0.00684 |
| s.dist | 0.218 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IDI1 | 441 |
| IDH2 | 417 |
| COQ3 | 409 |
| FECH | 406 |
| FDXR | 392 |
| MAOA | 372 |
| PNKD | 350 |
| LDHAL6B | 347 |
| IDH3G | 341 |
| BCL2 | 307 |
| IDH3B | 287 |
| MRS2 | 280 |
| AKR7A2 | 259 |
| HMGCS2 | 255 |
| IDH3A | 244 |
| SPTLC2 | 239 |
| AKR1B10 | 237 |
| ACAA1 | 234 |
| AMACR | 232 |
| SCP2 | 218 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IDI1 | 441 |
| IDH2 | 417 |
| COQ3 | 409 |
| FECH | 406 |
| FDXR | 392 |
| MAOA | 372 |
| PNKD | 350 |
| LDHAL6B | 347 |
| IDH3G | 341 |
| BCL2 | 307 |
| IDH3B | 287 |
| MRS2 | 280 |
| AKR7A2 | 259 |
| HMGCS2 | 255 |
| IDH3A | 244 |
| SPTLC2 | 239 |
| AKR1B10 | 237 |
| ACAA1 | 234 |
| AMACR | 232 |
| SCP2 | 218 |
| ACLY | 211 |
| SOD1 | 207 |
| CAT | 200 |
| DHRS4 | 197 |
| RDH14 | 193 |
| ALDH3A2 | 164 |
| LDHB | 123 |
| PARK7 | 115 |
| FDPS | 102 |
| HSD17B10 | 97 |
| ABCD3 | 88 |
| PANK2 | 57 |
| HAGH | 55 |
| QDPR | 36 |
| SPR | 31 |
| CYB5R3 | 9 |
| ACADVL | 3 |
| GPD2 | -27 |
| ALDH1B1 | -32 |
| CBR4 | -42 |
| ACO2 | -44 |
| COMT | -132 |
| SPHK2 | -149 |
| FDX1 | -169 |
| ALDH2 | -170 |
| PCBD2 | -174 |
| RDH13 | -182 |
| CYP27B1 | -273 |
| COQ2 | -297 |
| ABAT | -384 |
| OSBPL1A | -416 |
| ACAA2 | -458 |
| PNPO | -499 |
| PCK2 | -502 |
NEGATIVE REGULATION OF CATABOLIC PROCESS
| set | NEGATIVE REGULATION OF CATABOLIC PROCESS |
| setSize | 13 |
| pANOVA | 0.00732 |
| s.dist | 0.432 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| USP30 | 444 |
| SLIRP | 428 |
| LRPPRC | 395 |
| FMC1 | 377 |
| NOCT | 360 |
| BCL2 | 307 |
| POLDIP2 | 285 |
| NSUN2 | 223 |
| PRKACA | 172 |
| MCL1 | 139 |
| PARK7 | 115 |
| TSPO | -357 |
| LYPLA1 | -472 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| USP30 | 444 |
| SLIRP | 428 |
| LRPPRC | 395 |
| FMC1 | 377 |
| NOCT | 360 |
| BCL2 | 307 |
| POLDIP2 | 285 |
| NSUN2 | 223 |
| PRKACA | 172 |
| MCL1 | 139 |
| PARK7 | 115 |
| TSPO | -357 |
| LYPLA1 | -472 |
PROTEIN TRANSPORT
| set | PROTEIN TRANSPORT |
| setSize | 69 |
| pANOVA | 0.00768 |
| s.dist | -0.192 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PCK2 | -502 |
| HADH | -485 |
| VPS13D | -483 |
| PAM16 | -478 |
| LYPLA1 | -472 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AIFM1 | -412 |
| GLUD1 | -407 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| ABAT | -384 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508.0 |
| PCK2 | -502.0 |
| HADH | -485.0 |
| VPS13D | -483.0 |
| PAM16 | -478.0 |
| LYPLA1 | -472.0 |
| DNAJC19 | -457.0 |
| GRPEL1 | -449.0 |
| AIFM1 | -412.0 |
| GLUD1 | -407.0 |
| AGK | -405.0 |
| MTX2 | -402.0 |
| CHCHD4 | -391.0 |
| PHB2 | -389.0 |
| ABAT | -384.0 |
| TIMM10 | -377.0 |
| TOMM40L | -376.0 |
| TIMM9 | -372.0 |
| TOMM40 | -362.0 |
| ROMO1 | -360.0 |
| TIMM10B | -359.0 |
| NDUFA13 | -342.0 |
| TIMM22 | -340.0 |
| GRPEL2 | -333.0 |
| TOMM22 | -328.0 |
| TIMM13 | -327.0 |
| NDUFAF2 | -324.0 |
| HSPD1 | -315.0 |
| TIMM44 | -248.0 |
| SIRT3 | -238.0 |
| TIMM8A | -233.0 |
| DNLZ | -210.0 |
| SLC25A22 | -162.0 |
| TIMM29 | -148.0 |
| TIMM50 | -145.0 |
| TIMM8B | -142.0 |
| COMT | -132.0 |
| MCU | -71.0 |
| PREPL | -21.5 |
| MTCH2 | -14.0 |
| TOMM70 | 10.0 |
| RAB24 | 30.0 |
| DNAJC15 | 34.0 |
| CPT1A | 35.0 |
| TOMM20 | 48.0 |
| BAD | 63.0 |
| AHCYL1 | 66.0 |
| SNAP29 | 73.0 |
| MTX1 | 84.0 |
| SPIRE1 | 85.0 |
| PARK7 | 115.0 |
| GOLPH3 | 121.0 |
| DNM1L | 126.0 |
| MCL1 | 139.0 |
| STX17 | 160.0 |
| MAVS | 171.0 |
| PRKACA | 172.0 |
| TIMM17B | 181.0 |
| TIMM23 | 192.0 |
| MTCH1 | 243.0 |
| ARF5 | 248.0 |
| GUK1 | 253.0 |
| TIMM17A | 263.0 |
| MPC2 | 306.0 |
| UQCC2 | 343.0 |
| SAMM50 | 394.0 |
| MTX3 | 402.0 |
| HSPA9 | 413.0 |
| TOMM7 | 462.0 |
RESPONSE TO HYDROGEN PEROXIDE
| set | RESPONSE TO HYDROGEN PEROXIDE |
| setSize | 15 |
| pANOVA | 0.00779 |
| s.dist | 0.4 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| MT-ND6 | 359 |
| BCL2 | 307 |
| BAK1 | 274 |
| PPIF | 267 |
| MT-ND5 | 260 |
| SOD2 | 247 |
| CASP3 | 226 |
| SOD1 | 207 |
| CAT | 200 |
| BNIP3 | 169 |
| PARK7 | 115 |
| GPX1 | 32 |
| FXN | -151 |
| AIFM1 | -412 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| MT-ND6 | 359 |
| BCL2 | 307 |
| BAK1 | 274 |
| PPIF | 267 |
| MT-ND5 | 260 |
| SOD2 | 247 |
| CASP3 | 226 |
| SOD1 | 207 |
| CAT | 200 |
| BNIP3 | 169 |
| PARK7 | 115 |
| GPX1 | 32 |
| FXN | -151 |
| AIFM1 | -412 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY
| set | REGULATION OF APOPTOTIC SIGNALING PATHWAY |
| setSize | 38 |
| pANOVA | 0.00786 |
| s.dist | 0.254 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| FIS1 | 430 |
| PYCR1 | 423 |
| PRELID1 | 408 |
| MPV17L | 357 |
| NDUFS3 | 354 |
| SLC25A5 | 345 |
| GHITM | 338 |
| BCL2 | 307 |
| SEPTIN4 | 302 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| PPIF | 267 |
| PMAIP1 | 258 |
| SOD2 | 247 |
| BOK | 214 |
| SOD1 | 207 |
| ARMC10 | 184 |
| SLC25A6 | 161 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| FIS1 | 430 |
| PYCR1 | 423 |
| PRELID1 | 408 |
| MPV17L | 357 |
| NDUFS3 | 354 |
| SLC25A5 | 345 |
| GHITM | 338 |
| BCL2 | 307 |
| SEPTIN4 | 302 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| PPIF | 267 |
| PMAIP1 | 258 |
| SOD2 | 247 |
| BOK | 214 |
| SOD1 | 207 |
| ARMC10 | 184 |
| SLC25A6 | 161 |
| MCL1 | 139 |
| DNM1L | 126 |
| PRDX2 | 125 |
| PARK7 | 115 |
| BCL2L1 | 114 |
| BAD | 63 |
| GPX1 | 32 |
| PTPMT1 | -93 |
| TRAP1 | -100 |
| FXN | -151 |
| BAX | -223 |
| PARL | -263 |
| OPA1 | -269 |
| BID | -295 |
| NDUFA13 | -342 |
| VDAC2 | -439 |
| ACAA2 | -458 |
| TRIAP1 | -503 |
PROTEIN LOCALIZATION TO MITOCHONDRION
| set | PROTEIN LOCALIZATION TO MITOCHONDRION |
| setSize | 64 |
| pANOVA | 0.00793 |
| s.dist | -0.198 |
| p.adjustANOVA | 0.516 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| TSPO | -357 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508.0 |
| PAM16 | -478.0 |
| DNAJC19 | -457.0 |
| GRPEL1 | -449.0 |
| ATP5IF1 | -431.0 |
| AIFM1 | -412.0 |
| AGK | -405.0 |
| MTX2 | -402.0 |
| CHCHD4 | -391.0 |
| TIMM10 | -377.0 |
| TOMM40L | -376.0 |
| TIMM9 | -372.0 |
| TOMM40 | -362.0 |
| ROMO1 | -360.0 |
| TIMM10B | -359.0 |
| TSPO | -357.0 |
| NDUFA13 | -342.0 |
| TIMM22 | -340.0 |
| GRPEL2 | -333.0 |
| TOMM22 | -328.0 |
| TIMM13 | -327.0 |
| MIPEP | -316.0 |
| HSPD1 | -315.0 |
| BID | -295.0 |
| PARL | -263.0 |
| TIMM44 | -248.0 |
| COX18 | -236.0 |
| TIMM8A | -233.0 |
| BAX | -223.0 |
| PMPCA | -222.0 |
| DNLZ | -210.0 |
| PMPCB | -196.0 |
| IMMP2L | -189.0 |
| TMEM126A | -178.0 |
| TIMM29 | -148.0 |
| TIMM50 | -145.0 |
| TIMM8B | -142.0 |
| MAIP1 | -102.0 |
| PITRM1 | -88.0 |
| BCS1L | -61.0 |
| MTCH2 | -14.0 |
| MTERF4 | -2.0 |
| TOMM70 | 10.0 |
| MFN2 | 24.0 |
| DNAJC15 | 34.0 |
| TOMM20 | 48.0 |
| FKBP8 | 71.5 |
| MTX1 | 84.0 |
| DNM1L | 126.0 |
| TOMM34 | 142.0 |
| MARCHF5 | 155.0 |
| BNIP3L | 165.0 |
| MAVS | 171.0 |
| MFF | 177.0 |
| TIMM17B | 181.0 |
| TIMM23 | 192.0 |
| MTCH1 | 243.0 |
| TIMM17A | 263.0 |
| OXA1L | 368.0 |
| SAMM50 | 394.0 |
| FIS1 | 430.0 |
| TOMM7 | 462.0 |
| HTRA2 | 463.0 |
| GDAP1 | 466.0 |
PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE
| set | PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE |
| setSize | 21 |
| pANOVA | 0.00889 |
| s.dist | -0.333 |
| p.adjustANOVA | 0.524 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AIFM1 | -412 |
| CHCHD4 | -391 |
| TOMM40L | -376 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| GRPEL2 | -333 |
| HSPD1 | -315 |
| TIMM44 | -248 |
| DNLZ | -210 |
| TIMM50 | -145 |
| TOMM70 | 10 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| TIMM17A | 263 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AIFM1 | -412 |
| CHCHD4 | -391 |
| TOMM40L | -376 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| GRPEL2 | -333 |
| HSPD1 | -315 |
| TIMM44 | -248 |
| DNLZ | -210 |
| TIMM50 | -145 |
| TOMM70 | 10 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| TIMM17A | 263 |
| TOMM7 | 462 |
NITROGEN COMPOUND TRANSPORT
| set | NITROGEN COMPOUND TRANSPORT |
| setSize | 109 |
| pANOVA | 0.00901 |
| s.dist | -0.153 |
| p.adjustANOVA | 0.524 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC25A39 | -514 |
| TIMM21 | -508 |
| PCK2 | -502 |
| HADH | -485 |
| VPS13D | -483 |
| PAM16 | -478 |
| LYPLA1 | -472 |
| SLC25A32 | -466 |
| SLC25A42 | -464 |
| MRPL18 | -463 |
| DNAJC19 | -457 |
| SFXN1 | -454 |
| GRPEL1 | -449 |
| SLC25A26 | -429 |
| MGST1 | -417 |
| AIFM1 | -412 |
| GLUD1 | -407 |
| AGK | -405 |
| MTX2 | -402 |
| TMEM14C | -400 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC25A39 | -514.0 |
| TIMM21 | -508.0 |
| PCK2 | -502.0 |
| HADH | -485.0 |
| VPS13D | -483.0 |
| PAM16 | -478.0 |
| LYPLA1 | -472.0 |
| SLC25A32 | -466.0 |
| SLC25A42 | -464.0 |
| MRPL18 | -463.0 |
| DNAJC19 | -457.0 |
| SFXN1 | -454.0 |
| GRPEL1 | -449.0 |
| SLC25A26 | -429.0 |
| MGST1 | -417.0 |
| AIFM1 | -412.0 |
| GLUD1 | -407.0 |
| AGK | -405.0 |
| MTX2 | -402.0 |
| TMEM14C | -400.0 |
| CHCHD4 | -391.0 |
| PHB2 | -389.0 |
| ABAT | -384.0 |
| TIMM10 | -377.0 |
| TOMM40L | -376.0 |
| ABCB8 | -374.0 |
| TIMM9 | -372.0 |
| TOMM40 | -362.0 |
| ROMO1 | -360.0 |
| TIMM10B | -359.0 |
| NDUFA13 | -342.0 |
| TIMM22 | -340.0 |
| SLC25A20 | -334.0 |
| GRPEL2 | -333.0 |
| TOMM22 | -328.0 |
| TIMM13 | -327.0 |
| NDUFAF2 | -324.0 |
| HSPD1 | -315.0 |
| SLC25A15 | -300.0 |
| SLC25A19 | -285.0 |
| TIMM44 | -248.0 |
| SIRT3 | -238.0 |
| TIMM8A | -233.0 |
| SLC25A23 | -232.0 |
| SDHD | -226.0 |
| DNLZ | -210.0 |
| SLC25A51 | -188.0 |
| ABCB7 | -172.0 |
| SLC25A22 | -162.0 |
| SLC25A16 | -158.0 |
| SLC25A33 | -150.0 |
| TIMM29 | -148.0 |
| TIMM50 | -145.0 |
| TIMM8B | -142.0 |
| COMT | -132.0 |
| SFXN2 | -131.0 |
| SLC25A36 | -109.0 |
| VDAC3 | -103.0 |
| MCU | -71.0 |
| PREPL | -21.5 |
| MTCH2 | -14.0 |
| TOMM70 | 10.0 |
| SLC25A24 | 13.0 |
| PNPT1 | 16.0 |
| RAB24 | 30.0 |
| DNAJC15 | 34.0 |
| CPT1A | 35.0 |
| TOMM20 | 48.0 |
| SLC25A38 | 61.0 |
| BAD | 63.0 |
| AHCYL1 | 66.0 |
| SNAP29 | 73.0 |
| MTX1 | 84.0 |
| SPIRE1 | 85.0 |
| ABCB6 | 96.0 |
| PARK7 | 115.0 |
| GOLPH3 | 121.0 |
| DNM1L | 126.0 |
| SLC25A44 | 128.0 |
| MCL1 | 139.0 |
| ABCD1 | 141.0 |
| TST | 149.0 |
| STX17 | 160.0 |
| SLC25A6 | 161.0 |
| MAVS | 171.0 |
| PRKACA | 172.0 |
| TIMM17B | 181.0 |
| TIMM23 | 192.0 |
| SLC25A29 | 194.0 |
| NSUN2 | 223.0 |
| MTCH1 | 243.0 |
| ARF5 | 248.0 |
| GUK1 | 253.0 |
| TIMM17A | 263.0 |
| SLC25A4 | 270.0 |
| SLC25A12 | 273.0 |
| SLC25A13 | 277.0 |
| SLC25A40 | 290.0 |
| MPC2 | 306.0 |
| UQCC2 | 343.0 |
| SLC25A5 | 345.0 |
| SFXN3 | 361.0 |
| SLC25A25 | 382.0 |
| SAMM50 | 394.0 |
| LRPPRC | 395.0 |
| MTX3 | 402.0 |
| HSPA9 | 413.0 |
| SLC25A53 | 419.0 |
| TOMM7 | 462.0 |
2FE 2S CLUSTER ASSEMBLY
| set | 2FE 2S CLUSTER ASSEMBLY |
| setSize | 8 |
| pANOVA | 0.00971 |
| s.dist | -0.53 |
| p.adjustANOVA | 0.525 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LYRM4 | -491 |
| HSCB | -381 |
| NDUFAB1 | -354 |
| FDX2 | -321 |
| ISCU | -221 |
| GLRX5 | -181 |
| NFS1 | -152 |
| FXN | -151 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| LYRM4 | -491 |
| HSCB | -381 |
| NDUFAB1 | -354 |
| FDX2 | -321 |
| ISCU | -221 |
| GLRX5 | -181 |
| NFS1 | -152 |
| FXN | -151 |
REGULATION OF PROGRAMMED CELL DEATH
| set | REGULATION OF PROGRAMMED CELL DEATH |
| setSize | 88 |
| pANOVA | 0.00996 |
| s.dist | 0.166 |
| p.adjustANOVA | 0.525 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| HIGD1A | 451 |
| PRDX3 | 445 |
| FIS1 | 430 |
| PYCR1 | 423 |
| HSPA9 | 413 |
| PRELID1 | 408 |
| UNG | 400 |
| SUPV3L1 | 390 |
| YME1L1 | 366 |
| MPV17L | 357 |
| NDUFS3 | 354 |
| PLSCR3 | 349 |
| SLC25A5 | 345 |
| FTH1 | 340 |
| GHITM | 338 |
| BCL2 | 307 |
| SEPTIN4 | 302 |
| BAK1 | 274 |
| BCL2L2 | 272 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463.0 |
| HIGD1A | 451.0 |
| PRDX3 | 445.0 |
| FIS1 | 430.0 |
| PYCR1 | 423.0 |
| HSPA9 | 413.0 |
| PRELID1 | 408.0 |
| UNG | 400.0 |
| SUPV3L1 | 390.0 |
| YME1L1 | 366.0 |
| MPV17L | 357.0 |
| NDUFS3 | 354.0 |
| PLSCR3 | 349.0 |
| SLC25A5 | 345.0 |
| FTH1 | 340.0 |
| GHITM | 338.0 |
| BCL2 | 307.0 |
| SEPTIN4 | 302.0 |
| BAK1 | 274.0 |
| BCL2L2 | 272.0 |
| SLC25A4 | 270.0 |
| PPIF | 267.0 |
| CASP8 | 262.0 |
| PMAIP1 | 258.0 |
| VDAC1 | 250.0 |
| SOD2 | 247.0 |
| MTCH1 | 243.0 |
| CASP3 | 226.0 |
| BOK | 214.0 |
| SOD1 | 207.0 |
| GPX4 | 206.0 |
| CAT | 200.0 |
| ARMC10 | 184.0 |
| HTATIP2 | 179.0 |
| APEX1 | 173.0 |
| BNIP3 | 169.0 |
| BNIP3L | 165.0 |
| SLC25A6 | 161.0 |
| MCL1 | 139.0 |
| NDUFAF4 | 137.0 |
| DNM1L | 126.0 |
| PRDX2 | 125.0 |
| ALKBH1 | 122.0 |
| GOLPH3 | 121.0 |
| GPAM | 120.0 |
| PARK7 | 115.0 |
| BCL2L1 | 114.0 |
| AIFM2 | 101.0 |
| ENDOG | 81.0 |
| FKBP8 | 71.5 |
| BAD | 63.0 |
| PTRH2 | 45.0 |
| MUTYH | 40.0 |
| GPX1 | 32.0 |
| MFN2 | 24.0 |
| TOMM70 | 10.0 |
| BCL2L13 | 4.0 |
| MTCH2 | -14.0 |
| NNT | -18.0 |
| ARG2 | -43.0 |
| PTPMT1 | -93.0 |
| TRAP1 | -100.0 |
| PRDX5 | -147.0 |
| SPHK2 | -149.0 |
| FXN | -151.0 |
| SIRT5 | -168.0 |
| DIABLO | -203.0 |
| GFER | -217.0 |
| BAX | -223.0 |
| GLS2 | -242.0 |
| OXR1 | -259.0 |
| PARL | -263.0 |
| OPA1 | -269.0 |
| HIGD2A | -270.0 |
| BID | -295.0 |
| OMA1 | -311.0 |
| HSPD1 | -315.0 |
| NDUFA13 | -342.0 |
| ATAD3A | -345.0 |
| TSPO | -357.0 |
| PHB2 | -389.0 |
| AIFM1 | -412.0 |
| VDAC2 | -439.0 |
| C1QBP | -445.0 |
| ACAA2 | -458.0 |
| DNAJA3 | -484.0 |
| TRIAP1 | -503.0 |
| FAM162A | -506.0 |
RESPONSE TO REACTIVE OXYGEN SPECIES
| set | RESPONSE TO REACTIVE OXYGEN SPECIES |
| setSize | 24 |
| pANOVA | 0.0117 |
| s.dist | 0.301 |
| p.adjustANOVA | 0.561 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| MPV17 | 443 |
| GLRX2 | 371 |
| MT-ND6 | 359 |
| BCL2 | 307 |
| BAK1 | 274 |
| PPIF | 267 |
| MT-ND5 | 260 |
| SOD2 | 247 |
| CASP3 | 226 |
| PDK2 | 220 |
| SOD1 | 207 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| PARK7 | 115 |
| GPX1 | 32 |
| TRAP1 | -100 |
| PRDX5 | -147 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| MPV17 | 443 |
| GLRX2 | 371 |
| MT-ND6 | 359 |
| BCL2 | 307 |
| BAK1 | 274 |
| PPIF | 267 |
| MT-ND5 | 260 |
| SOD2 | 247 |
| CASP3 | 226 |
| PDK2 | 220 |
| SOD1 | 207 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| PARK7 | 115 |
| GPX1 | 32 |
| TRAP1 | -100 |
| PRDX5 | -147 |
| FXN | -151 |
| COA8 | -338 |
| ROMO1 | -360 |
| AIFM1 | -412 |
DETOXIFICATION
| set | DETOXIFICATION |
| setSize | 24 |
| pANOVA | 0.0117 |
| s.dist | 0.301 |
| p.adjustANOVA | 0.561 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| GSTZ1 | 418 |
| MGST3 | 397 |
| SOD2 | 247 |
| AKR1B10 | 237 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| AIFM2 | 101 |
| ABCB6 | 96 |
| MTARC2 | 90 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| GSTZ1 | 418 |
| MGST3 | 397 |
| SOD2 | 247 |
| AKR1B10 | 237 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| AIFM2 | 101 |
| ABCB6 | 96 |
| MTARC2 | 90 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
| NNT | -18 |
| PRXL2A | -97 |
| PRDX5 | -147 |
| MGST1 | -417 |
RESPONSE TO TOXIC SUBSTANCE
| set | RESPONSE TO TOXIC SUBSTANCE |
| setSize | 36 |
| pANOVA | 0.0124 |
| s.dist | 0.245 |
| p.adjustANOVA | 0.572 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| PRDX3 | 445 |
| GSTZ1 | 418 |
| FECH | 406 |
| MGST3 | 397 |
| BCL2 | 307 |
| BAK1 | 274 |
| SOD2 | 247 |
| AKR1B10 | 237 |
| SOD1 | 207 |
| GPX4 | 206 |
| MT-CYB | 202 |
| CAT | 200 |
| MPST | 150 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| PRDX3 | 445 |
| GSTZ1 | 418 |
| FECH | 406 |
| MGST3 | 397 |
| BCL2 | 307 |
| BAK1 | 274 |
| SOD2 | 247 |
| AKR1B10 | 237 |
| SOD1 | 207 |
| GPX4 | 206 |
| MT-CYB | 202 |
| CAT | 200 |
| MPST | 150 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| AIFM2 | 101 |
| ABCB6 | 96 |
| MTARC2 | 90 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
| NNT | -18 |
| PRXL2A | -97 |
| COMT | -132 |
| CPS1 | -144 |
| PRDX5 | -147 |
| GFER | -217 |
| BAX | -223 |
| BPHL | -241 |
| AIFM1 | -412 |
| MGST1 | -417 |
CELLULAR KETONE METABOLIC PROCESS
| set | CELLULAR KETONE METABOLIC PROCESS |
| setSize | 38 |
| pANOVA | 0.0164 |
| s.dist | 0.229 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| COQ3 | 409 |
| COQ6 | 401 |
| GOT2 | 399 |
| CBR3 | 362 |
| COQ7 | 355 |
| PNKD | 350 |
| ADCK2 | 297 |
| MLYCD | 278 |
| AKR7A2 | 259 |
| AKR1B10 | 237 |
| PDK2 | 220 |
| DHRS4 | 197 |
| PDSS2 | 189 |
| COQ9 | 185 |
| COQ5 | 146 |
| ABCD1 | 141 |
| PARK7 | 115 |
| KYAT3 | 106 |
| AIFM2 | 101 |
| HSD17B10 | 97 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| COQ3 | 409 |
| COQ6 | 401 |
| GOT2 | 399 |
| CBR3 | 362 |
| COQ7 | 355 |
| PNKD | 350 |
| ADCK2 | 297 |
| MLYCD | 278 |
| AKR7A2 | 259 |
| AKR1B10 | 237 |
| PDK2 | 220 |
| DHRS4 | 197 |
| PDSS2 | 189 |
| COQ9 | 185 |
| COQ5 | 146 |
| ABCD1 | 141 |
| PARK7 | 115 |
| KYAT3 | 106 |
| AIFM2 | 101 |
| HSD17B10 | 97 |
| PANK2 | 57 |
| HAGH | 55 |
| COQ8A | 53 |
| PDSS1 | 51 |
| CPT1A | 35 |
| PDK3 | 19 |
| PPTC7 | 18 |
| ACADVL | 3 |
| GPD2 | -27 |
| CBR4 | -42 |
| COQ8B | -86 |
| BCKDK | -94 |
| PDK1 | -155 |
| SIRT5 | -168 |
| RTN4IP1 | -243 |
| COQ2 | -297 |
| OXCT1 | -349 |
| NDUFA9 | -456 |
REGULATION OF CELLULAR CATABOLIC PROCESS
| set | REGULATION OF CELLULAR CATABOLIC PROCESS |
| setSize | 29 |
| pANOVA | 0.0179 |
| s.dist | 0.258 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| USP30 | 444 |
| SLC25A5 | 345 |
| BCL2 | 307 |
| POLDIP2 | 285 |
| MLYCD | 278 |
| SLC25A4 | 270 |
| VDAC1 | 250 |
| SPTLC2 | 239 |
| CASP3 | 226 |
| BOK | 214 |
| PRKACA | 172 |
| BNIP3 | 169 |
| NRDC | 168 |
| BNIP3L | 165 |
| ABCD1 | 141 |
| MCL1 | 139 |
| DNM1L | 126 |
| PARK7 | 115 |
| ENDOG | 81 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463.0 |
| USP30 | 444.0 |
| SLC25A5 | 345.0 |
| BCL2 | 307.0 |
| POLDIP2 | 285.0 |
| MLYCD | 278.0 |
| SLC25A4 | 270.0 |
| VDAC1 | 250.0 |
| SPTLC2 | 239.0 |
| CASP3 | 226.0 |
| BOK | 214.0 |
| PRKACA | 172.0 |
| BNIP3 | 169.0 |
| NRDC | 168.0 |
| BNIP3L | 165.0 |
| ABCD1 | 141.0 |
| MCL1 | 139.0 |
| DNM1L | 126.0 |
| PARK7 | 115.0 |
| ENDOG | 81.0 |
| FKBP8 | 71.5 |
| BAD | 63.0 |
| CPT1A | 35.0 |
| NNT | -18.0 |
| PARL | -263.0 |
| CISD1 | -296.0 |
| TSPO | -357.0 |
| LYPLA1 | -472.0 |
| VPS13D | -483.0 |
MITOCHONDRIAL TRANSCRIPTION
| set | MITOCHONDRIAL TRANSCRIPTION |
| setSize | 13 |
| pANOVA | 0.0192 |
| s.dist | -0.377 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLRMT | -507 |
| MTERF1 | -440 |
| MRPL12 | -408 |
| TFAM | -299 |
| TEFM | -271 |
| MTRES1 | -234 |
| TFB1M | -201 |
| CHCHD10 | -180 |
| SLC25A33 | -150 |
| MTERF3 | -65 |
| MTERF4 | -2 |
| TWNK | 33 |
| TFB2M | 41 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| POLRMT | -507 |
| MTERF1 | -440 |
| MRPL12 | -408 |
| TFAM | -299 |
| TEFM | -271 |
| MTRES1 | -234 |
| TFB1M | -201 |
| CHCHD10 | -180 |
| SLC25A33 | -150 |
| MTERF3 | -65 |
| MTERF4 | -2 |
| TWNK | 33 |
| TFB2M | 41 |
RESPONSE TO INORGANIC SUBSTANCE
| set | RESPONSE TO INORGANIC SUBSTANCE |
| setSize | 38 |
| pANOVA | 0.0192 |
| s.dist | 0.224 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| FECH | 406 |
| GLRX2 | 371 |
| MT-ND6 | 359 |
| MT-CO1 | 328 |
| BCL2 | 307 |
| SLC25A13 | 277 |
| BAK1 | 274 |
| SLC25A12 | 273 |
| PPIF | 267 |
| CASP8 | 262 |
| MT-ND5 | 260 |
| HMGCS2 | 255 |
| SOD2 | 247 |
| CASP3 | 226 |
| SOD1 | 207 |
| MT-CYB | 202 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| FECH | 406 |
| GLRX2 | 371 |
| MT-ND6 | 359 |
| MT-CO1 | 328 |
| BCL2 | 307 |
| SLC25A13 | 277 |
| BAK1 | 274 |
| SLC25A12 | 273 |
| PPIF | 267 |
| CASP8 | 262 |
| MT-ND5 | 260 |
| HMGCS2 | 255 |
| SOD2 | 247 |
| CASP3 | 226 |
| SOD1 | 207 |
| MT-CYB | 202 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| PARK7 | 115 |
| ABCB6 | 96 |
| AHCYL1 | 66 |
| GPX1 | 32 |
| DTYMK | 27 |
| SLC25A24 | 13 |
| D2HGDH | -53 |
| COMT | -132 |
| CPS1 | -144 |
| FXN | -151 |
| ATP5F1D | -171 |
| SLC25A23 | -232 |
| ATP5F1A | -275 |
| TSPO | -357 |
| ABAT | -384 |
| AIFM1 | -412 |
| SLC25A39 | -514 |
CELLULAR RESPONSE TO TOXIC SUBSTANCE
| set | CELLULAR RESPONSE TO TOXIC SUBSTANCE |
| setSize | 25 |
| pANOVA | 0.0196 |
| s.dist | 0.273 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| GSTZ1 | 418 |
| MGST3 | 397 |
| SOD2 | 247 |
| AKR1B10 | 237 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| AIFM2 | 101 |
| ABCB6 | 96 |
| MTARC2 | 90 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| GSTZ1 | 418 |
| MGST3 | 397 |
| SOD2 | 247 |
| AKR1B10 | 237 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| AIFM2 | 101 |
| ABCB6 | 96 |
| MTARC2 | 90 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
| NNT | -18 |
| PRXL2A | -97 |
| PRDX5 | -147 |
| GFER | -217 |
| MGST1 | -417 |
APOPTOTIC SIGNALING PATHWAY
| set | APOPTOTIC SIGNALING PATHWAY |
| setSize | 60 |
| pANOVA | 0.0226 |
| s.dist | 0.175 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| FIS1 | 430 |
| PYCR1 | 423 |
| PRELID1 | 408 |
| RHOT1 | 404 |
| MPV17L | 357 |
| NDUFS3 | 354 |
| PLSCR3 | 349 |
| SLC25A5 | 345 |
| GHITM | 338 |
| BCL2 | 307 |
| SEPTIN4 | 302 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| PPIF | 267 |
| CASP8 | 262 |
| PMAIP1 | 258 |
| CYCS | 251 |
| SOD2 | 247 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| FIS1 | 430 |
| PYCR1 | 423 |
| PRELID1 | 408 |
| RHOT1 | 404 |
| MPV17L | 357 |
| NDUFS3 | 354 |
| PLSCR3 | 349 |
| SLC25A5 | 345 |
| GHITM | 338 |
| BCL2 | 307 |
| SEPTIN4 | 302 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| PPIF | 267 |
| CASP8 | 262 |
| PMAIP1 | 258 |
| CYCS | 251 |
| SOD2 | 247 |
| CASP3 | 226 |
| PDK2 | 220 |
| BOK | 214 |
| SOD1 | 207 |
| MUL1 | 187 |
| ARMC10 | 184 |
| MFF | 177 |
| HINT1 | 170 |
| BNIP3 | 169 |
| BNIP3L | 165 |
| SLC25A6 | 161 |
| MCL1 | 139 |
| DNM1L | 126 |
| PRDX2 | 125 |
| PARK7 | 115 |
| BCL2L1 | 114 |
| BAD | 63 |
| RHOT2 | 59 |
| GPX1 | 32 |
| PTPMT1 | -93 |
| TRAP1 | -100 |
| DAP3 | -126 |
| TIMM50 | -145 |
| FXN | -151 |
| PDK1 | -155 |
| CHCHD10 | -180 |
| DIABLO | -203 |
| BAX | -223 |
| PARL | -263 |
| OPA1 | -269 |
| BID | -295 |
| COA8 | -338 |
| NDUFA13 | -342 |
| FASTK | -361 |
| AIFM1 | -412 |
| ATP5IF1 | -431 |
| VDAC2 | -439 |
| ACAA2 | -458 |
| TRIAP1 | -503 |
| FAM162A | -506 |
RESPONSE TO OXIDATIVE STRESS
| set | RESPONSE TO OXIDATIVE STRESS |
| setSize | 60 |
| pANOVA | 0.0227 |
| s.dist | 0.175 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| NDUFB4 | 456 |
| PRDX3 | 445 |
| MPV17 | 443 |
| PYCR1 | 423 |
| MT-ND1 | 412 |
| NDUFS2 | 407 |
| ETFDH | 398 |
| GLRX2 | 371 |
| MT-ND6 | 359 |
| MT-CO1 | 328 |
| NDUFA12 | 315 |
| BCL2 | 307 |
| NDUFA6 | 291 |
| BAK1 | 274 |
| PPIF | 267 |
| MT-ND5 | 260 |
| SOD2 | 247 |
| LIAS | 241 |
| CASP3 | 226 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| NDUFB4 | 456 |
| PRDX3 | 445 |
| MPV17 | 443 |
| PYCR1 | 423 |
| MT-ND1 | 412 |
| NDUFS2 | 407 |
| ETFDH | 398 |
| GLRX2 | 371 |
| MT-ND6 | 359 |
| MT-CO1 | 328 |
| NDUFA12 | 315 |
| BCL2 | 307 |
| NDUFA6 | 291 |
| BAK1 | 274 |
| PPIF | 267 |
| MT-ND5 | 260 |
| SOD2 | 247 |
| LIAS | 241 |
| CASP3 | 226 |
| PDK2 | 220 |
| NDUFS8 | 208 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| BNIP3 | 169 |
| MSRB3 | 167 |
| ABCD1 | 141 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| CYB5B | 130 |
| PRDX2 | 125 |
| PARK7 | 115 |
| GSR | 110 |
| AIFM2 | 101 |
| PRDX4 | 80 |
| GPX1 | 32 |
| PNPT1 | 16 |
| SLC25A24 | 13 |
| MSRA | -4 |
| LONP1 | -68 |
| MSRB2 | -90 |
| TRAP1 | -100 |
| COMT | -132 |
| PRDX5 | -147 |
| FXN | -151 |
| OXR1 | -259 |
| SLC25A14 | -294 |
| COA8 | -338 |
| TXN2 | -356 |
| PNPLA8 | -358 |
| ROMO1 | -360 |
| CHCHD2 | -385 |
| THG1L | -387 |
| CHCHD4 | -391 |
| AIFM1 | -412 |
| NUDT2 | -414 |
| MGST1 | -417 |
| PYCR2 | -470 |
| MT-ND3 | -477 |
MITOCHONDRIAL FISSION
| set | MITOCHONDRIAL FISSION |
| setSize | 20 |
| pANOVA | 0.0234 |
| s.dist | 0.296 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GDAP1 | 466 |
| FIS1 | 430 |
| COX10 | 415 |
| MIEF2 | 281 |
| MTFR1 | 215 |
| MUL1 | 187 |
| MIEF1 | 178 |
| MFF | 177 |
| MTFR2 | 176 |
| BNIP3 | 169 |
| MARCHF5 | 155 |
| MTFR1L | 147 |
| DNM1L | 126 |
| MYO19 | 108 |
| SPIRE1 | 85 |
| SLC25A46 | 8 |
| MCU | -71 |
| PGAM5 | -140 |
| OPA1 | -269 |
| MTFP1 | -468 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GDAP1 | 466 |
| FIS1 | 430 |
| COX10 | 415 |
| MIEF2 | 281 |
| MTFR1 | 215 |
| MUL1 | 187 |
| MIEF1 | 178 |
| MFF | 177 |
| MTFR2 | 176 |
| BNIP3 | 169 |
| MARCHF5 | 155 |
| MTFR1L | 147 |
| DNM1L | 126 |
| MYO19 | 108 |
| SPIRE1 | 85 |
| SLC25A46 | 8 |
| MCU | -71 |
| PGAM5 | -140 |
| OPA1 | -269 |
| MTFP1 | -468 |
CELLULAR OXIDANT DETOXIFICATION
| set | CELLULAR OXIDANT DETOXIFICATION |
| setSize | 20 |
| pANOVA | 0.0236 |
| s.dist | 0.295 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| GSTZ1 | 418 |
| MGST3 | 397 |
| SOD2 | 247 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
| NNT | -18 |
| PRXL2A | -97 |
| PRDX5 | -147 |
| MGST1 | -417 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| GSTZ1 | 418 |
| MGST3 | 397 |
| SOD2 | 247 |
| SOD1 | 207 |
| GPX4 | 206 |
| CAT | 200 |
| PRDX6 | 138 |
| TXNRD2 | 135 |
| PRDX2 | 125 |
| GSTK1 | 118 |
| PARK7 | 115 |
| GSR | 110 |
| PRDX4 | 80 |
| TXNRD1 | 76 |
| GPX1 | 32 |
| NNT | -18 |
| PRXL2A | -97 |
| PRDX5 | -147 |
| MGST1 | -417 |
INTRACELLULAR PROTEIN TRANSPORT
| set | INTRACELLULAR PROTEIN TRANSPORT |
| setSize | 43 |
| pANOVA | 0.0243 |
| s.dist | -0.203 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| TIMM10 | -377 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| TIMM13 | -327 |
| TIMM44 | -248 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| VPS13D | -483 |
| PAM16 | -478 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| TIMM10 | -377 |
| TIMM9 | -372 |
| TOMM40 | -362 |
| ROMO1 | -360 |
| TIMM10B | -359 |
| NDUFA13 | -342 |
| TIMM22 | -340 |
| GRPEL2 | -333 |
| TOMM22 | -328 |
| TIMM13 | -327 |
| TIMM44 | -248 |
| TIMM8A | -233 |
| TIMM29 | -148 |
| TIMM50 | -145 |
| TIMM8B | -142 |
| MTCH2 | -14 |
| TOMM70 | 10 |
| RAB24 | 30 |
| DNAJC15 | 34 |
| TOMM20 | 48 |
| AHCYL1 | 66 |
| MTX1 | 84 |
| PARK7 | 115 |
| STX17 | 160 |
| MAVS | 171 |
| PRKACA | 172 |
| TIMM17B | 181 |
| TIMM23 | 192 |
| MTCH1 | 243 |
| ARF5 | 248 |
| TIMM17A | 263 |
| SAMM50 | 394 |
| HSPA9 | 413 |
| TOMM7 | 462 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
| set | REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
| setSize | 28 |
| pANOVA | 0.025 |
| s.dist | 0.248 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| PYCR1 | 423 |
| PRELID1 | 408 |
| BCL2 | 307 |
| BAK1 | 274 |
| PPIF | 267 |
| PMAIP1 | 258 |
| SOD2 | 247 |
| NDUFS1 | 230 |
| BOK | 214 |
| SOD1 | 207 |
| MUL1 | 187 |
| BNIP3 | 169 |
| BNIP3L | 165 |
| ABCD1 | 141 |
| PARK7 | 115 |
| BCL2L1 | 114 |
| MFN1 | 112 |
| BAD | 63 |
| PANK2 | 57 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRDX3 | 445 |
| PYCR1 | 423 |
| PRELID1 | 408 |
| BCL2 | 307 |
| BAK1 | 274 |
| PPIF | 267 |
| PMAIP1 | 258 |
| SOD2 | 247 |
| NDUFS1 | 230 |
| BOK | 214 |
| SOD1 | 207 |
| MUL1 | 187 |
| BNIP3 | 169 |
| BNIP3L | 165 |
| ABCD1 | 141 |
| PARK7 | 115 |
| BCL2L1 | 114 |
| MFN1 | 112 |
| BAD | 63 |
| PANK2 | 57 |
| NNT | -18 |
| SLC25A36 | -109 |
| SLC25A33 | -150 |
| PPA2 | -163 |
| BAX | -223 |
| BID | -295 |
| TSPO | -357 |
| ATP5IF1 | -431 |
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND
| set | SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
| setSize | 10 |
| pANOVA | 0.0262 |
| s.dist | 0.408 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| BCL2 | 307 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| BOK | 214 |
| MCL1 | 139 |
| PRDX2 | 125 |
| BCL2L1 | 114 |
| BAD | 63 |
| BAX | -223 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| BCL2 | 307 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| BOK | 214 |
| MCL1 | 139 |
| PRDX2 | 125 |
| BCL2L1 | 114 |
| BAD | 63 |
| BAX | -223 |
ISOPRENOID METABOLIC PROCESS
| set | ISOPRENOID METABOLIC PROCESS |
| setSize | 13 |
| pANOVA | 0.0266 |
| s.dist | 0.357 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| IDI1 | 441 |
| HMGCS2 | 255 |
| AKR1B10 | 237 |
| DHRS4 | 197 |
| RDH14 | 193 |
| PDSS2 | 189 |
| ALDH3A2 | 164 |
| PHYH | 133 |
| FDPS | 102 |
| PDSS1 | 51 |
| RDH13 | -182 |
| COQ2 | -297 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| IDI1 | 441 |
| HMGCS2 | 255 |
| AKR1B10 | 237 |
| DHRS4 | 197 |
| RDH14 | 193 |
| PDSS2 | 189 |
| ALDH3A2 | 164 |
| PHYH | 133 |
| FDPS | 102 |
| PDSS1 | 51 |
| RDH13 | -182 |
| COQ2 | -297 |
ESTABLISHMENT OF PROTEIN LOCALIZATION
| set | ESTABLISHMENT OF PROTEIN LOCALIZATION |
| setSize | 98 |
| pANOVA | 0.0268 |
| s.dist | -0.136 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508 |
| PCK2 | -502 |
| HADH | -485 |
| VPS13D | -483 |
| PAM16 | -478 |
| LYPLA1 | -472 |
| DNAJC19 | -457 |
| GRPEL1 | -449 |
| ATP5IF1 | -431 |
| AIFM1 | -412 |
| GLUD1 | -407 |
| AGK | -405 |
| MTX2 | -402 |
| CHCHD4 | -391 |
| PHB2 | -389 |
| ABAT | -384 |
| TIMM10 | -377 |
| TOMM40L | -376 |
| TIMM9 | -372 |
| TOMM40 | -362 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TIMM21 | -508.0 |
| PCK2 | -502.0 |
| HADH | -485.0 |
| VPS13D | -483.0 |
| PAM16 | -478.0 |
| LYPLA1 | -472.0 |
| DNAJC19 | -457.0 |
| GRPEL1 | -449.0 |
| ATP5IF1 | -431.0 |
| AIFM1 | -412.0 |
| GLUD1 | -407.0 |
| AGK | -405.0 |
| MTX2 | -402.0 |
| CHCHD4 | -391.0 |
| PHB2 | -389.0 |
| ABAT | -384.0 |
| TIMM10 | -377.0 |
| TOMM40L | -376.0 |
| TIMM9 | -372.0 |
| TOMM40 | -362.0 |
| ROMO1 | -360.0 |
| TIMM10B | -359.0 |
| TSPO | -357.0 |
| NDUFA13 | -342.0 |
| TIMM22 | -340.0 |
| GRPEL2 | -333.0 |
| TOMM22 | -328.0 |
| TIMM13 | -327.0 |
| NDUFAF2 | -324.0 |
| MIPEP | -316.0 |
| HSPD1 | -315.0 |
| SYNJ2BP | -301.0 |
| BID | -295.0 |
| PARL | -263.0 |
| TIMM44 | -248.0 |
| SIRT3 | -238.0 |
| COX18 | -236.0 |
| TIMM8A | -233.0 |
| BAX | -223.0 |
| PMPCA | -222.0 |
| DNLZ | -210.0 |
| PMPCB | -196.0 |
| IMMP2L | -189.0 |
| TMEM126A | -178.0 |
| SLC25A22 | -162.0 |
| TIMM29 | -148.0 |
| TIMM50 | -145.0 |
| TIMM8B | -142.0 |
| COMT | -132.0 |
| MAIP1 | -102.0 |
| PITRM1 | -88.0 |
| MCU | -71.0 |
| BCS1L | -61.0 |
| PREPL | -21.5 |
| MTCH2 | -14.0 |
| MTERF4 | -2.0 |
| ATAD1 | 5.0 |
| TOMM70 | 10.0 |
| MFN2 | 24.0 |
| RAB24 | 30.0 |
| DNAJC15 | 34.0 |
| CPT1A | 35.0 |
| TOMM20 | 48.0 |
| STOM | 49.0 |
| BAD | 63.0 |
| AHCYL1 | 66.0 |
| SNAP29 | 73.0 |
| MTX1 | 84.0 |
| SPIRE1 | 85.0 |
| PARK7 | 115.0 |
| GOLPH3 | 121.0 |
| DNM1L | 126.0 |
| MCL1 | 139.0 |
| TOMM34 | 142.0 |
| STX17 | 160.0 |
| BNIP3L | 165.0 |
| MAVS | 171.0 |
| PRKACA | 172.0 |
| MFF | 177.0 |
| MIEF1 | 178.0 |
| TIMM17B | 181.0 |
| RAB5IF | 186.0 |
| TIMM23 | 192.0 |
| MTCH1 | 243.0 |
| ARF5 | 248.0 |
| GUK1 | 253.0 |
| TIMM17A | 263.0 |
| MIEF2 | 281.0 |
| MPC2 | 306.0 |
| UQCC2 | 343.0 |
| OXA1L | 368.0 |
| SAMM50 | 394.0 |
| MTX3 | 402.0 |
| HSPA9 | 413.0 |
| FIS1 | 430.0 |
| TOMM7 | 462.0 |
| HTRA2 | 463.0 |
| GDAP1 | 466.0 |
RESPONSE TO HYPEROXIA
| set | RESPONSE TO HYPEROXIA |
| setSize | 6 |
| pANOVA | 0.0275 |
| s.dist | 0.521 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MT-ATP6 | 432 |
| SOD2 | 247 |
| MT-CYB | 202 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MT-ATP6 | 432 |
| SOD2 | 247 |
| MT-CYB | 202 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
RESPONSE TO INCREASED OXYGEN LEVELS
| set | RESPONSE TO INCREASED OXYGEN LEVELS |
| setSize | 6 |
| pANOVA | 0.0275 |
| s.dist | 0.521 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MT-ATP6 | 432 |
| SOD2 | 247 |
| MT-CYB | 202 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MT-ATP6 | 432 |
| SOD2 | 247 |
| MT-CYB | 202 |
| CAT | 200 |
| BNIP3 | 169 |
| TXNRD2 | 135 |
MICROTUBULE BASED MOVEMENT
| set | MICROTUBULE BASED MOVEMENT |
| setSize | 10 |
| pANOVA | 0.0282 |
| s.dist | 0.403 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLIRP | 428 |
| RHOT1 | 404 |
| LRPPRC | 395 |
| SEPTIN4 | 302 |
| SPG7 | 276 |
| SOD1 | 207 |
| RHOT2 | 59 |
| ARMCX3 | 23 |
| VDAC3 | -103 |
| OPA1 | -269 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLIRP | 428 |
| RHOT1 | 404 |
| LRPPRC | 395 |
| SEPTIN4 | 302 |
| SPG7 | 276 |
| SOD1 | 207 |
| RHOT2 | 59 |
| ARMCX3 | 23 |
| VDAC3 | -103 |
| OPA1 | -269 |
CELL DIVISION
| set | CELL DIVISION |
| setSize | 10 |
| pANOVA | 0.0283 |
| s.dist | 0.402 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| YME1L1 | 366 |
| SEPTIN4 | 302 |
| POLDIP2 | 285 |
| LIG3 | 233 |
| NSUN2 | 223 |
| CAT | 200 |
| BCL2L1 | 114 |
| MYO19 | 108 |
| SPIRE1 | 85 |
| TTC19 | -195 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| YME1L1 | 366 |
| SEPTIN4 | 302 |
| POLDIP2 | 285 |
| LIG3 | 233 |
| NSUN2 | 223 |
| CAT | 200 |
| BCL2L1 | 114 |
| MYO19 | 108 |
| SPIRE1 | 85 |
| TTC19 | -195 |
ISOCITRATE METABOLIC PROCESS
| set | ISOCITRATE METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.0312 |
| s.dist | 0.558 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IDH2 | 417 |
| IDH3G | 341 |
| IDH3B | 287 |
| IDH3A | 244 |
| ACO2 | -44 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IDH2 | 417 |
| IDH3G | 341 |
| IDH3B | 287 |
| IDH3A | 244 |
| ACO2 | -44 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS
| set | PHOSPHOLIPID BIOSYNTHETIC PROCESS |
| setSize | 19 |
| pANOVA | 0.0312 |
| s.dist | 0.288 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IDI1 | 441 |
| TAMM41 | 411 |
| PLSCR3 | 349 |
| CRLS1 | 296 |
| HMGCS2 | 255 |
| SPTLC2 | 239 |
| DHRS7B | 203 |
| AGPAT5 | 175 |
| SERAC1 | 151 |
| CHPT1 | 134 |
| AGPAT4 | 127 |
| GPAM | 120 |
| FDPS | 102 |
| HDHD5 | -50 |
| PTPMT1 | -93 |
| ACP6 | -117 |
| SPHK2 | -149 |
| PISD | -164 |
| PGS1 | -240 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IDI1 | 441 |
| TAMM41 | 411 |
| PLSCR3 | 349 |
| CRLS1 | 296 |
| HMGCS2 | 255 |
| SPTLC2 | 239 |
| DHRS7B | 203 |
| AGPAT5 | 175 |
| SERAC1 | 151 |
| CHPT1 | 134 |
| AGPAT4 | 127 |
| GPAM | 120 |
| FDPS | 102 |
| HDHD5 | -50 |
| PTPMT1 | -93 |
| ACP6 | -117 |
| SPHK2 | -149 |
| PISD | -164 |
| PGS1 | -240 |
REGULATION OF IMMUNE EFFECTOR PROCESS
| set | REGULATION OF IMMUNE EFFECTOR PROCESS |
| setSize | 8 |
| pANOVA | 0.0316 |
| s.dist | -0.441 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| C1QBP | -445 |
| PHB2 | -389 |
| HSPD1 | -315 |
| NLRX1 | -292 |
| OPA1 | -269 |
| GFER | -217 |
| SPHK2 | -149 |
| MAVS | 171 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| C1QBP | -445 |
| PHB2 | -389 |
| HSPD1 | -315 |
| NLRX1 | -292 |
| OPA1 | -269 |
| GFER | -217 |
| SPHK2 | -149 |
| MAVS | 171 |
REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
| set | REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY |
| setSize | 8 |
| pANOVA | 0.0319 |
| s.dist | 0.44 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| PYCR1 | 423 |
| SOD2 | 247 |
| SOD1 | 207 |
| MCL1 | 139 |
| PARK7 | 115 |
| GPX1 | 32 |
| TRAP1 | -100 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| PYCR1 | 423 |
| SOD2 | 247 |
| SOD1 | 207 |
| MCL1 | 139 |
| PARK7 | 115 |
| GPX1 | 32 |
| TRAP1 | -100 |
NEGATIVE REGULATION OF MEMBRANE PERMEABILITY
| set | NEGATIVE REGULATION OF MEMBRANE PERMEABILITY |
| setSize | 9 |
| pANOVA | 0.032 |
| s.dist | 0.415 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MPV17L | 357 |
| SLC25A5 | 345 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| BOK | 214 |
| BNIP3 | 169 |
| SLC25A6 | 161 |
| ACAA2 | -458 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MPV17L | 357 |
| SLC25A5 | 345 |
| BAK1 | 274 |
| BCL2L2 | 272 |
| SLC25A4 | 270 |
| BOK | 214 |
| BNIP3 | 169 |
| SLC25A6 | 161 |
| ACAA2 | -458 |
PROCESS UTILIZING AUTOPHAGIC MECHANISM
| set | PROCESS UTILIZING AUTOPHAGIC MECHANISM |
| setSize | 41 |
| pANOVA | 0.0323 |
| s.dist | 0.197 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| TOMM7 | 462 |
| USP30 | 444 |
| FIS1 | 430 |
| LRPPRC | 395 |
| SLC25A5 | 345 |
| BCL2 | 307 |
| POLDIP2 | 285 |
| SLC25A4 | 270 |
| VDAC1 | 250 |
| SPTLC2 | 239 |
| CASP3 | 226 |
| BOK | 214 |
| NBR1 | 212 |
| MUL1 | 187 |
| PRKACA | 172 |
| BNIP3 | 169 |
| BNIP3L | 165 |
| STX17 | 160 |
| MCL1 | 139 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463.0 |
| TOMM7 | 462.0 |
| USP30 | 444.0 |
| FIS1 | 430.0 |
| LRPPRC | 395.0 |
| SLC25A5 | 345.0 |
| BCL2 | 307.0 |
| POLDIP2 | 285.0 |
| SLC25A4 | 270.0 |
| VDAC1 | 250.0 |
| SPTLC2 | 239.0 |
| CASP3 | 226.0 |
| BOK | 214.0 |
| NBR1 | 212.0 |
| MUL1 | 187.0 |
| PRKACA | 172.0 |
| BNIP3 | 169.0 |
| BNIP3L | 165.0 |
| STX17 | 160.0 |
| MCL1 | 139.0 |
| DNM1L | 126.0 |
| PARK7 | 115.0 |
| ENDOG | 81.0 |
| SNAP29 | 73.0 |
| FKBP8 | 71.5 |
| BAD | 63.0 |
| RAB24 | 30.0 |
| FBXL4 | 29.0 |
| MFN2 | 24.0 |
| FUNDC1 | 7.0 |
| FUNDC2 | 2.0 |
| NIPSNAP1 | -5.0 |
| PGAM5 | -140.0 |
| PARL | -263.0 |
| CISD1 | -296.0 |
| TSPO | -357.0 |
| PHB2 | -389.0 |
| ATP5IF1 | -431.0 |
| LYPLA1 | -472.0 |
| NIPSNAP2 | -480.0 |
| VPS13D | -483.0 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
| set | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
| setSize | 12 |
| pANOVA | 0.033 |
| s.dist | 0.358 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| FIS1 | 430 |
| SEPTIN4 | 302 |
| PMAIP1 | 258 |
| BOK | 214 |
| SOD1 | 207 |
| MCL1 | 139 |
| DNM1L | 126 |
| PARK7 | 115 |
| BAD | 63 |
| BAX | -223 |
| BID | -295 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| FIS1 | 430 |
| SEPTIN4 | 302 |
| PMAIP1 | 258 |
| BOK | 214 |
| SOD1 | 207 |
| MCL1 | 139 |
| DNM1L | 126 |
| PARK7 | 115 |
| BAD | 63 |
| BAX | -223 |
| BID | -295 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS
| set | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
| setSize | 11 |
| pANOVA | 0.0334 |
| s.dist | 0.372 |
| p.adjustANOVA | 0.701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| PYCR1 | 423 |
| BCL2 | 307 |
| SOD2 | 247 |
| BOK | 214 |
| SOD1 | 207 |
| ALKBH1 | 122 |
| PARK7 | 115 |
| BCL2L1 | 114 |
| BAX | -223 |
| OXR1 | -259 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HTRA2 | 463 |
| PYCR1 | 423 |
| BCL2 | 307 |
| SOD2 | 247 |
| BOK | 214 |
| SOD1 | 207 |
| ALKBH1 | 122 |
| PARK7 | 115 |
| BCL2L1 | 114 |
| BAX | -223 |
| OXR1 | -259 |
Network diagram
Only used for one-dimensional analysis.
Here, the network diagram is used to depict the similarity between some of the top ranked gene sets. It makes separate charts for up and downregulated sets. It works best when prioritisation is done by effect size during the mitch_calc() step. By default, we only show the top 20 genes, but you can use the networkplot() command yourself with other options. See ?networkplot for more detail. There is an element of stochasticity with regard to the network projection, so if you see a lot of overlapping labels or labels getting cut off, you could repeat the chart generation until you get a nice layout. See ?networkplot for more detail.
Below the network diagrams, you will see lists of genes that make up the up and downregulated sets respectively. For upregulated genes the score needs to be >2 and for downregulated genes it needs to be < -2. This is to remove genes that have uninteresting differential expression and do not contribute enrichment.
if (d==1) {
networkplot(eres=res,FDR=0.05,n_sets=20)
network_genes(eres=res,FDR=0.05,n_sets=20)
} else {
message("Network charts only generated in one-dimensional analysis.")
}## Can't plot upregulated sets. Fewer than 5 found.## Can't plot downregulated sets. Fewer than 5 found.## No significant upregulated sets to show.## [[1]]
## [[1]]$`DOWN genesets.MITOCHONDRIAL GENE EXPRESSION`
## [1] "AARS2" "ALKBH1" "AURKAIP1" "C1QBP" "CDK5RAP1"
## [6] "CHCHD1" "CHCHD10" "COA3" "DAP3" "DARS2"
## [11] "EARS2" "ELAC2" "FASTK" "FASTKD1" "FASTKD2"
## [16] "FASTKD3" "FASTKD5" "GADD45GIP1" "GARS1" "GATB"
## [21] "GATC" "GFM1" "GFM2" "HSD17B10" "IARS2"
## [26] "LARS2" "LRPPRC" "MALSU1" "METTL8" "MPV17L2"
## [31] "MRPL1" "MRPL10" "MRPL11" "MRPL12" "MRPL13"
## [36] "MRPL14" "MRPL15" "MRPL16" "MRPL17" "MRPL18"
## [41] "MRPL19" "MRPL2" "MRPL21" "MRPL22" "MRPL23"
## [46] "MRPL24" "MRPL27" "MRPL28" "MRPL3" "MRPL30"
## [51] "MRPL32" "MRPL33" "MRPL34" "MRPL36" "MRPL37"
## [56] "MRPL38" "MRPL39" "MRPL4" "MRPL40" "MRPL41"
## [61] "MRPL42" "MRPL44" "MRPL46" "MRPL47" "MRPL48"
## [66] "MRPL49" "MRPL50" "MRPL51" "MRPL52" "MRPL53"
## [71] "MRPL54" "MRPL55" "MRPL57" "MRPL58" "MRPL9"
## [76] "MRPS10" "MRPS11" "MRPS12" "MRPS14" "MRPS15"
## [81] "MRPS16" "MRPS17" "MRPS18A" "MRPS18B" "MRPS18C"
## [86] "MRPS2" "MRPS21" "MRPS22" "MRPS23" "MRPS24"
## [91] "MRPS25" "MRPS26" "MRPS27" "MRPS30" "MRPS31"
## [96] "MRPS33" "MRPS34" "MRPS35" "MRPS5" "MRPS6"
## [101] "MRPS7" "MRPS9" "MTERF1" "MTERF3" "MTERF4"
## [106] "MTG1" "MTG2" "MTIF2" "MTIF3" "MTO1"
## [111] "MTPAP" "MTRES1" "MTRF1" "MTRF1L" "NDUFA7"
## [116] "NGRN" "NSUN3" "PNPT1" "POLRMT" "PRORP"
## [121] "PTCD3" "PUS1" "QRSL1" "RARS2" "RCC1L"
## [126] "RMND1" "RPUSD3" "SARS2" "SHMT2" "SLC25A33"
## [131] "SUPV3L1" "TACO1" "TARS2" "TBRG4" "TEFM"
## [136] "TFAM" "TFB1M" "TFB2M" "TRMT10C" "TRMT5"
## [141] "TRMT61B" "TRNT1" "TRUB2" "TSFM" "TUFM"
## [146] "TWNK" "UQCC2" "YARS2"
##
## [[1]]$`DOWN genesets.MITOCHONDRIAL TRANSLATION`
## [1] "AARS2" "ALKBH1" "AURKAIP1" "C1QBP" "CDK5RAP1"
## [6] "CHCHD1" "COA3" "DAP3" "DARS2" "EARS2"
## [11] "FASTKD2" "FASTKD3" "GADD45GIP1" "GARS1" "GATB"
## [16] "GATC" "GFM1" "GFM2" "IARS2" "LARS2"
## [21] "LRPPRC" "MALSU1" "METTL8" "MPV17L2" "MRPL1"
## [26] "MRPL10" "MRPL11" "MRPL12" "MRPL13" "MRPL14"
## [31] "MRPL15" "MRPL16" "MRPL17" "MRPL18" "MRPL19"
## [36] "MRPL2" "MRPL21" "MRPL22" "MRPL23" "MRPL24"
## [41] "MRPL27" "MRPL28" "MRPL3" "MRPL30" "MRPL32"
## [46] "MRPL33" "MRPL34" "MRPL36" "MRPL37" "MRPL38"
## [51] "MRPL39" "MRPL4" "MRPL40" "MRPL41" "MRPL42"
## [56] "MRPL44" "MRPL46" "MRPL47" "MRPL48" "MRPL49"
## [61] "MRPL50" "MRPL51" "MRPL52" "MRPL53" "MRPL54"
## [66] "MRPL55" "MRPL57" "MRPL58" "MRPL9" "MRPS10"
## [71] "MRPS11" "MRPS12" "MRPS14" "MRPS15" "MRPS16"
## [76] "MRPS17" "MRPS18A" "MRPS18B" "MRPS18C" "MRPS2"
## [81] "MRPS21" "MRPS22" "MRPS23" "MRPS24" "MRPS25"
## [86] "MRPS26" "MRPS27" "MRPS30" "MRPS31" "MRPS33"
## [91] "MRPS34" "MRPS35" "MRPS5" "MRPS6" "MRPS7"
## [96] "MRPS9" "MTG1" "MTG2" "MTIF2" "MTIF3"
## [101] "MTRF1" "MTRF1L" "NDUFA7" "NGRN" "NSUN3"
## [106] "PTCD3" "QRSL1" "RARS2" "RCC1L" "RMND1"
## [111] "RPUSD3" "SARS2" "SHMT2" "TACO1" "TARS2"
## [116] "TRMT10C" "TRUB2" "TSFM" "TUFM" "UQCC2"
## [121] "YARS2"Session information
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.6.0 (2026-04-24)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 24.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.26.so; LAPACK version 3.12.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] stats graphics grDevices utils datasets methods base
##
## other attached packages:
## [1] gtools_3.9.5 kableExtra_1.4.0 mitch_1.24.0
##
## loaded via a namespace (and not attached):
## [1] gtable_0.3.6 beeswarm_0.4.0 bslib_0.11.0
## [4] xfun_0.57 ggplot2_4.0.3 htmlwidgets_1.6.4
## [7] caTools_1.18.3 GGally_2.4.0 lattice_0.22-9
## [10] vctrs_0.7.3 tools_4.6.0 bitops_1.0-9
## [13] generics_0.1.4 parallel_4.6.0 tibble_3.3.1
## [16] pkgconfig_2.0.3 KernSmooth_2.23-26 RColorBrewer_1.1-3
## [19] S7_0.2.2 lifecycle_1.0.5 compiler_4.6.0
## [22] farver_2.1.2 stringr_1.6.0 textshaping_1.0.5
## [25] gplots_3.3.0 httpuv_1.6.17 sass_0.4.10
## [28] htmltools_0.5.9 yaml_2.3.12 jquerylib_0.1.4
## [31] later_1.4.8 pillar_1.11.1 tidyr_1.3.2
## [34] MASS_7.3-65 cachem_1.1.0 mime_0.13
## [37] ggstats_0.13.0 network_1.20.0 tidyselect_1.2.1
## [40] digest_0.6.39 stringi_1.8.7 dplyr_1.2.1
## [43] reshape2_1.4.5 purrr_1.2.2 fastmap_1.2.0
## [46] grid_4.6.0 cli_3.6.6 magrittr_2.0.5
## [49] dichromat_2.0-0.1 withr_3.0.2 scales_1.4.0
## [52] promises_1.5.0 rmarkdown_2.31 otel_0.2.0
## [55] gridExtra_2.3 coda_0.19-4.1 shiny_1.13.0
## [58] evaluate_1.0.5 knitr_1.51 viridisLite_0.4.3
## [61] rlang_1.2.0 Rcpp_1.1.1-1.1 xtable_1.8-8
## [64] glue_1.8.1 echarts4r_0.5.0 xml2_1.5.2
## [67] jsonlite_2.0.0 svglite_2.2.2 rstudioapi_0.18.0
## [70] R6_2.6.1 plyr_1.8.9 statnet.common_4.13.0
## [73] systemfonts_1.3.2END of report